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         Abstract 
HCO3- secretion plays a vital role in regulating the pH and mucus viscosity of airway 
surface liquid to facilitate airway mucociliary clearance of inhaled pathogen. In cystic 
fibrosis (CF), reduced HCO3- secretion contributes to defective mucociliary clearance 
which predisposes the lungs to bacterial infection. Calu-3 cells are used as a model of 
human submucosal gland serous cells which are involved in CFTR (cystic fibrosis 
transmembrane conductance regulator)-dependent HCO3- secretion, a process that 
appears to involve functional interactions with both apical and basolateral Cl-/HCO3- 
anion exchangers (AE), but through regulatory pathways that are not well understood. 
The aim of this thesis was to investigate the signalling mechanisms that regulate 
CFTR-dependent AE activity in Calu-3 cells.  
Under resting conditions, Calu-3 cells showed a DIDS-sensitive Cl- and HCO3--
dependent basolateral anion exchange activity consistent with AE2 (SLC4A2) 
expression. However, apical AE activity was not detected. Increasing cytosolic Ca2+, 
or removal of extracellular Ca2+, had no effect on basolateral AE activity. In contrast, 
lowering cytosolic Ca2+ with BAPTA-AM, or inhibiting calmodulin (CaM), reduced 
basolateral AE activity. Furthermore, an intact actin cytoskeleton, as well as active 
dynamin, were essential for maintaining basolateral AE activity, possibly via supply 
of new proteins to the basolateral membrane. Inhibiting CK2 or protein phosphatase 1 
(PP1) abolished basolateral AE activity, and CK2 inhibition was linked to CaM. This 
suggests that AE activity was maintained through a novel CaM-dependent mechanism 
involving phosphorylation/dephosphorylation by CK2/PP1.  In support of this, 
transient transfection of HEK293 cells with mouse AE2, with and without CK2 co-
transfection, clearly demonstrated CK2-dependent AE2 activity.  
Stimulation of Calu-3 cells with cAMP agonists both activated an apical anion 
exchanger via a PKA and Epac-dependent mechanism, and inhibited the basolateral 
anion exchanger, but through a PKA and Epac-independent mechanism. Blocking 
CFTR with GlyH-101 caused an apparent inhibition of apical AE activity, but 
addition of basolateral DIDS restored apical activity, suggesting that a basolateral 
HCO3- transporter was activated when CFTR was inhibited. Removal of extracellular 
Ca2+ partially reduced the cAMP-induced inhibition of the basolateral AE activity, but 
had no effect on cAMP-stimulated apical AE activity. Moreover, increasing cytosolic 
Ca2+, or lowering cytosolic Ca2+ with BAPTA-AM, markedly reduced cAMP-
stimulated apical AE activity, but it had no effect on cAMP-induced inhibition of the 
basolateral anion exchanger. Actin-cytoskeleton disruption had no effect on apical AE 
activity but dynamin inhibition caused a significant decrease. A similar decrease in 
apical AE activity was observed when CK2 was inhibited, but in contrast to the 
basolateral anion exchanger, this appeared to be via a CaM-independent mechanism. 
Inhibiting CK2, however, had no effect on the cAMP-induced inhibition of the 
basolateral AE activity, suggesting that CK2 regulation of Calu-3 anion exchangers is 
through cAMP-independent mechanisms.  
These findings provide new insights into the signalling pathways that regulate both 
the apical and basolateral anion exchangers in Calu-3 cells and help define their 
respective roles in airway HCO3- secretion. The results could potentially open up new 
avenues for modulating AE activity which could be beneficial in HCO3- secretory 
diseases such as CF. 
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Figure 4. 1: Cl- and HCO3- dependence of the basolateral Cl-/HCO3- AE in Calu-3 cells. (A) 
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Cl-/HCO3- anion exchanger. Plot of percent inhibition of the mean change in pHi caused by basolateral 
Cl- removal (B), and the rate of reacidification upon Cl- readdition (C) at different DIDS 
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transfected, HEK-293T cells, respectively. Summary data showing the effect of 25μM DIDS on mean 
alkalinisation in pHi in response to Cl- free solution (C) and the rate of reacidification upon Cl- 
readdition (D) in control and mAE2 transfected HEK-293T cells. Data are shown as Mean±SEM. C: 
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as Mean±SEM. B: *P<0.001 compared to DIDS 25μM and 0Cl-. C: *P<0.001 compared to DIDS 
25μM and P<0.001 compared 0Cl-, #P<0.01 compared to 0Cl-, n=3 for each condition, paired 
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mean alkalinisation in response to Cl- free solution (B), and the rate of reacidification upon Cl- 
readdition (C). Data are shown as Mean±SEM. P>0.05 no significant difference compared to control, 
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Figure 5. 11: Role of CFTR in HCO3- transport in transfected HEK-293T cells. HEK293T cells co-
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(AE2), #P<0.001 compared to (AE2+CFTR), †P<0.01compared to (CFTR). B: #P<0.01 compared to 
(AE2+CFTR), n=4 for (AE2), n=6 for (CFTR) and (CFTR+AE2), and n=5 for (CFTR) +GlyH-101.
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compared to control response. Data are shown as Mean±SEM. No significant difference (P>0.05) 
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presence of 25μM DIDS. Summary of the effect of BAPTA-AM (50µM) preincubation for 60 min, in 
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the rate of reacidification upon Cl- readdition (D). Data are shown as Mean±SEM. *P<0.05 compared 
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(10μM), on mAE2 activity, both the mean alkalinisation in pHi in response to Cl- free solution (B), 
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Chapter 1 Introduction 
1.1  HCO3- secretion by epithelial cells    
The secretion of bicarbonate (HCO3-) by epithelial cells is essential for 
maintaining the normal function of many epithelial tissues as HCO3- plays a 
major role in the regulation of both intracellular and extracellular pH (Durie, 
1989; Allen et al., 1993). Extracellular HCO3- is also important for many other 
epithelial functions. As HCO3- is a biological buffer, it plays an important role in 
the process of acid-base homeostasis by preventing metabolic and respiratory 
disease (Kellum, 2000). The pH of mucosal layers that line all epithelia is also 
buffered by HCO3- which can protect them from injury (Allen et al., 1993). 
HCO3- also plays a crucial role in the process of nutrient digestion and 
solubilisation of complex mixtures of protein, including digestive enzyme and 
mucin secreted by epithelial cells (Scratcherd and Case, 1973). Furthermore, 
HCO3- secretion by epithelial cells drives fluid secretion in many epithelial 
tissues, such as in the gastro-intestinal tract (GIT) and reproductive tracts (Hug 
et al., 2011). Recently, it has been demonstrated that the local HCO3- 
concentration, which controls the pH and HCO3- availability at the plasma 
membrane surface, plays a critical role in regulating the HCO3- transporters 
involved in fluid and HCO3- secretion (McKenna and Frost, 2014). Mutation in 
HCO3- transporters, such as the cystic fibrosis transmembrane conductance 
regulator (CFTR), Cl-/HCO3- anion exchangers (AEs) belonging to the SLC26 
and SLC4 families, as well as Na+-HCO3--cotransporters (NBCe1) (Lee et al., 
2012) lead to absence or altered HCO3- secretion and development of several 
diseases such as the cystic fibrosis (CF) (Yang et al., 2009; Quinton, 2010), 
pancreatitis (Lee et al., 2012; Maleth and Hegyi, 2014), congenital chloride 
diarrhoea, deafness and hypotension (Durie, 1989; Hoglund et al., 1996; 
Moseley et al., 1999; Taylor and Aswani, 2002; Wall, 2006; Wangemann et al., 
2007) and Sjogren’s syndrome (Almstahl and Wikstrom, 2003).  
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In the GIT, it has been shown that mammalian pancreatic ducts secrete HCO3- 
when stimulated by cAMP agonists such as secretin and forskolin, which  is 
critical for neutralizing the acidic chyme in the small intestine to provide the 
optimum conditions for  activation of pH-sensitive digestive enzymes  
(Scratcherd and Case, 1973; Ishiguro et al., 1996). In addition, HCO3- secretion 
by epithelial cells of the GIT plays an important role in the protection of the GI  
mucosa, and the presence of high amounts of HCO3-, together with gastric 
mucins in the stomach, provides a protective barrier for the gastroduodenal 
mucosa against gastric acid and pepsin (Flemstrom and Isenberg, 2001; Allen 
and Flemstrom, 2005). Furthermore, it has been found that there is cAMP-
dependent HCO3- secretion in the duodenum, jejunum and ileum of mice which 
is critically important to neutralize gastric acid and thereby protect the intestinal 
mucosa (Seidler et al., 1997; Seidler et al., 2001). HCO3- secretion in the GIT 
also plays a crucial role in mucus release, as HCO3- has a critical importance in 
expansion and solubilisation of secreted mucins to prevent the formation of 
aggregated mucus (Garcia et al., 2009). Furthermore, it has been demonstrated 
that reduced HCO3- secretion in CF leads to the secretion of aggregated and 
viscous mucus in affected organs (Chen et al., 2010). A recent study has shown 
a thick and less penetrable mucus secretion from CF mouse ileum, which 
adhered to the epithelium (Gustafsson et al., 2012), but importantly the defective 
properties of this secreted mucus were normalized by adding a high 
concentration of bicarbonate (100 mM).    
 
As shown in figure 1.1, the mucin glycoproteins inside the intracellular mucin 
granules are condensed and tightly packed together by the presence of high 
amounts of Ca2+. As mucin are secreted by exocytosis onto extracellular surface, 
HCO3- plays an essential role in chelation of these cations which causes 
expansion of the negatively charged mucins chain to form normal mucus (Garcia 
et al., 2009; Borowitz, 2015). A more recent study has shown that MUC5B, a 
mucin expressed by respiratory epithelia, bound to Ca2+ at its N-terminal D3-
domain and formed cross-links which play an essential role in MUC5B 
condensation and packing inside the secretary granules. The maximal cross-link 
formation is dependent on the presence of high calcium concentrations and low 
pH (5-6) in secretory granules. Thus, after MUC5B secretion from secretory 
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granules, the presence of HCO3- allows for efficient mucin expansion and 
secretion by uncoupling the cross-links between Ca2+ and MUC5B (Ridley et 
al., 2014). Furthermore, HCO3- can mimic the effect of EGTA as a Ca2+ 
chelator, to reduce the amount of free Ca2+ concentration bound to mucins, 
which enhances mucin swelling and hydration, thereby dissolving mucin 
aggregates and likely increasing its transportation (Chen et al., 2010).  
 
Human oesophageal submucosal glands have the ability to secrete sufficient 
amounts of HCO3- that is capable of neutralizing the remaining acid in the 
esophagous after bolus swallowing which comes near to the HCO3- output by 
salivary glands at rest (Meyers and Orlando, 1992).  Another critically important 
role for HCO3- is in the process of fertilisation. It has been shown that HCO3- is 
required for stimulation of sperm motility and spermatogenesis in Leydig cells, 
and sperm capacitation inside the female reproductive tract (Medina et al., 2003; 
Hess et al., 2005). Also, it has been reported that defects in CFTR-dependent 
HCO3- secretion leads to reduction in spermatogenesis and thereby azoospermia 
(Xu et al., 2011). 
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 Figure 1. 1: A Schematic diagram of the HCO3- dependent mechanism of 
extracellular mucin expansion and solubilisation from condensed mucin granules. 
Presence of HCO3- in the extracellular surface dissociates the bounded Ca2+ with the 
condensed mucin in granule and therefore rapidly expands the released mucin, and 
prevents the formation of abnormal mucus. Figure taken from (Borowitz, 2015). 
 
 
1.1.1 Mechanism of Bicarbonate secretion in epithelial tissues  
 
Although HCO3- secretion plays a critical role in the regulation of normal body 
function, it is still controversial how HCO3- secretion is actually achieved in 
many epithelial tissues, although CFTR appears to be a critical requirement. 
This may be because different epithelial tissues employ a different complement 
of transporters, and/or because the mechanism may also be dependent on the 
agonist employed (Seidler et al., 1997).  
The exocrine pancreas is probably the most thoroughly studied tissue, and 
pancreatic duct cells are capable of secreting several litres per day of a near 
isotonic NaHCO3 fluid known as pancreatic juice (Ishiguro et al., 2012). In the 
ductal cells HCO3- secretion across the apical membrane is an electrogenic 
process, but it is still not fully clear whether HCO3- exit   is mediated solely by 
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CFTR or by an electrogenic SLC26 anion exchanger (Steward et al., 2005), 
and/or a combination of the two transporters working together. Furthermore, 
HCO3- secretion is an active process that occurs against an electrochemical 
gradient, which depends on Na+, K+, and Cl-, and involves a number of proteins 
including Na+-K+ ATPase, Na+-H+ exchangers, Cl-/HCO3- exchangers, as well as 
carbonic anhydrase (CA). Bicarbonate secretion is stimulated by an increase in 
intracellular cAMP in response to the hormone, secretin, (Argent et al., 2012), 
and  early  studies showed that this led to an increase in the Cl- conductance 
across the apical membrane of ductal epithelial cell of the rat pancreas (Gray et 
al., 1988; Novak and Greger, 1988b), which was  later identified to be due to 
activation of  CFTR (Gray et al., 1993). These studies together with other 
electrophysiological data (Novak and Greger, 1988a) and intracellular pH 
measurements (Stuenkel et al., 1988) led to a model of HCO3- secretion in 
pancreatic duct epithelial cells, as shown in figure 1.2A  (Gray et al., 1988; 
Novak and Greger, 1988b). In this model of HCO3- secretion, CO2 enters the 
ductal epithelial cells across the basolateral membrane by simple diffusion, 
where it is then hydrated by the action of cytoplasmic CA to generate HCO3-. 
The protons generated via CA activity are then then actively extruded from the 
cells across the basolateral membrane by the Na+/H+ exchanger, whose activity 
is maintained by the inward Na+-gradient, via continuous activity of Na+-K+ 
ATPase. At the apical membrane, HCO3- is secreted into the duct lumen by Cl-
/HCO3- AE activity, which depends on the luminal availability of Cl- that is 
maintained by the activity of CFTR and calcium-activated Cl- channels, in the 
case of calcium-stimulated secretion. In later studies, results from Ishiguro et al., 
(2001) led to a modification of this model to account for the ability of ductal 
cells to maintain the secretion of HCO3- against a high concentration of luminal 
HCO3- (>120mM). They showed that bilateral perfusion of high Cl--low HCO3- 
solutions in pancreatic ducts under resting conditions, lead to HCO3- uptake via 
NBC and HCO3- recycling by Cl-/HCO3- exchanger at the basolateral membrane, 
and Cl- and HCO3- secretion at the apical membrane via Cl-/HCO3- exchanger 
and CFTR (Figure 1.2B). However, cAMP-stimulation provided more HCO3- to 
accumulate inside the cells, by inhibition of the basolateral Cl-/HCO3- exchanger 
and activation of the NBC, thereby providing the driving force for HCO3-  
secretion across the apical membrane, where Cl- exits from the cells via 
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activated CFTR and HCO3- leaves the cells in exchange with Cl- via Cl-/HCO3-  
exchange activity (Ishiguro et al., 2001) (Figure 1.2C). However, they also 
showed that perfusion of a high HCO3-, but low Cl- solution in the lumen of the 
ducts, under cAMP stimulated conditions, abolished the apical Cl-/HCO3- 
exchange activity and subsequently reduced the luminal content of Cl-, which 
favoured HCO3- efflux across the apical membrane solely via CFTR (Figure 
1.2D). In addition,  Stewart et al., (2009) demonstrated that there is a functional 
interaction between CFTR and the SLC26A6 Cl-/HCO3- AE in HCO3- secretion 
across the luminal membrane of pancreatic interlobular ducts (Stewart et al., 
2009). Here, they showed that HCO3- secretion was mediated mainly by 
SLC26A6 Cl-/HCO3- exchanger, which was enhanced by CFTR inhibition. 
Overall, these studies in the pancreas highlight the dynamic nature of HCO3- 
secretion in this epithelium.    
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Figure 1. 2: Model of HCO3- secretion in pancreatic duct epithelial cells. (A) 
Proposed cellular mechanism of HCO3- secretion in pancreatic duct epithelium. (B) 
Anion fluxes in unstimulated duct cells with bilateral perfusion of high Cl- and low 
HCO3- solutions. (C) Anion fluxes in stimulated cells and bilateral perfusion of high Cl- 
and low HCO3- solutions. (D) Anion fluxes in stimulated cells and bilateral perfusion of 
low Cl- and high HCO3- solutions.  Diagrams taken from (Steward et al., 2005). 
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1.2 HCO3- secretion in the airways 
The human respiratory system consists of a series of branching tubes and is 
composed of two main parts: (i) the conducting zone (larynx, trachea, bronchi 
and bronchioles) which is lined by a thin layer of fluid (6-10μm) known as the 
airway surface liquid (ASL; see section 1.4)), and it is the site for gas 
transportation into the lung; (ii) the respiratory zone that consist of respiratory 
bronchioles and alveolar ducts terminating in alveoli, which is responsible for 
gas exchange (Fowler, 1948), as shown in Figure 1.3.  
 
The surface of the conducting airways mainly consists of a ciliated epithelium 
that is  found in the nasal cavity, trachea, and bronchi  (Willumsen and Boucher, 
1989). The epithelial cells lining the bronchioles are more columnar, with Clara 
cells interspersed along with ciliated cells. There are also goblet cells which 
secrete mucus. The ability of the epithelium to maintain different apical and 
basolateral membranes is determined by the tight junctions (TJs), which play an 
important role in the regulation of pH by maintaining concentration gradients 
between the serosa and the ASL that lines the epithelium (Widdicombe, 2002b). 
The tracheobronchial part of the conducting airways of higher mammals also 
contain numerous submucosal glands (SMGs) (Goco et al., 1963).  These are 
composed of secretory tubules, a collecting duct, and a ciliated duct that open to 
the luminal surface of the airway (Meyrick et al., 1969). The glands are lined by 
ciliated pseudo-stratified columnar epithelial cells, with a small number of 
goblet cells and brush cells (Carden DL, 2000). SMGs secrete mucins and 
antimicrobial substances, such as lysozyme, lactoferrin, collectins, and Beta-
defensins. Indeed, airway mucus is produced primarily by SMGs. Mucus  is a 
complex mixture of water, salts, mucins and other macromolecules, including 
antimicrobials, antiproteases and antioxidants (Krouse et al., 2004). Moreover, 
SMGs are responsible for the secretion of liquid which is important for the 
transport of macromolecules from the secretory tubules of the glands, as well as 
producing a significant fraction of the ASL. The foundation of the airway innate 
host defence mechanism is formed by the concerted action of mucus (which 
traps pathogens), antimicrobial substances (which eliminate pathogens) and 
mucociliary transport (which cleans the airways of pathogens) (Verkman et al., 
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2003; Ballard and Inglis, 2004; Wine and Joo, 2004; Inglis and Wilson, 2005). 
Studies by Welsh and Smith, (2001) found that cAMP agonists can also provoke 
HCO3- secretion through the apical membrane of airway epithelia (Welsh and 
Smith, 2001).        
 
The active secretion of both Cl- and HCO3- is responsible for liquid secretion by 
submucosal glands (see section 1.3 for more details). Bicarbonate  performs a 
wide range of functions, such as the solubilisation and transportation of mucus 
(Quinton, 2008). Furthermore, the recent finding that mucus secretion is assisted 
by HCO3- secretion (Quinton, 2001; Garcia et al., 2009) and that the viscosity 
and expansion of mucins are controlled by HCO3- (Chen et al., 2010; 
Muchekehu and Quinton, 2010) at least in the GIT, suggests that a robust  
secretion of HCO3- by SMGs is essential for appropriate mucus homeostasis, 
which is consistent with  a recent study that  demonstrated HCO3- secretion 
plays critical role in mucus hydration (Xiao et al., 2012) in the GIT. However, 
whether this is true for the airways is currently not clear. However,, it has been 
shown that acidic pH leads to decline in ciliary beating (Clary-Meinesz et al., 
1998) and impairs the function of phagocytic cells to destroy pathogenic 
microorganism (Allen et al., 1997). More recently, Pezzulo (2012) showed that 
acidic pH in CF human and pig airways led to a marked reduction in bacterial 
killing, which could be partially recovered after re-alkalinisation of the ASL pH 
(Pezzulo et al., 2012a). In brief, insufficient HCO3- secretion by SMGs is 
thought to be followed by accumulation of mucus plugs in the airways, bacterial 
colonisation and biofilm formation, inflammation and pathology characteristic 
of chronic lung disease such as seen in the lungs of CF patients (Hug et al., 
2003). Although it is well known that HCO3- has a critical role in a variety of 
body tissues, the role of HCO3- in the lungs is gaining a major interest within the 
field of airway physiology. 
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Figure 1. 3: Schematic illustration of the human respiratory system. Diagram 
shows the conductive airway and the respiratory zone, which is the site of gas 
exchange. Figure is adapted from (Tu et al., 2013).  
 
 
1.3 Submucosal glands (SMGs) 
SMGs are responsible for the secretion of approximately 95% of upper airway 
mucus (Reid, 1960). SMGs consist of four distinct regions that play crucial roles 
in the production and processing of liquid mucus to be secreted onto the airway 
surface. The first part consists of serous tubules and acini, which are responsible 
for secretion of salt, water and a wide range of antimicrobial proteins (Tom-Moy 
et al., 1983; Zhao et al., 1996; Bals et al., 1998; Singh et al., 1998). The second 
part are the mucus tubules that are lined by epithelia cells which are filled with 
mucin containing secretory granules (Nadel, 1983). These tubules allow the 
serous secretion to pass through. The third part, which is lined by non-ciliated 
columnar epithelial cells, is called the collecting duct. It has been suggested that 
epithelial cells lining the collecting duct adjust the ionic composition of serous 
and mucus epithelial cell secretions (Nadel et al., 1979). The last part is the 
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ciliated duct that is enclosed by cells which line the opening of the gland and an 
extension of the airway surface epithelium (Figure 1.4A). The majority of gland 
salt and water, as well as antimicrobial proteins, are thought to be secreted by 
the epithelial cells lining the serous acini and tubules (Tom-Moy et al., 1983; 
Zhao et al., 1996; Bals et al., 1998; Singh et al., 1998). The secretion of fluid 
and antimicrobial factors then become mixed together with mucin, which are 
then transported onto the luminal surface of the airway through the collecting 
duct.  
 
 
1.3.1 Mechanism and regulation of SMG secretion 
 
SMG produce a small amount of liquid secretion at rest, but will secretes 
copious amount of fluid under synergistic stimulation by either acetylcholine or 
substance P and vasoactive intestinal peptide (VIP) (Choi et al., 2007; Ianowski 
et al., 2008). Airway SMG secretions are primarily controlled by two main 
mechanisms; (i) a non-cholinergic mechanism, which is mediated by airway 
intrinsic neurons mostly secreting, VIP and tachykinins, and (ii) a cholinergic 
mechanism, which is under the control of vagal pathways (Wine, 2007); see 
figure 1.4B)). SMG serous cells are tightly innervated by mutual excitatory 
intrinsic airway neurons (Widdicombe and Wine, 2015). The neurotransmitters 
released by intrinsic airway neurons, including VIP and substance P, play an 
important role in liquid secretion by SMG through activation of VIP receptor 2 
(VPAC2) and NK1 tachykinin receptors, respectively, (Groneberg et al., 2001; 
Phillips et al., 2003). It has been shown that stimulation of tachykinin receptors 
by substance P leads to an increase in [Ca2+]i, which enhances fluid secretion by 
SMG in the feline trachea (Nagaki et al., 1994). Stimulation of VPAC receptors 
by VIP leads to an increase in [cAMP]i via activation  of adenylyl cyclase, 
which stimulates  SMG secretion (Groneberg et al., 2006). The function of SMG 
serous cells in the secretion of salt and fluid is shown in figure 1.4C. Active 
transepithelial Cl- and HCO3- secretion plays an important role in fluid secretion 
by the airway SMG (Ballard and Inglis, 2004). The study by Joo et al., (2001) 
confirmed the HCO3--dependence of fluid secretion from isolated sheep tracheal 
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SMG where carbachol stimulated fluid secretion was inhibited ~ 67% by 
replacing HCO3- with HEPES (Joo et al., 2001). Moreover, the Cl- and HCO3- 
dependence of fluid secretion was also observed in porcine SMG, where 
forskolin or VIP stimulated fluid secretion was inhibited ~50% by either 
bumetanide or HCO3- replacement (Joo et al., 2002). Salt and fluid secretion by 
serous cells is primarily regulated by the apical anion channel CFTR, which is 
more strongly expressed in the apical membrane of serous epithelial cells than 
other types of cells in the airways (Engelhardt et al., 1992; Jacquot et al., 1993; 
Sehgal et al., 1996), (for more details see section 1.5). In addition, strong 
evidence has shown that stimulation of CFTR with either forskolin or 
cholinergic agonists plays an important role in fluid secretion, which was 
inhibited by the CFTR inhibitor, CFTRinh-172, in human and pig airway SMGs 
(Thiagarajah et al., 2004). Absence of CFTR in the apical membrane of serous 
epithelial cells leads to a decrease in Cl- and HCO3-  secretion onto the airway 
surface, as well as reduction in ASL, and thereby produces a defect in 
mucociliary clearance (Boucher, 2007a). 
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Figure 1. 4: Overview of airway submucosal gland innervation and structures. (A) 
Schematic presentation of SMG and its four compartments. Reproduced from (Verkman 
et al., 2003). (B) shows airway innervation by the autonomic nervous system, with 
parasympathetic (solid lines), and sympathetic system (dashed lines), figure is taken 
from (Wine, 2007). (C) The extended observation of serous cell of submucosal glands, 
which plays a major role in the secretion of a watery fluid via the CFTR activity located 
on the apical surface of the serous cells.  Figure adapted from (Salinas et al., 2005). 
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1.4 Airway surface liquid (ASL) 
The ASL is defined as a thin layer of aqueous solution about 10μm deep that 
lines the airway surface (Widdicombe, 2002a), which contains ions, water, gel-
forming glycoprotein (mucin; MUC5B) (Widdicombe and Wine, 2015), and a 
variety of proteins including lactoferrin, defensins and lysozyme that are 
considered to play a vital function in airway hydration, natural immunity and 
antimicrobial defense (Zabner et al., 1998). The majority of the ASL is secreted 
by SMGs upon stimulation by Ca2+ and/or cAMP agonist, that plays an 
important role in mucociliary clearance and removal of inhaled pathogen from 
the lung (Cole et al., 1999; Wine and Joo, 2004; Widdicombe and Wine, 2015). 
It has been suggested by in vivo studies of radiotracer particle clearance that 
normal ASL removes deposited particles, including bacteria, on the airway 
surface within approximately six hours (Wanner et al., 1996). As shown in 
Figure 1.5A, the ASL consists of two layers, defined by light and electron 
microscopy: the periciliary liquid layer (PCL) located next to the airway 
epithelium, and an overlying thicker gel layer, made up of mucus (Boucher, 
2002). Normally, a very thin layer of ASL covers the luminal surface of the 
airways. Its quantity is accurately regulated to compensate for evaporation. 
During mucociliary clearance, the ASL facilitates cilia beating, and collectively 
with antimicrobial factors, plays an important role in the elimination of inhaled 
pathogens (Boucher, 1999). Deposited particles on the airways surface are 
effectively removed by the synchronized function of the two-phase gel system 
on the airway surface as shown in Figure 1.5. The PCL extends from the cell 
surface to the height of the extended cilia, The mucus layer is situated on the top 
of the cilia (Knowles and Boucher, 2002). Originally, the PCL was believed to 
be composed of liquid. However, the polyanionic gel properties of this layer 
(Randell and Boucher, 2006) give a perfect low resistance environment for cilia 
beating and also avoids the mucus layers from sticking together with the cell 
surface. The mucus layer is primarily composed of  mucins (Raviv et al., 2003).  
 
Recently, a new model of the periciliary layer has been proposed by Button et 
al., (2012). They showed that a macromolecular meshwork is present in the PCL 
of primary human bronchial epithelial cell cultures. Here they proposed that the 
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macromolecular meshwork is occupied by mucins and mucopolysaccharides that 
are tethered to cilia, microvilli and the epithelial surface to form an extracellular 
brush that prevents penetration of mucins and inhaled particles deposited on the 
mucus layer, into the PCL, which is required for effective mucociliary clearance 
(Button et al., 2012). Inadequate secretion from the SMGs, in combination with 
improper ion transport activity of the epithelial cells lining the luminal surface 
of the airways, leads to a reduction in ASL as seen in CF patients. Therefore, 
regulation of the ASL plays a crucial role in the process of mucociliary 
clearance, and it is this which is defective in CF, where mucus become more 
viscous and dehydrated (Matsui et al., 1998). It has been concluded that a 
reduction in ASL also inhibits neutrophil migration, which prevents the ability 
of neutrophils to capture and kill bacteria on the surface of airway epithelia 
(Matsui et al., 2005). In normal airway epithelia (Figure 1.5A), both CFTR and 
the epithelial Na+ channel (ENaC) play a critical role in the regulation of ASL 
volume and composition (see section 1.6 for more detail). As shown in figure 
1.0B, defects in CFTR function produces a viscous mucus gel, which adheres to 
the airway surface and ciliary beating is impaired (Mall et al., 2004), and 
thereby it becomes the site for chronic bacterial infection (Worlitzsch et al., 
2002). Recent studies have utilized Calu-3 cells as a model of airway SMG 
serous cells (for more details see section 1.11).  
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Figure 1. 5: The mechanism of airway mucus ciliary clearance. This illustration 
shows normal airways (A) in which the process of airways hydration controlled by the 
coordinated rate of Na+ absorption and Cl- secretion to support mucus clearance. It also 
shows airway surface dehydration (B) due to absence of CFTR function in CF. ENaC= 
epithelial Na+ channel, PCL refers to periciliary liquid, CFTR= refers to cystic fibrosis 
transmembrane conductance regulator. Figure is taken from Ratjen et al., (2015) 
(Ratjen et al., 2015). 
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1.5 Cystic fibrosis transmembrane conductance regulator (CFTR) 
CFTR is a membrane spanning glycoprotein which serves as ion channel to 
transport anions across the apical surface of epithelial cells, and has an impact 
on a variety of cellular process (Ratjen et al., 2015). This ATP-binding cassette 
(ABC) transporter-protein functions primarily as a Cl- channel on the apical 
membrane of epithelial cells of various organs, such as liver, pancreas, digestive 
tract, reproductive tract and the airways (Nagel et al., 1992). CFTR also 
functions as HCO3- transporter in epithelial cells of many organs, including 
lungs, gastrointestinal tract, and pancreas (Gray et al., 2001). Thus, reduced 
HCO3- secretion has been reported in CF tissue (Ko et al., 2002). Energy is used 
in the form of adenosine triphosphate (ATP) by all family members of ABC 
transporters in order to move a wide range of substance through the plasma 
membrane of cells (Dean et al., 2001). However, CFTR is the only ABC 
transporter that is not an active pump, and instead uses ATP binding and 
hydrolysis to induce structural changes in the protein that leads to channel pore 
opening and closing (channel gating), respectively. CFTR has a significant 
impact on the amount and composition of epithelial secretions by conducting Cl- 
and HCO3-,  as well as being involved in regulating absorption and secretion of 
salt across the epithelial cells, which is followed by the creation of osmotic 
gradients leading to water transport across the epithelial cells to the mucosal 
surface (Riordan, 2008). Although CFTR serves as an anion channel, it acts also 
as a regulator, either directly, or indirectly, of a wide range of other ion 
channels, receptors, and transporters. 
 As shown in Figure 1.6, CFTR is composed of two repeating units which 
consist of two domains: a membrane spanning domain (MSD) which is 
hydrophobic and composed of six transmembrane segments; and a nucleotide 
binding domains (NBD), which is hydrophilic and is located in the cytoplasm, 
where its function is to bind and hydrolyse ATP  (Naren and Kirk, 2000). The 
two repeated units are connected to each other through a unique regulatory (R) 
domain. Phosphorylation of this domain by cAMP-PKA is responsible for the 
activation of CFTR (Cheng et al., 1991; Gadsby and Nairn, 1999). Activation of 
the CFTR increases the permeability of the apical membrane to Cl- ions, which 
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then flow out from the cells (Figure 1.6). It has been shown that movement of 
Cl- via the CFTR is stimulated by ATP binding to the NBDs, which is followed 
by dimerisation of the NBDs (Vergani et al., 2005). CFTR can also interact via 
its R-domain with the C and N-terminal domains of a variety of other 
transporters and regulatory proteins, including members of SLC26 family of 
anion transporter (see section 1.7) (Ko et al., 2004).  
 
 
 
 
  
18 
 
  
 
 
 
 
 
Figure 1. 6: Structures of the cystic fibrosis transmembrane conductance regulator 
(CFTR) anion channel. (A) Shows the linear structure of CFTR. (B) shows the 
domains of the CFTR Cl- channel, which consists of two membrane spanning domain 
(MSD; MSD1 and MSD1) that function as the ion channel pore through the plasma 
membrane, each connected with a nucleotide binding domain (NBD; NBD1 and 
NBD2). The CFTR channel opens when ATP is bound at the NBDs, and when the (R) 
domain is phosphorylated by PKA. Figure taken from (Ratjen et al., 2015). 
Figure 1. 7: Gating of the CFTR channel. Figure (A) shows the inactive (closed) 
form of the CFTR Cl- channel without ATP bound to the NBDs and so Cl- anions are 
trapped inside the cell until the process of phosphorylation and ATP binding to the 
NBDs occurs. (B) Illustrates the active (open) form of CFTR where the R domain is 
phosphorylated by PKA and ATP is bound to NBD1 and 2 which leads to NBD 
dimerisation, and channel opening. MSD=membrane spanning protein; NBD= 
Nucleotide binding membrane; RD= Regulatory domain. Figure taken from (Hwang 
and Sheppard, 2009). 
  
A 
B 
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1.6 Regulation of CFTR 
It has been shown that the cAMP/PKA signalling pathway is the major pathway 
that regulates CFTR activity and which stimulates Cl- and fluid secretion in 
CFTR-expressing epithelial cells (Cheng et al., 1991; Haws et al., 1994; Cobb et 
al., 2002; Cobb et al., 2003; Derand et al., 2004; Hentchel-Franks et al., 2004). 
In addition to PKA, CFTR has been shown to be phosphorylated by a range of 
different protein kinases, including Ca2+-independent and Ca2+-dependent 
isoforms of protein kinase C (PKC), cGMP-dependent protein kinases, PKGI 
and PKGII (Berger et al., 1993), adenosine monophosphate stimulated kinase 
(AMPK) (Kongsuphol et al., 2009), transmembrane human lemur tyrosine 
kinase 2 (LMTK2) (Wang and Brautigan, 2006) and casein kinase 2 (CK2) 
(Pagano et al., 2008). 
 
More recently, it has been shown that the ‘master kinase’ CK2 also plays an 
important role in the regulation of ENaC (Bachhuber et al., 2008) and CFTR 
activity (Treharne et al., 2009). CK2 is generally composed of two α catalytic 
subunits and two regulatory β subunits (Litchfield, 2003), which can specifically 
bind to and phosphorylate the CK2-binding subunits at the C-terminus of the 
ENaC (Bachhuber et al., 2008). In addition, it has been found that CFTR 
interacts with CK2 in the apical membrane of human airway epithelia (Treharne 
et al., 2009). In the NBD1 of CFTR, there is a CK2 binding motif, known as 
SYDE, which is located close to the F508 residue of CFTR (Venerando et al., 
2014). In addition, in vitro studies have shown that the α-catalytic subunit of 
CK2 phosphorylates NBD1 of CFTR (Pagano et al., 2008), and disruption of 
CK2-CFTR interaction by either CK2 inhibition or ∆F508-CFTR closes the 
CFTR channel and reduces CFTR-dependent Cl- transport (Treharne et al., 
2009). In the airways, CFTR also functions as a down regulator of  the ENaC, 
and therefore intracellular increases of cAMP also inhibit ENaC, which prevents 
Na+ reabsorption from the lumen of the airways, and thereby provides an 
osmotic driving force for water transport into the ASL (Mall et al., 1999). 
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1.7 Cystic fibrosis  
CF is the most common, life threatening, inherited disease with approximately 
9,000 affected people (1 in 2,500 live births) in the UK (Rowntree and Harris, 
2003). CF is an autosomal recessive disorder caused by mutations in the CFTR 
gene which interferes with the functions of a wide range of body organs 
(Xingshen Sun, 2010). Around 2000 CF mutations in the CFTR gene have been 
identified (www.genet.sickkids.on.ca). The most common CFTR mutation is 
deletion of phenylalanine at position 508 (deltaF508), which affects around 70% 
of CF patients (Davis, 2006). Mutations in the CFTR gene leads to either a 
reduction in the amount of the CFTR or dysfunction of this protein (Cheng et 
al., 1990; Welsh and Smith, 1995). DeltaF508 mutated CFTR is unable to reach 
the proper location in the cell membrane, instead it is retained in the 
endoplasmic reticulum, via the endoplasmic reticulum quality control (ERQC) 
and subsequently destroyed by the cytoplasmic proteasome (Cheng et al., 1990; 
Ward and Kopito, 1994; Ward et al., 1995; Gelman et al., 2002). Therefore, the 
CFTR protein is not produced, or severely reduced, at the cell membrane, and 
affected tissues suffer from failure of cAMP dependent Cl- secretion. 
Investigation of HCO3- secretion in cystic fibrosis (CF) tissue highlighted the 
importance of CFTR in regulating HCO3- secretion. Reduced HCO3- secretion 
has been reported in a wide range of CF tissue, including CF canine airways 
(Smith and Welsh, 1992), CF murine intestinal epithelia (Xiao et al., 2012), CF 
human nasal epithelia (Paradiso et al., 2003) as well as in transfected cell lines 
with a mutant CFTR (Choi et al., 2001). Moreover, it has been shown that ASL 
[HCO3-] in normal cultured primary human bronchial epithelia (HBEs) is higher 
than CF ASL (Coakley et al., 2003). Here they also found that an increase in 
[cAMP]i stimulates HCO3- secretion in response to an acidic ASL, thereby 
causing rapid ASL alkalinisation. However, acidic ASL was not alkalinised in 
HBEs isolated from CF patients, in resting or cAMP elevated conditions, 
consistent with lack of CFTR-dependent HCO3- secretion by CF airway epithelia 
(Coakley et al., 2003). Furthermore, similar finding has been demonstrated that 
the rate of HCO3- secretion was markedly decreased in CF human nasal 
epithelia, compared to non-CF nasal epithelia (Paradiso et al., 2003). 
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 In CF, respiratory failure is the primary cause of death among patients, and 
occurs as a result of production of a high amount of mucus, and a decrease in the 
process of mucociliary clearance, which leads to obstructive lung disease and 
chronic bacterial airway disease (Figure 1.5). It has been shown that over 85% 
of people with CF, suffer from improper functioning of the pancreas, which is 
characterised by loss of their ability to produce pancreatic digestive enzyme and 
subsequently malnutrition occurs (Kerem et al., 1989; Estivill et al., 1995; 
Mateu et al., 2002).  
Current studies have suggested that susceptibility of the airway surfaces to 
dehydration and failure of mucus clearance in CF lung disease is caused by 
CFTR gene mutation leading to loss of CFTR dependent Cl- efflux and control 
of ENaC activity (Boucher, 2007b). In CF patients, the two main factors that are 
responsible for chronic bacterial infection and failure of the lung are defects in 
SMG function and abnormality in the ASL composition, as shown in figure 1. 8. 
Inadequate secretion of Cl- across the apical membrane of airway epithelia, 
together with the absorption of a high amount of Na+ from the extracellular 
surface, creates an osmotic gradient and copious amount of water is removed 
from ASL, this leads to formation of thick, viscous, mucus, which block the 
airway and then leads to chronic airway infection with bacteria, most commonly 
Pseudomonas aeruginosa. As a result, localized areas of the bronchial tree 
become irreversibly dilated as its muscle and elastic tissue are destroyed. 
Moreover, there is progressive destruction of the airway (Welsh, (1995)).  
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Figure 1. 8: Mutated CFTR Cl- ion channel and CF of the lung. This figure 
illustrates the theoretical relationship between defected CFTR protein and several organ 
systems. Figure is adapted from Goodman and Precy, 2005 (Goodman and Percy, 
2005). 
 
 
1.8 Role of SLC26 Cl-/HCO3- anion exchangers and HCO3- secretion in epithelial cells 
The human solute carrier (SLC26) gene family are large transmembrane protein 
anion transporters that consist of 10 members (SLC26A1-A11, SLC26A10 
being a pseudogene) (Li et al., 2014),  many of which are expressed in epithelial 
cells where  they  play an important role in anion secretion and absorption 
(Ohana et al., 2009). All members of the SLC26 family, except SLC26A5 
(Prestin), can function as anion exchangers, and they have a significant role in 
the transportation of a wide range of monovalent and divalent anions in 
epithelial cells. For instance, sulphate, chloride, iodide, oxalate, formate, 
bicarbonate and hydroxyl ion (Bissig et al., 1994; Karniski et al., 1998; Satoh H 
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and Yadav, 1998; Moseley et al., 1999; Jiang et al., 2002; Xie et al., 2002; Scott 
DA, (2000) ; Soleimani M and P, (2001)). Most of the SLC26 anion transporters 
are expressed in the luminal membrane of epithelial cells, and play an important 
role in epithelial Cl- and HCO3- transportation (Mount and Romero, 2004). 
However, it has been suggested that SLC26A7 function as Cl- channel in 
Xenopus oocytes and transfected HEK cells, and it does not conduct HCO3- 
(Kim et al., 2005). Also, a study  by Loriol et al., (2008) has shown that 
SLC26A9 plays an important role in  human airway epithelia cells as a Cl- 
channel, but was not involved in regulating intracellular pH because it also does 
not conduct HCO3- (Loriol et al., 2008). Recently, it has been demonstrated that 
SLC26A9 plays an important role in Cl- secretion in mouse airway epithelial 
cells, and helps prevent airway mucus obstruction (Anagnostopoulou et al., 
2012). In addition, it has been shown that SLC26A9 plays an important role in 
Cl- transportation through a cAMP-dependent mechanism when co-expressed 
with CFTR in HEK-293Tcells, and that SLC26A9 activity was also CFTR-
dependent in HBE cells (Bertrand et al., 2009).  
 
The SLC26 family members have an NH2 terminal domain that encompasses the 
transmembrane segments, which are thought to be the sites for anion binding, as 
well as the COOH terminal, which is predicted to contain a sulfate transporter 
and anti-sigma factor antagonist (STAS) domain (Aravind and Koonin, 2000). It 
has been described that there is a reciprocal regulation between SLC26 
transporters and the CFTR channel, which is facilitated by binding of the STAS-
domain of the SLC26 transporters to the R-domain of CFTR, which plays an 
important role in the regulation of CFTR activity (Ko et al., 2004).  It has also 
been reported that members of SLC26 family are more likely to be involved in 
Cl-/HCO3- exchange than Cl-/OH- exchange (Ko et al., 2002; Wang et al., 2002; 
Xie et al., 2002). The SLC26 family members of Cl-/HCO3– exchangers, 
SLC26A3, SLC26A4 and SLC26A6, are known to play an important role in 
HCO3 – secretions in kidney , intestinal  and pancreatic duct cells (Soleimani et 
al., 2001; Stewart et al., 2011).  
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Several human genetic diseases are associated with mutations in members of the 
SLC26 family including; chondrodysplasias that is caused by mutation in 
SLC26A2 (Hastbacka et al., 1994; Superti-Furga et al., 1996); chloride losing 
diarrhoea (DRA) caused by mutations in SLC26A3 (Mount and Romero, 2004), 
pendred syndrome and congenital deafness that is linked to mutations in 
SLC26A4 (Everett et al., 1997; Liu et al., 2003).. It has also been reported that 
defective SLC26A5 (Prestin) leads to non-syndromic hearing impairment (Liu et 
al., 2003; Tang et al., 2005). Moreover, it has been reported that absence of 
SLC26A6 protein in mice produces kidney nephrolithiasis due to abnormal 
transportation of oxalate (Jiang et al., 2006). SLC26A6 is also involved in 
HCO3- secretion by pancreatic and parotid ducts (Wang et al., 2006; 
Shcheynikov et al., 2008). Also, SLC26A8 mutation leads to a decrease in the 
capability of being fertile (Toure et al., 2007). The characteristics of the SLC26 
family and diseases linked to their dysfunction are shown in Table 1.01.  
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Table 1.1: The characteristics of the SLC26 gene family. Table adapted from Mount 
& Romero 2004 (Mount and Romero, 2004). 
 
 
 
1.8.1 SLC26A4 (Pendrin)  
 
SLC26A4 (pendrin) is an electroneutral anion exchanger that functions as a Cl-
/HCO3- exchanger (Ohana et al., 2009). Pendrin is essential for transcellular 
movement of monovalent anions, including chloride, iodide and formate, 
although it doesn’t transport divalent anions (sulphate and oxalate) (Scott et al., 
1999; Scott DA, (2000) ).  
Pendrin is highly expressed in the inner ear, thyroid gland and the kidney 
(Royaux et al., 2000; Lacroix et al., 2001). It has been shown that human 
pendrin expressed in Xenopus oocytes functions as a Cl-/formate exchanger, 
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similar to the renal Cl-/formate exchanger, which is  thought to play a critical 
role in transepithelial Cl- transport by renal proximal tubule (Scott and Karniski, 
2000). However, immunolocalisation studies have shown pendrin expression on 
the apical surface of renal β-intercalated cells of collecting ducts, but failed to 
detect any expression in the proximal tubules (Royaux et al., 2001). Here, they 
also showed that pendrin plays an important role in HCO3- secretion in the 
kidney. In addition, a study by Amlal et al., (2010) showed that genetic deletion 
of SLC26A4 (pendrin) in mice impaired HCO3- secretion by renal collecting 
ducts and these animals displayed significantly acidic urine, along with elevated 
HCO3- concentration in the serum, compared to WT mice (Amlal et al., 2010). 
Furthermore, pHi measurements in β-intercalated cells of renal collecting ducts 
showed that the alkalinisation in pHi due to Cl- removal in the extracellular 
solution, was markedly decreased in pendrin knock out mice, compared to wild 
type mice, suggesting that pendrin functions as a Cl/HCO3- anion exchanger 
(Amlal et al., 2010). It has been also reported that pendrin can be found in other 
organs, such as epithelial cells of the airway (Pedemonte et al., 2007; Di 
Valentin E, 2009), mammary gland (Rillema and Hill, 2003), testis (Lacroix et 
al., 2001), placenta (Bidart et al., 2000), endometrium (Suzuki et al., 2002) and 
liver (Alesutan et al., 2011). Mutations in the pendrin gene lead to pendred 
syndrome which is an autosomal recessive illness in which the anion exchanger 
does not function properly. Pendred syndrome is distinguished by loss of 
hearing in newborns and enlargement of the thyroid gland, due to a defect in the 
formation of thyroglobulin in the thyroid gland, that leads to development of 
goiter (Morgans and Trotter, 1958; Dror et al., 2010).  
A recent study showed that there is cooperation between CFTR and pendrin  in 
the process of Cl- and HCO3- secretion by serous cells of airway submucosal 
glands (Garnett et al., 2011; Garnett et al., 2013).  Abnormality in the regulation 
of pendrin function by CFTR, as would occur in CF, would lead to reduced Cl-
/HCO3- exchange. This would be predicted to lead to a decrease in the quantity 
of bicarbonate secreted into the luminal airway surface liquid (Mount and 
Romero, 2004). Moreover, it has been shown that pendrin plays an important 
role in thiocyanate secretion into the ASL, which provides ability for scavenging 
oxidants and innate defense against bacterial infection, in human bronchial 
27 
 
epithelial cells under resting and IL-4 stimulated conditions (Pedemonte et al., 
2007).  
Furthermore, it has been shown that pendrin plays an important role in the 
regulation of ASL thickness and asthma exacerbation induced by rhinovirus 
infection or allergic airway diseases (Nakagami et al., 2008). Here, they showed 
that pendrin expression was significantly increased about 5 fold in infected 
human with common colds caused by rhinovirus. They also showed that pendrin 
deficiency in mice caused a significant decrease in airway hyperactivity and 
inflammation by improving ASL hydration. Thus pendrin might be a potential 
therapeutic target in asthma exacerbations. 
  
 
1.9 Regulation of SLC26 anion exchangers by CFTR 
CFTR plays an important role in the activation of SLC26 Cl-/HCO3- exchangers, 
indicating the importance of SLC26 anion exchangers in HCO3- transportation in 
many epithelial cells  (Mount and Romero, 2004). In unstimulated cells, 
unnecessary fluid and electrolyte secretion is avoided through interaction of the 
unphosphorylated R-domain with NBD1 that blocks its binding with NBD2 
(Baker et al., 2007) and thus leads to inhibition of CFTR Cl- channel activity. 
However, phosphorylation of the R domain by PKA is followed by the 
detachment of the R domain from NBD1, which stimulates its interaction with 
the STAS domain of SLC26 anion transporters (Lamprecht et al., 2002; Ko et 
al., 2004). CFTR-associated protein 70 (CAP70) which is one of the PDZ 
proteins that are primarily located in the apical membrane of epithelial cells, has 
been reported to play an important role in the opening of CFTR in Calu-3 cells 
of airway SMG via its binding to the C-terminal of CFTR (Wang et al., 2000; 
Raghuram et al., 2001). This interaction leads to the combined activation of 
CFTR and SLC26 anion transporters (Ko et al., 2002; Ko et al., 2004) and 
subsequently electrolyte and fluid efflux (figure 1.9). In addition, it has been 
found that this type of regulatory activation is present for SLC26A3, SLC26A4 
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and SLC26A6, while other types of SLC26 transporters might be involved in 
this regulatory process (Wang et al., 2006).  
Recently, a clinical study has confirmed the functional cooperation between 
SLC26 AE and the CFTR channel (Dirami et al., 2013). Here, they showed that 
SLC26A8 strongly stimulates CFTR channel activity in human sperm, which 
plays an important role in anion exchange activity that is required for sperm 
motility and capacitation, and subsequently fertilization. The study by Dirami et 
al., (2013) also suggested that SLC26A8 mutations impair the formation of the 
SLC26-CFTR complex, and thereby leads to human asthenozoospermia (Dirami 
et al., 2013). The SLC26 anion exchangers also play an essential role in the 
activation of CFTR channel in vivo (Dirami et al., 2013). It has also been shown 
that salivary and pancreatic ductal fluid and HCO3- secretion involves 
basolateral HCO3- influx by NBCe1 to provide more HCO3- to accumulate inside 
the cells, and luminal HCO3- efflux and Cl- absorption across the apical 
membrane by coordinated activity of the CFTR and SLC26A6 Cl-/HCO3- AE 
(Lee et al., 2012; Ahuja et al., 2014). 
Moreover, a recent study in primary cultures of human nasal cells from normal 
and patients carrying mutations in pendrin (DFNB4) showed that mutation in 
SLC26A4 lead to reduced anion exchange activity in the apical membrane of IL-
13 treated cells, but enhanced ASL height. In addition, there was as a decrease in 
expression of CFTR and short circuit current in the pendrin mutant airway cells 
(Lee et al., 2015). Furthermore, preliminary co-immunoprecipitation 
experiments suggested that pendrin may be coupled to CFTR, with the two 
proteins working in concert to transport Cl- and HCO3- across the apical 
membrane of human airway epithelial cells (Lee et al., 2015). However, based 
on the observed changes in ASL height, the authors concluded that this was 
evidence that pendrin actually works in an absorptive, rather than a secretory 
mode, to regulate ASL volume. Overall, it is clear that regulation of these anion 
exchangers is an important area of research, and might be a novel target for 
future therapy of CF. 
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Figure 1. 9: The physical and functional interaction between CFTR and SLC26 
transporters. The CFTR plays a crucial role in the regulation of SLC26A transporters. 
An increase in intracellular cAMP leads to activation of PKA, resulting in 
phosphorylation of R-domain of CFTR, which binds to SLC26 transporters via their 
STAS domain to enables CFTR to directly regulate the SLC26 anion exchanger 
activity. Figure taken from (Dorwart et al., 2008).  
 
 
1.10 The SLC4 family of anion transporters 
In addition to the SLC26 family that code for Cl-/HCO3- exchangers, there is 
another family which is called solute carrier 4 (SLC4) family of transporters that 
consist of ten genes, and all SLC4 family members encode plasma membrane 
spanning proteins (Romero et al., 2004). The SLC4 family members play an 
important role in HCO3- transportation across the mammalian plasma membrane 
to regulate intracellular and extracellular pH, as well as transportation of Na+ 
and/or Cl-, and potentially water (Bevensee et al., 2000; Kurtz, 2014). It has 
been shown that mutations in SLC4 transporter proteins lead to a wide range of 
human genetic diseases (Cordat and Casey, 2009), such as haemolytic anaemia 
and distal renal tubular acidosis by SLC4AE1 mutation (Schofield et al., 1992; 
Bruce et al., 1997), generalized epilepsy by SLC4AE3 mutation (Sander et al., 
2002), glaucoma, cataract and bad keratopathy by NBCe1 mutation (Usui et al., 
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1999; Demirci et al., 2006) and hypertension by NBCe2 mutation (Barkley et 
al., 2004; Hunt et al., 2006). 
 
Most recently, it has been shown that eight members of the SLC4 family encode 
proteins that are involved in the process of HCO3- transportation, and 
functionally they are classified into two main groups: three electroneutral Cl-
/HCO3- exchangers, AE1, AE2 and AE3 (SLC4A1, SLC4A2, SLC4A3, 
respectively) and five Na+-coupled HCO3- transporters (NBC) (Romero et al., 
2013; Kurtz, 2014). NBCe1 (SLC4A4), and NBCe2 (SLC4A5) are two 
electrogenic NBCs, while NBCn1 (SLC4A7), NBCn2 (SLC4A10), and Na+-
driven Cl-/HCO3- exchanger (NDCBE; SLC4A8) are three electroneutral 
transporters  (Romero et al., 2013; Kurtz, 2014). Although  SLC4A9 (AE4) was 
initially reported to perform anion exchange activity, it  mostly resembles Na+-
coupled SLC4 transporters (Kurtz, 2014). Electrogenic NBCe’s plays an 
important role in HCO3- secretion in the pancreatic duct, and HCO3- 
reabsorption in the proximal renal tubules. However, the electroneutral NBCn 
and Na+-driven Cl-/HCO3- exchanger (NDCBE’s) play a vital role in the 
regulation of pHi in vascular smooth muscle and CNS neurons, respectively 
(Boron, 2001). Furthermore, the products of the SLC4 gene family  perform a 
vital role in the process of CO2 transportation from the systemic circulation to 
the lungs by red blood cells, H+ or HCO3- absorption or secretion by a wide 
range of epithelial cells, as well as controlling intracellular pH and cell size 
(Romero et al., 2004).  
 
The gene products of SLC4 transporters are comprised of three domains:  (i) N-
terminal cytoplasmic domain comprising of 400–700 amino acids, (ii) a 
transmembrane domain (TMD) of 500 amino acids, and (iii) a short C-terminal 
tail that binds to carbonic anhydrase II. The amino acid sequences of AE1–3 
TMDs are ∼65% identical, while the homologous cytoplasmic N-terminal 
domains are only ∼35% identical in amino acid sequence identity (Vince and 
Reithmeier, 2000). AE1 is the most numerous membrane protein in erythrocytes 
(Hunter, 1977) and α-intercalated cells of renal collecting duct  (Verlander et al., 
1988). AE2 is highly expressed at the basolateral membrane of most epithelia 
including stomach mucosa (Stuart-Tilley et al., 1994), colon (Gawenis et al., 
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2010), collecting duct of the kidney (Alper et al., 1997), pancreatic duct 
epithelial cells (Rakonczay et al., 2008; Ishiguro et al., 2009) and respiratory 
airway (Dudeja et al., 1999). AE3 is mostly expressed in excitable tissues, 
including brain (Kudrycki et al., 1990), retina (Kobayashi et al., 1994), heart 
(Yannoukakos et al., 1994) and smooth muscle (Brosius et al., 1997), which 
plays an important role in the regulation of intracellular pH by exporting  HCO3- 
during intracellular alkalinisation (Sander et al., 2002). Most, if not all, of the 
SLC4 family members are functionally inhibited by 4,4'-Diisothiocyanato-2,2'-
stilbenedisulfonic acid disodium salt (DIDS) (Romero et al., 2013). It has been 
shown that DIDS, used extensively to characterize the HCO3- transport activity 
of the SLC4 family members, covalently interacts with a lysine residue in the 
protein (Landolt-Marticorena et al., 1995). The characteristics of the SLC4 
family members are shown in figure 1.10.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 10: SLC4 family members and their transport activity. The SLC4 gene 
family contains 10 members; all are involved in HCO3- transportation apart from one 
member, SLC4A11. Figure taken from (Alvarez-Leefmans and Delpire., 2009).  
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1.10.1  Anion exchanger 2 (SLC4A2 or AE2)  
 
The electroneutral Cl-/HCO3- anion exchanger 2 (AE2) (Huang et al., 2012) is a 
trans membrane protein that plays an important role in the regulation of 
intracellular pH and cell volume (Turi et al., 2003). It has also been shown that 
SLC4A2 function as a Na+-independent Cl-/HCO3- anion exchanger in polarized 
epithelial cells that plays a pivotal role in the regulation of intracellular pH, 
intracellular Cl- concentration and cell volume by excretion of HCO3- from cells, 
and loading of cells with Cl- (Alper, 2002; Romero et al., 2004). In addition, it 
has been assumed that expression of AE2 in most epithelial cells plays important 
role in the regulation of intracellular pH by outward transportation of HCO3- 
during intracellular alkalinisation, and /or control of cell volume by Cl- uptake 
(Stewart et al., 2002). AE2 plays an important role in the regulation of 
intracellular pH and transepithelial acid-base transportation in biliary epithelial 
cells (Concepcion et al., 2013). Also, it has been reported that AE2 is expressed 
on the apical surface of both biliary epithelial cells and hepatocytes and is 
critically involved in pHi regulation and HCO3- secretion into the bile (Martinez-
Anso et al., 1994; Medina et al., 1997). Furthermore, it has been shown that 
AE2 is expressed in the airways (Al-Bazzaz et al., 2001) as well as Calu-3 cells 
at the basolateral membrane by immunofluorescence (Loffing et al., 2000)  
More recently, it has been confirmed that AE2 mRNA and protein are expressed 
in the basolateral membrane of Calu-3 cells, which plays an important role in 
basolateral Cl- loading and HCO3- recycling under cAMP stimulated condition 
in Calu-3 cells (Huang et al., 2012). Moreover, the intracellular alkalinisation 
produced by basolateral Cl- removal was inhibited by 80% in AE2 knock down 
Calu-3 cells (Huang et al., 2012). Basolateral AE2 is thought to plays an 
important role in the regulation of intracellular pH in Calu-3 cells by 
participating in HCO3- absorption, and also it facilitates the inward movement of 
Cl- through the basolateral membrane, together with the sodium-potassium 
chloride cotransporter NKCC1 (Loffing et al., 2000; Inglis et al., 2002). In 
contrast to results by Huang et al., (2012), most recent results by Garnett et al, 
have demonstrated that a functional AE was present  in the basolateral surface of 
Calu-3 cells under resting, non-stimulated conditions, with properties that are 
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consistent with AE2, and which was almost completely inhibited by intracellular 
elevation of cAMP (Garnett et al., 2011; Garnett et al., 2013). In addition to 
regulating pHi and cell volume, AE2 also plays a vital role in superoxide (O2-) 
transportation into the extracellular space in exchange for extracellular HCO3- 
(Turi et al., 2002). AE2 has been shown to be involved in hyperoxia-induced 
oxidative lung injury, which was markedly reduced by inhibition of AE2 by 
DIDS or perfusion with a bicarbonate free buffer solution (Nozik-Grayck et al., 
1997). However, the mechanisms that regulate AE2 activity in epithelia are not 
well understood. This gives much interest to further investigate the mechanism 
that regulates this anion exchanger in airway epithelia.  
 
 
1.11 Calu-3 Cells as a model of human submucosal gland serous cells 
 
There was an excitement about discovering a human cell line that has many 
characteristics resembling serous cells, as primary human serous cells are 
difficult to isolate and grow in culture (Shen et al., 1994). The Calu-3 cell line 
was derived from human lung adenocarcinoma cells (Shen et al., 1994) and was 
introduced as a serous cell model based on the presence of many properties of 
serous cells, such as high CFTR expression, production of antimicrobials, 
including lysozyme and lactoferrin (Haws et al., 1994; Duszyk, 2001a; Dubin et 
al., 2004). Also, Calu-3 cells form polarized monolayers (Garnett et al., 2011; 
Shan et al., 2011) capable of anion secretion in response to secretagogues that 
increase intracellular cAMP concentration (Shen et al., 1994; Devor et al., 1999; 
Garnett et al., 2011; Garnett et al., 2013). cAMP stimulation of Calu-3 cells 
leads to CFTR-dependent electrogenic Cl- secretion (Cobb et al., 2002), as well 
as HCO3- secretion (Shan et al., 2012; Garnett et al., 2013; Kim et al., 2014). 
Also, stimulation of Calu-3 cells with cAMP agonist, VIP, caused a CFTR-
dependent I- transport through a DIDS insensitive but PKA-dependent 
mechanism (Derand et al., 2004). Based on the presence of these features, Calu-
34 
 
3 cells are a good model to use for studying transepithelial HCO3- secretion, and 
the importance of CFTR and anion exchangers in serous cell anion secretion. 
A current model for mechanism of anion secretion in Calu-3 is summarised in 
figure 1.11. At the basolateral membrane of the Calu-3 cells, NBC is responsible 
for HCO3- influx into the cells due to the positive regulatory effect of cAMP on 
NBC, with an inwardly-directed Na+ gradient maintained by Na+-K+ ATPase 
(not shown in the figure). Interestingly, recent work in our laboratory has shown 
that increases in intracellular cAMP leads to inhibition of basolateral Cl-/HCO3- 
(AE) activity, which is followed by stimulation of NBC and HCO3- 
transportation into the cell (M. Turner, PhD thesis 2014). Cl- uptake across the 
basolateral membrane is regulated by Na+-K+-Cl- cotransporter (NKCC) and 
potentially AE2 (Devor et al., 1999). At the apical membrane, Cl- exits from the 
cells by the CFTR channel. It has been discovered for the first time that there is 
a cAMP/PKA activated Cl-/HCO3- exchanger on the apical surface of Calu-3 
cells, and its functional properties are similar to those of pendrin (SLC26A4) 
that play a crucial role in HCO3- secretion across the cell membrane of airway 
epithelia Calu-3 cells, while Cl- is recycled by coordinated activity between 
CFTR and pendrin (Garnett et al., 2013). An inwardly-directed Cl- concentration 
gradient acts as the main driving force for HCO3- secretion by luminal Cl-
/HCO3- exchangers. In addition an apical Cl- conductance is essential for 
efficient operation of apical Cl-/HCO3- exchangers (Dorwart et al., 2008). 
Intracellular elevation of cAMP leads to stimulation of CFTR Cl- efflux and 
HCO3- secretion across the apical membrane via pendrin, while inhibiting 
basolateral AE2 (Garnett et al., 2011; Garnett et al., 2013). Paradoxically, recent 
studies by Shan et al., (2012) and Kim et al. (2014) found that CFTR was the 
predominant pathway for HCO3- secretion in Calu-3 cells, and it worked 
independently of an apical Cl-/HCO3- exchanger (Shan et al., 2012; Kim et al., 
2014). In addition HCO3- secretion was blocked by CFTR inhibitors or genetic 
knock down of CFTR (Shan et al., 2012). Furthermore, basolateral AE2 was not 
abolished during cAMP stimulation in Calu-3 cells (Huang et al., 2012; Shan et 
al., 2012; Kim et al., 2014). The reason for these different findings is not clear 
but may be related to different growth conditions or batches of Calu-3 cells.  
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However, we don’t have a full understanding how CFTR regulates HCO3- 
secretion in the airways, or the molecular mechanisms that regulate both the 
apical and basolateral Cl-/HCO3- AE in airway HCO3- transportation. Thus, 
regulation of CFTR-dependent apical Cl-/HCO3- AE activity, as well as the 
basolateral AE is an important area of research, and forms the basis of this 
thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 11: Mechanism of anion secretion in the Calu-3 cells. This new model 
shows HCO3- transportation across the apical and basolateral membrane in cAMP-
stimulated Calu-3 cells. tmAC= transmembrane adenylyl cyclase, CFTR= Cystic 
fibrosis transmembrane conductance regulator, NKCC= Na+-K+-2Cl– cotransporter, 
NBC= Na+-HCO3- cotransporter, NHE= Na+-H+ exchanger, AE2= anion exchanger 2, 
VIP= Vasoactive intestinal peptide. (+) denotes stimulation, (-) denotes inhibition. 
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Aims  
 
The major aim of the current study was to investigate the signalling mechanisms 
that regulate the CFTR-dependent apical Cl-/HCO3- anion exchanger (AE), as 
well as the basolateral Cl-/HCO3- AE, to better understand their role in 
bicarbonate secretion in a model human airway epithelial cell line.  
 
 
The detailed aims of this study were to: 
 
• Study the functional properties of the basolateral Cl-/HCO3- AE in polarised 
cultures of Calu-3 cells  
• Investigate the effect of cAMP agonists on the activity of the apical and 
basolateral Cl-/HCO3- AEs in polarised cultures of Calu-3 cells 
• Investigate the role of intracellular and extracellular Ca2+ on the regulation of 
the apical and basolateral Cl-/HCO3- AE activity in polarised cultures of Calu-3 
cells 
• Identify the protein kinases and phosphatases that regulate the apical and 
basolateral Cl-/HCO3- activity under resting and cAMP-stimulated conditions. 
• Study the role of the actin cytoskeleton and dynamin in the regulation of the 
apical and basolateral Cl-/HCO3- AE activity in polarised cultures of Calu-3 cells 
• Compare the properties of the basolateral Cl-/HCO3- AE in Calu-3 cells to those 
of mouse AE2, after transient transfection in HEK-293T cells. 
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Chapter 2 Methods  
2.1 Cell culture  
Routine cell culture was carried out in a vertical laminar flow hood (Jouan Ltd, 
UK).  The human adenocarcinoma-derived cell line, Calu-3  (ATCC HTB-55) 
(Shen et al., 1994) were grown in T75 Costar cell culture flasks (75cm2) with 30 
mls of Eagle’s Minimum Essential Medium (EMEM)  supplemented with 10%  
fetal bovine serum  (FBS), 100 Um1-1 penicillin and 100µgml-1 streptomycin, 
1% non-essential amino acids, 2mM L-Glutamine (Sigma) and incubated at 
37ºC in a humidified air containing 5% CO2. Culture media and solutions were 
pre-warmed to 37˚C in a water bath prior to use. All culture media, supplements 
and consumables were sterile, and all the equipment was sterilized before use in 
the hood using ethyl alcohol (70%). Cells were initially seeded at 3 x 106 cells 
per flask, and then incubated in humidified air at 37°C containing 5% (v/v) 
CO2. Cells became confluent after 7 days, and then passaged once per week. 
Frozen stocks were stored in liquid nitrogen, and were only used between 
passages 20-50. To subculture Calu-3 cells, the media was removed from the 
flask and cells were washed 3 times with sterile phosphate buffered saline 
(PBS). Cells were trypsinized in 5 mls of trypsin solution (0.05% trypsin and 
0.02% ethylenediaminetetraacetic acid (EDTA) in Earle’s balanced salt solution) 
for 20 minutes in a humidified incubator at 37ºC. After the first 20 minutes, the 
detached cells (approximately 50% of the cells) were added to 10 mls pre-
warmed culture medium, and then another 5 mls of trypsin solution was added 
to the flask and incubated for another 20 minutes to ensure detachment of the 
remaining cells, and these cells were added to the culture medium. The resulting 
cell suspension was agitated gently, and then centrifuged at 1500g for 3 minutes.  
The supernatant was discarded but the cell pellet was re-suspended in 10 mls of 
culture media before seeding the cells into a new flask. For pHi experiments, 
cells were seeded at 250,000 cells cm2 initial seeding density onto semi-
permeable Transwell supports (0.4 μm pore, polyester membrane insert, 1.12 
cm2 surface area, (Corning, UK)). Calu-3 cells generally produced a polarized 
38 
 
monolayer after 7 days. All experiments described in this thesis were carried out 
8-14 days after seeding. 
Human Embryonic Kidney-293T cells (HEK-293T) and CK2 (alpha and alpha 
prime) knock out HEK-293T cells were cultured in flasks (75cm2) with 30 mls 
of Dulbecco's Modified Eagle's Medium (DMEM), supplemented as for Calu-3 
cells. HEK-293T cells were initially seeded at 1 x 106 cells in a T75 flask, and 
then incubated at 37°C in a 5% (v/v) CO2 atmosphere. Cells became confluent 
after 7 days, and were only used between passage 35 and passage 50. HEK-293T 
cells were subcultured once per week, using the same protocol as Calu-3 cells 
apart from the fact that HEK-293T cells were much more easily detached after 
incubation in 5 mls of trypsin solution for 1 minute in a humidified incubator at 
37ºC. For pHi experiments, HEK-293T cells were seeded onto the glass 
coverslips (25mm diameter) at 100,000 cells cm2 initial seeding density, and 
then transiently transfected with cDNA coding for mAE2, CFTR and/or various 
CK2 constructs, 1 day post seeding.  
The knockout CK2 (alpha and alpha prime) cells were a kind gift from Dr. Salvi 
and were generated in Dr. Salvi lab (University of Padova, Italy) in 
collaboration with Horizon Discovery, using the CRISPR/CaS9 method. The 
absence of the catalytic subunits kinase was confirmed by western blotting (see 
figure 2.1) 
For transient transfections, DNA was pre-complexed with Lipofectamine-2000 
(Manufacturers) at a ratio of 1: 2.28 respectively. After that, Opti-MEM media 
with GlutaMax was added for 15 minutes at room temperature, and then diluted 
in culture media to 1µgDNA/ml prior to adding to the cells. The transfected cells 
were incubated for 6 hours at 37°C, and then the complex media was removed 
and cells incubated with  OptiMEM+10% FCS overnight, after which the cells 
were returned back to normal culture media. pHi experiments were performed on 
the transfected cells 48 hours post transfection.   
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Figure 2. 1: Western blotting against CK2 alpha subunits. The absence of both CK2 
alpha (α) and alpha prime (α’) subunits of CK2, in the knockout cells, was confirmed by 
western blot analysis, which was performed in Dr. Salvi lab in collaboration with 
Horizon Discovery. 
 
 
2.1.1 Expression constructs: 
 
Mouse AE2 cDNA (HA-tag) was a kind gift from Beth Lee and Ron Kopito's 
lab, for more detail see Lee et al., (1991) (Lee et al., 1991). Empty plasmid  
(pcDNA 3.1 myc/His), human WT-CK2 (CK2-alpha), and double mutant CK2 
(DM-CK2; less sensitive to TBB) cDNA were a kind gift from Dr. M Salvi Lab, 
see reference (Salvi et al., 2006), DNA sequencing analysis to confirm the 
constructs. Human CFTR was a kind gift from Dr. Paul Linsdell, and was 
inserted into the pIRES2-EGFP vector, which allows strong expression of green 
fluorescent as well as CFTTR. For more detail see (Zhou et al., 2010). CFTR 
transfected cells were visualized under the fluorescent microscope before doing 
the pHi experiments and the GFP did not interfered with pHi measurements in 
BCECF-loaded cells. 
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2.2 Transepithelial Resistance Measurements 
The trans-epithelial electrical resistance (TEER) of Calu-3 cells grown on 
Transwell supports was used to determine whether cells had formed a polarized, 
resistive monolayer, and was measured using an Epithelial Voltohmmeter 
(World Precision Instruments, UK).  
Resistance measurements were corrected for the resistance of an empty 
transwell which was calculated as 111± 4 Ω cm-2. Cells were only used for 
experiments when TEER had reached a stable resistance of above 600 Ω cm-2. 
 
2.3 Measurement of intracellular pH  
Real-time intracellular pH measurements (pHi) were performed to investigate 
the H+/HCO3- transport in Calu-3 and HEK-293T cells. 
  
(i) Calu-3 cells. Following culture of Calu-3 cells on Transwell supports, the cells  
were first washed with  NaHEPES, and then the  cells were loaded with 10µM 
of the pH sensitive dye, 2'-7'-bis (carboxyethyl)-5(6)-carboxyfluorescein 
acetoxymethyl ester (BCECF-AM) in NaHEPES. 0.5 ml of the dye solution was 
added to the apical chamber and 1 ml of dye-free NaHEPES was added to the 
basolateral compartment. Cells were then incubated for 60 mins at 37 ºC. After 
dye loading, transwells were placed in a perfusion chamber and then mounted 
onto the stage of a Nikon inverted microscope. Cells were viewed at x60 
magnification using a long working distance objective (N.A 0.6) and perfused 
with a high chloride KREBS solution at 37 ºC gassed with 5% CO2/95%O2,  in 
order to adjust the pH of the solution to 7.4. Perfusion of the apical and 
basolateral side of the cells was at a rate of 3 and 6 ml per minute, respectively.  
 
(ii) HEK-293T cells. Following culture and transient transfection of HEK-293T 
cells on glass coverslips, the cells were washed with NaHEPES, and then were 
loaded with 10µM of the pH sensitive dye, BCECF-AM in NaHEPES solution. 
1 ml of the dye solution was added onto the coverslip inside the well plate, and 
then incubated for 10 mins at 37 ºC. After dye loading, coverslips were placed in 
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a perfusion chamber and then mounted onto the stage of a Nikon inverted 
microscope. Cells were viewed at x100 magnification using an oil immersion 
objective (N.A 1.2) and perfused with a high chloride KREBS solution at 37 ºC 
gassed with 5% CO2/95%O2,  in order to adjust the pH of the solution. Cells 
were then perfused with the solution at a rate of 3 ml per minute.  
 
To measure pHi, a Life Sciences Microfluorimeter system (Life Science 
Resources, UK) was used. Cells were excited by two different wavelengths, 490 
nm (proton-bound BCECF-AM; pHi-dependent) and 440 nm (proton-free 
BCECF-AM; pHi-independent) with emitted light collected at 510 nm every 
1.024 s using a photomultiplier tube. The ratio (R) of 490 nm emission to 440 
nm emission was recorded using the PhoCal 1.6b software and used to calculate 
pHi using the intracellular pH calibration (see section 2.4).  
 
 
2.4 Intracellular pH Calibration 
The intracellular pH calibration was performed by using the high K+/nigericin 
method as described by James-Kracke, (1992) (James-Kracke, 1992). In brief, 
Calu-3 cells were prepared in the same way as intracellular pH measurements 
and high K+/nigericin solutions of set pH were perfused across the cells without 
gassing. A standard curve was generated by plotting the resulting mean R value 
calculated over a 60 s period against the pH of the perfused solutions. (pHi 
calibration data is shown in Figure 2.2). During the period of my research, 
several calibrations were performed to calibrate pHi in different batches of Calu-
3 cells. The experimental R value was converted to pHi by using the following 
equation: 
            pHi = R – (Y-axis intercept) / slope  
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Where: 
R = 490/440 ratio value 
Slope = slope of the linear regression fit to the standard curve 
Y-intercept = point at which the line crosses the X-axis of a graph, when X= 0. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 2: Intracellular pH calibration using the high K+/nigericin technique. (A) 
Shows a representative trace of BCECF-AM (10µM) loaded Calu-3 cells illustrating 
how the R value alters when cells are perfused with high K+/nigericin solutions of 
different pH. (B) Shows the standard curve generated from the pHi calibration and is 
used for the calculation of pHi from the 490/440 ratio data. Data represents mean ± 
S.E.M.; n = 4. 
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2.5 Data analysis of pHi measurements 
As shown in figure 2.3, estimation of the mean change in pHi (ΔpHi) was 
calculated by taking the average pHi over 60 s before (labelled A) and after 
(labelled B) the new solution was applied, in order to establish a basal pHi. This 
value was then subtracted from the mean pHi obtained in the presence of test 
solution after the pHi had reached a new steady state (labelled C). Linear 
regression was used to calculate the initial rate of re-acidification (ΔpHi/Δt) 
following Cl- re-addition (labelled D) over a period of no less than 30 s of data. 
The ΔpHi/Δt was converted to transmembrane HCO3
- efflux by multiplying 
ΔpHi/Δt by the total buffering capacity of the cell (see section 2.6). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 3: Data analysis of intracellular pH measurements. Standard response to 
Cl- free solution showing the effect of high Cl- and free Cl- buffer solution on pHi in 
Calu-3 cells. Red areas represent data used to calculate mean pHi change, and the green 
line represents the data points for linear regression used to calculate the rate of pHi 
change (reacidification) by linear regression. 
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2.6 Determination of Total and Intrinsic Intracellular Buffering Capacity of cells 
 
In order to determine the total buffering capacity (βtot) of both cell lines used in 
this study (Calu-3 cells and HEK-293T cells), the intrinsic buffering capacity 
(βi) was first obtained by experimentation and then added to the buffering 
capacity of the CO2-HCO3- buffer system (βHCO3-). Calu-3 cells and HEK-
293T cells βi was calculated using the NH4
+  pulse technique (Roos and Boron, 
1981). Cells were exposed to solutions containing differing amounts of NH4Cl 
(0, 2.5, 5, 10, 20, 30mM NH4Cl). The perfused ammonium solution was free 
from Na+ and HCO3- to block Na+ and HCO3--dependent pH regulatory 
mechanisms, respectively (Figure 2.4). NH3 enters the cell and subsequently 
binds to free protons to form NH4+ which causes an alkalinisation of pHi. βi is 
then calculated via the following equation: 
 
 
 
 
 
Where Δ[NH4+]i = [NH4+]out  x 10(pHout-pHin) 
 
 
 
Where [NH4+]out = [NH4Cl]/(1+10(pH out - pKa)) 
 
pHout =7.4, pKa = 8.9 
 
So for 30 mM NH4Cl, [NH4+]o = 29.08mM at pH 7.4 
 
βHCO3
-
 is calculated using the formula:   βHCO3- = 2.3 x [HCO3-]i,  
in which the Henderson Hasselbach equation states:   
[HCO3-]i = pCO2 x 10(pH –pK)  
where pK= 6.1 
  
Δ[NH4+]i 
ΔpHi 
βi = 
45 
 
12
3
4
5
6
7
8
0mM NH4Cl2 30mM NH4Cl2 20mM NH4Cl2 10mM NH4Cl2 5mM NH4Cl22.5mM NH4Cl2 0mM NH4Cl2
49
0/
44
0
The total buffering capacity is then calculated by the following equation;  
 
βtot = βi + βHCO3- where βi represents the intrinsic buffering capacity and βHCO3- 
is the CO2-HCO3--dependent buffer capacity. 
 
The buffering capacity for Calu-3 cells and HEK-293T cells at 5% CO2 are 
displayed in figure 2.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 4: Determining of total intrinsic buffering capacity in Clau-3 cells. 
Experimental pH trace showing the changes in ratio in Calu-3 cells in response to 
differing concentration of NH4Cl solutions containing of (0, 2.5, 5, 10, 20, 30 mM/L 
NH4Cl). 
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Figure 2. 5: Buffering capacity at various pH values in Calu-3 cells (A) and HEK-
293T cells (B). Total buffering capacity (βtot) was calculated by adding the intrinsic 
buffering capacity of Calu-3 cells (βi) to the buffering capacity of the CO2/HCO3- buffer 
system (βHCO3
-). βtot was calculated for cells exposed to 5% CO2, n = 6. 
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2.7 Fluid Secretion Assays 
Polarized monolayers of Calu-3 cells grown on permeable Transwell supports 
for 7-10 days, were first washed three times with PBS (1ml to apical and 
basolateral compartments) in order to remove any mucus  from the apical 
surface of cells that may have accumulated over time. All PBS was then 
aspirated from the apical and basolateral sides with extra care to ensure no 
residual fluid remained on both sides of the transwell at the end of the washes. 
To determine the rate and pH of the secreted fluid, 200 μl and 1ml of 
KREBS/HCO3- solution was added to the apical and basolateral compartments 
respectively, as well as the desired pharmacological agonist or inhibitor. Cells 
were then incubated at 37˚C in humidified air containing 5% (v/v) CO2 over a 
24 hour period. The volume of apical fluid was then measured using an 
appropriate Gilson pipette by removing the first 180μl of the fluid and placing 
this in an eppendorf.  Then the remaining fluid was removed, 1μl at a time, to 
ensure high accuracy and combined with the first 180μl.  
 
For pH measurements, the collected samples were incubated at 37˚C in 
humidified air containing 5% (v/v) CO2 for at least 5 mins for pH to equilibrate, 
and then pH measured using a micro pH electrode attached to a pH meter (pH 
meter 240, Corning).  
 
 
2.8 Confocal Microscopy 
(i) Actin-cytoskeleton. Confluent Calu-3 cell monolayers, grown for 8-12 days on 
12 mm transwell supports, were used to visualise the actin cytoskeleton network 
using confocal microscopy. After removing the culture media from the 
transwells, 10μM cytochalasin-D or solvent control was added to the cells and 
incubated at 37˚C in for 1 h in humidified air containing 5% (v/v) CO2. 
Following treatment, cells were washed with PBS three times and then fixed 
with 4% paraformaldehyde (PFA) for 10 minutes. Cells were then washed three 
times with PBS (each for 5 minutes), and then washed with 50mM NH4Cl to 
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quench any remaining PFA. After washing, cells were permeabilized by Triton 
X-100 (1% in PBS) for 5 minutes at room temperature and then rinsed with PBS 
three times for 5 minutes. Blocking buffer containing PBS with 3% FCS and 
0.1% azide was added to the cells to block non-specific binding. At this point, 
the transwell membrane was cut out gently and placed in a 12 well plate with the 
apical side facing upwards. Cells were then treated with 200μl of PBS 
containing 3% fetal calf serum, 0.1% azide and 0.25% fluorescent Phalloidin–
Tetramethylrhodamine B isothiocyanate (Phalloidin-TRITC) (Sigma) for 30 
minutes at room temperature, and subsequently cells were washed twice with 
PBS to remove unbound phalloidin conjugate. 0.2μg/ml 4',6-diamidino-2-
phenylindole (DAPI) was then added for two minutes in order to stain nuclei, 
and then cells were rinsed with PBS, and then mounted on slides using 1-2 drops 
of Vectashield mounting medium (Vector Laboratories, UK). 
 
(ii) Detection of HA-tagged mAE2. Control, untransfected and transfected HEK-
293T cells expressing HA-tagged mAE2, grown on glass coverslips for 2 days, 
were fixed with 4% PFA for 10 mins at room temperature. Cells were then 
washed with PBS three times for 5 minutes, and then washed with 50mM 
NH4Cl to quench any remaining PFA. After washing, fixed cells were then 
incubated in Triton X-100 (1% in PBS) for 5 minutes at room temperature to 
permeabilize cells, and then washed in PBS three times for 5 minutes. To block 
non-specific binding, cells were incubated with blocking buffer containing 1% 
Na-azide and 5% Goat serum in PBS at room temperature for 30 minutes. 
Blocking buffer was removed and cells were then incubated in diluted primary 
antibody (Anti-HA16B12, 1/1000 in blocking buffer, Abcam) overnight at 4°C 
on a shaker. Cells were then rinsed in PBS three times for 15 minutes to remove 
any residual unbounded primary antibody. At this point, cells were incubated 
with the diluted FITC-conjugated secondary antibody (Goat-anti mouse 
antibody, 1/100 in blocking buffer) for 1hour at room temperature away from 
light by covering with aluminium foil. Cells were then washed with PBS three 
times for 15 minutes to remove any unbounded secondary antibody. After 
washing, DAPI dye (1μg/ml) was added onto coverslips for 2 minutes, at room 
temperature, away from light, to stain the nucleus and then gently washed in 
PBS to remove any remaining DAPI. Coverslips was then mounted onto a 
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labelled microscope slide, using mounting medium, with the cell-side faced 
down. Some silicone gel was added along the edge of coverslip to seal it to the 
slide to prevent drying and movement of the coverslip under the microscope.  
 
Cells were observed under Nikon A1R Confocal microscope at x60 
magnification (0.1 DIC lens) with a numerical aperture of 1.4. Cells were 
excited with the DAPI excitation wavelength of 405nm to visualize DAPI 
stained specimens, and imaged at the emission wavelength of 450nm. TRITC 
stained specimens was visualized with 595nm excitation wavelength and 561nm 
emission wavelength.  To visualize FITC stained specimens, cells were excited 
with the FITC-excitation wavelength of 495nm and imaged at the emission 
wavelength of 517nm.  
 
 
2.9 Solutions and reagents 
All reagents and inhibitors were purchased from Sigma-Aldrich (Sigma-Aldrich 
Company Ltd., UK), apart from forskolin, BAPTA-AM, and TBB (R & D 
Systems); BCECF-AM, DIDS, Lipofectamine 2000, WGA (Invitrogen), GlyH-
101, CFTRinh-172, J-8 (Santa Cruz), Okadaic acid (Calbiochem), RpcAMP 
(Enzo life science), and Anti-HA antibody (Abcam). Gas cylinders were 
purchased from BOC and consisted of the following mixtures: 5% CO2 /95% 
O2. CX-4945 was a kind gift from Dr. Andrea Venerando (University of Padova, 
Italy). 
 
All stock solutions of agonists and inhibitors used for pHi experiments and fluid 
secretion assay were made in DMSO, apart from nigericin (made in 100% 
ethanol), and 8CPT-2Me-cAMP, carbachol and adenosine (dissolved in 
deionised water).  
 
The HCO3- free Na-HEPES buffer solution consisted of 130mM NaCl, 5mM 
KCl, 1mM CaCl2, 1mM MgCl2, 10mM NaHEPES and 10mM D-Glucose. The 
Cl--free HEPES buffer solution consisted of 130mM Na-gluconate, 2.5mM 
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K2SO4, 6mM Ca-gluconate, 1mM Mg-gluconate, 10mM HEPES (free acid) and 
10mM D-Glucose. All HEPES-buffered solutions were calibrated to pH 7.6 at 
room temperature (7.4 at 37˚C) by addition of 1M HCl. 
 
High Cl-- Krebs solution consisted of NaHCO3- (25mM), NaCl (115mM), KCl 
(5mM), CaCl2 (1mM), MgCl2 (1mM) and D-Glucose (10mM). In the high 
K+/high Cl- Krebs solution, the KCl concentration was increased to 115mM and 
NaCl decreased to 5mM to maintain osmolarity. In the Ca2+-free high Cl-- Krebs 
solution, the NaCl concentration was increased to 116mM, and CaCl2 was 
replaced with MgCl2 and 0.5mM EGTA was added to chelate any remaining 
Ca2+. In the Cl--free HCO3- solution, Cl- was substituted for gluconate, and 
consisted of NaHCO3- (25mM), Na-Gluconate (115mM), K2SO4 (2.5mM), Ca-
Gluconate (6mM), Mg-Gluconate (1mM) and D-Glucose (10mM). In the Ca2+-
free Cl--free Krebs solution, the Na-Gluconate concentration was increased to 
124mM, and 0.5mM EGTA was added to chelate any remaining Ca2+. The 
solution was adjusted to pH 7.4 at 37°C by bubbling with %5CO2/%95O2.  
 
The intracellular pH calibration solutions consisted of (in mM) 5 NaCl, 130 
KCl, 1 CaCl2, 1MgCl2, 10 D-Glucose, 10 HEPES (for solutions set at pH 7.6 or 
below) or 10 TRIS (for solutions set at pH 7.8 or above) as well as 10μM 
nigericin. This was added just before the start of experiments. Solutions were set 
to the desired pH by using either 1M HCl or 1M NaOH.  
 
The ammonium pulse solutions used to determine intracellular buffering 
capacity consisted of (in mM) 4.5 KCl, 1MgCl2, 2 CaCl2, 5 BaCl, 10 HEPES, 10 
D-Glucose as well as varying concentrations of NH4Cl/NMDG-Cl, ranging from 
0 NH4Cl/145 NMDG-Cl to 30 NH4 Cl/115 NMDG-Cl. All solutions were 
titrated to pH 7.4 at 37˚C using 1M CsOH. 
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2.10 Statistical analysis 
 
All results are presented as mean ± S.E.M. where n is the number of 
experiments. For data presentation and statistical analysis, GraphPad Prism 4 
software (GraphPad Software, USA) was used for statistical analysis and either 
a Student’s t test (paired or unpaired), one-way ANOVA (with Tukey’s multiple 
comparison post-test) or two-way ANOVA (with Bonferroni’s post-test)  used 
where applicable. P values of <0.05 were considered statistically significant. 
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Chapter 3 Regulation of the apical Cl-/HCO3- anion exchange activity in 
polarised cultures of Calu-3 cells 
3.1 Introduction     
As detailed in the Introduction (section 1.1.1) it has been shown that 
transepithelial HCO3- secretion in many epithelial tissues is dependent on CFTR. 
However, there is still some uncertainty about the exact role that CFTR plays in 
this process, particularly in the airways.  Evidence from our own laboratory 
(Garnett et al., 2011), and more recently from (Lee et al., 2015) have 
demonstrated that SLC26A transporters are present in the airways, suggesting 
that airway HCO3- secretion could involve the combined activity of CFTR and 
Cl-/HCO3- exchange. However, this conclusion is in marked contrast to previous 
work from Calu-3 cells, which suggested that both Cl- and HCO3- secretion was 
mediated only by CFTR (Poulsen et al., 1994; Illek et al., 1997; Lee et al., 1998; 
Krouse et al., 2004; Shan et al., 2012). While the reasons for these different 
conclusions are still not resolved, it is clear that the molecular mechanisms that 
orchestrate HCO3- secretion in these cells is still incompletely understood 
(Garnett et al., 2013), and requires further investigation. Although, our previous 
work showed that stimulation of HCO3- secretion was clearly cAMP/PKA-
dependent (Garnett et al., 2011), little is known about the contribution of other 
cAMP-dependent binding proteins, or indeed other second messengers (such as 
intracellular calcium), and associated protein kinase signalling pathways, in 
regulating this process. This chapter details the investigations into the effects of 
non-cAMP/PKA dependent pathways in the regulation of CFTR-dependent 
apical anion exchange activity in human Calu-3 cells. Furthermore, it also 
describes the role of the actin cytoskeleton and dynamin in regulating apical AE 
activity. 
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3.2 Role of cyclic nucleotides (cAMP and cGMP) in the regulation of apical Cl-/HCO3- 
AE activity 
3.2.1 Role of cAMP/PKA in the regulation of apical Cl-/HCO3- AE activity  
Apical Cl-/HCO3- AE activity in Calu-3 cells was assessed by measuring the 
change in intracellular pH (pHi) in response to the removal and readdition of Cl- 
from the apical perfusate, using HCO3- containing buffers (see Methods) in the 
absence and presence of different treatments.  Figure 3.1A shows a typical pHi 
response trace to these manoeuvres in Calu-3 cells, in the absence and presence 
of the cAMP agonist forskolin (Fsk), which increases cAMP by directly 
stimulating transmembrane adenylyl cyclise (tmAC). Under non stimulated 
conditions, perfusion of a Cl- free solution to the apical side had little or no 
effect on pHi. Exposing cells to Fsk (5µM) in symmetrical high Cl- conditions, 
caused a significant acidification of 0.17±0.02 pH units, at a rate of 0.27±0.05 
pH units min-1 (P<0.05, n=10). Subsequent apical Cl- removal now produced an 
alkalinisation in pHi of 0.48 ± 0.03 pH units. Following Cl- readdition pHi 
reacidified at a rate of 0.86 ± 0.15 pH unit min-1 (P<0.05, n=10, Figure 3.1C and 
D). It was noticeable that the alkalinisation caused by apical Cl- removal was 
biphasic, with a fast initial rate of change, followed by a slower increase in pHi 
to a new plateau level, consistent with previous results published by our group 
(Garnett et al., 2011).  
In order to further investigate the dependency of apical Cl-/HCO3- AE activity 
on intracellular cAMP, the physiological cAMP agonist adenosine (ADO) was 
also tested on apical Cl-/HCO3- AE activity (Figure 3.1B). Adenosine can 
stimulate adenylyl cyclase activity via binding to adenosine type 2B receptors 
(A2BR) , and thus increase intracellular cAMP (Clancy et al., 1999). It has also 
been shown by short circuit measurements that A2B rare expressed on both the 
apical and basolateral membranes of Calu-3 cells (Szkotak et al., 2003). My 
results showed that apical Cl- removal under bilateral ADO stimulation (10μM) 
produced a significant alkalinisation in pHi of 0.22 ± 0.04 pH units, which 
reacidified at a rate of 0.09 ± 0.01 pH unit min-1 (P<0.05, n=3, Figure 3.1E and 
F) upon Cl- readdition. However, Fsk caused a significantly larger increase in 
apical Cl-/HCO3- AE activity, both in the magnitude of alkalinisation produced 
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by apical Cl- removal, and the rate of reacidification following Cl- readdition, 
compared to ADO stimulated cells. Also, the rate of HCO3- efflux upon Cl- 
readdition under Fsk stimulation was significantly greater compared to ADO 
stimulation (Figure 3.1G). Furthermore, in different experiments, stimulation of 
Calu-3 cells with 5μM forskolin and incubated in 5% CO2  (v/v) in air for 24 h 
in high Cl- Krebs solution at 37˚C, produced a significant increase in both 
volume and the pH of the secreted fluid, compared to untreated cells (Figure 
3.22A and B). These results indicate that Calu-3 cells have little AE activity in 
the apical membrane under resting conditions, while increasing [cAMP]i by Fsk 
(and ADO) caused activation of apical Cl-/HCO3- AE activity, as well as an 
increase in net HCO3- secretion. 
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Figure 3. 1: Apical Cl-/HCO3- AE activity in Calu-3 cells before and after 
stimulation with cAMP agonists. Representative pHi trace showing the effect of Cl- 
removal in the apical perfusate on pHi under basal and Fsk-stimulated conditions (A) or 
ADO-stimulated conditions (B). Summary of mean pHi change (alkalinisation) caused 
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by Cl- removal (C), and the rate of reacidification following Cl- readdition (D), in the 
presence and absence of forskolin (5µM), paired observations, n=10 for each condition. 
*P<0.05 compared to apical 0Cl- (Basal). (E) mean pHi change (alkalinisation) caused 
by Cl- removal, and the rate of reacidification (F) following Cl- readdition, in the 
presence and absence of ADO (10μM), n=3 for each condition. *P<0.05 compared to 
apical 0Cl- (G). The rate of HCO3- flux under both Fsk and ADO stimulated conditions 
*P<0.05 compared to apical 0Cl- + Fsk. Fsk denotes forskolin (5µM), ADO denotes 
adenosine (10µM), Apical 0Cl- refers to the removal of apical Cl-. Data are shown as 
mean ±SEM  
 
 
 
 
Another way to increase cAMP inside cells, aside from Fsk and ADO, but which 
is downstream of tmAC, was to expose cells to the general phosphodiesterase 
(PDE) inhibitor 3-Isobutyl-1-methylxanthine (IBMX) or to use a membrane 
permeable analogue of cAMP, such as dibutrylyl-cAMP (db-cAMP). My results 
showed that both these cAMP agonists caused stimulation of apical Cl-/HCO3- 
AE activity (Figure 3.2) which was not significantly different to the results 
obtained with Fsk. These results provide further support that stimulation of 
apical Cl-/HCO3- AE activity is cAMP dependent. 
 
 
      A                                                                          B                                C 
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Figure 3. 2: The PDE inhibitor, IBMX, and the membrane permeable analogue of 
cAMP, dbcAMP, mimic the effect of Fsk on apical Cl-/HCO3- AE activity in Calu-3 
cells. (A) Representative pHi trace showing the effect of Cl- removal in the apical 
perfusate on pHi under Fsk and IBMX (1.0mM added apically) stimulated conditions. 
Summary of mean pHi change (alkalinisation) caused by Cl- removal (B), and the rate 
of reacidification (C) following Cl- readdition in Fsk and IBMX stimulated conditions; 
no significant difference (P>0.05) compared to apical 0Cl-+Fsk. Mean pHi change 
(alkalinisation) caused by Cl- removal (D), and the rate of reacidification (E) following 
Cl- readdition in Fsk stimulated cells compared to dbcAMP stimulation (800µM, added 
bilaterally). No significant difference (P>0.05) compared to apical 0Cl-+Fsk, although 
mean pHi change was significantly (P<0.05) lower with dbcAMP compared to apical 
0Cl-+Fsk. Data are shown as mean ±SEM (n=3), paired observations. 
 
 
 
It was of interest to investigate the mechanism responsible for cAMP 
stimulation of apical Cl-/HCO3- AE activity, and to understand whether cAMP-
induced activation of apical Cl-/HCO3-AE was direct or through a downstream 
target of cAMP, including PKA and exchange protein directly activated by 
cAMP (Epac) (Schmidt et al., 2013). Therefore, I performed a series of 
experiments to assess the effect of two different protein kinase A (PKA) 
inhibitors, H-89 and Rp-adenosine-3',5'-cyclic monophosphorothioate (Rp-
cAMP) on the Fsk response, in Calu-3 cells. Results showed that preincubating 
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cells with H-89 (50μM for 60 min) significantly reduced Fsk activation of apical 
Cl-/HCO3- AE activity. Figure 3.3A and B shows that both the magnitude of 
alkalinisation, produced by apical Cl- removal, and the rate of reacidification, 
following Cl- readdition, were decreased in H-89 treated Calu-3 cells compared 
to  untreated control cells (Figure 3.3A and B). This is consistent with previous 
results from our laboratory that showed inhibition of PKA, using H-89, 
markedly decreased the Fsk-induced apical Cl-/HCO3- AE activity in Calu-3 
cells (Garnett et al., 2011). However, it was found that the resting pHi was 
significantly decreased in H-89 treated cells (7.14± 0.10, n=4), compared to 
control cells (7.60± 0.02, n=10, P<0.05).  
Since H-89 is a non-specific inhibitor of PKA, an alternative PKA inhibitor, Rp-
cAMP was also tested. Rp-cAMP has a different structure to H-89 and acts as a 
specific competitive antagonist of the cyclic nucleotide–binding domains on 
PKA (de Wit et al., 1984). Calu-3 cells were preincubated with 1mM Rp-cAMP 
on the apical side for one hour, before apical Cl-/HCO3- AE activity was 
measured. Results also showed that PKA inhibition significantly reduced Fsk 
stimulated alkalinisation in pHi produced by apical Cl- removal, as well as the 
rate of reacidification following Cl- readdition, compared to untreated control 
cells (Figure 3.3C and D). These results clearly indicate that stimulation of 
apical Cl-/HCO3- AE activity by cAMP is through a PKA-dependent mechanism 
in Calu-3 cells. However, it was evident that neither PKA inhibitor completely 
abolished Fsk stimulated AE activity. 
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Figure 3. 3: PKA inhibitors, H-89 and Rp-cAMP decrease forskolin activated 
apical Cl-/HCO3- AE activity in Calu-3 cells. Summary of the impact of PKA 
inhibitors, H-89 and Rp-cAMP, on apical Cl-/HCO3- AE activity in Calu-3 cells. (A) 
mean alkalinisation in pHi in response to Cl- free solution, and the rate of reacidification 
(B) in Calu-3 cells pre-treated with 50µM H-89 for 60 min, n=10 Apical 0Cl-+Fsk, n=4 
for +Fsk+H-89. (C) mean alkalinisation in pHi in response to Cl- free solution, (D) the 
rate of reacidification in Calu-3 cells pre-treated with 1mM Rp-cAMP for 60 min, n=6 
Apical 0Cl-+Fsk, n=3 for +Fsk+ Rp-cAMP. *P<0.05 compared to control apical 
0Cl+Fsk. Data are shown as mean ±SEM. Control cells run in parallel. 
 
 
 
3.2.2 Role of exchange protein directly activated by cAMP (Epac) in the regulation of 
apical Cl-/HCO3- AE activity 
Based on the fact that both PKA inhibitors, H-89 and RpcAMP, did not 
completely abolish the Fsk stimulated apical Cl-/HCO3- AE activity, my 
hypothesis was that other potential downstream targets of cAMP would be 
involved in regulating apical anion exchange activity, such as the exchange 
protein directly activated by cAMP (Epac) (Tsalkova et al., 2012).   Although a 
variety of cAMP dependent cellular processes were previously thought to be 
solely regulated by PKA, extensive studies have now shown that many of these  
are also controlled by Epac proteins (Tsalkova et al., 2012). Moreover, it has 
been found that Epac has novel cAMP properties that are independent of PKA 
60 
 
-Ap
ica
l 0C
l
+Fs
k
0.0
0.2
0.4
0.6
0.8
Control
+Epac agonist
M
ea
n 
ch
an
ge
 in
 p
H
i
-
Ap
ica
l 0C
l
+Fs
k
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Control
+Epac agonist
R
at
e 
of
 r
ec
id
ifi
ca
tio
n 
(p
H
im
in
-1
)
(Schmidt et al., 2013), and it has been reported that Epac1 plays a critical role in 
the regulation of intestinal Cl- secretion by Fsk, via a PKA independent 
mechanism (Hoque et al., 2010). Thus, I investigated whether Epac is involved 
in the regulation of apical Cl-/HCO3- AE activity by first preincubating Calu-3 
cells with the membrane permeable Epac agonist, 8CPT-2Me-cAMP-AM 
(Lamyel et al., 2011), for 60 mins during dye loading. Results showed that the 
Fsk-induced activation of the apical Cl-/HCO3- exchanger was not affected in 
Calu-3 cells exposed to the Epac agonist, nor did the Epac agonist stimulate 
apical Cl-/HCO3- AE activity itself, under basal conditions (Figure 3.4A and B). 
This suggests that Epac stimulation by cAMP is not involved in the regulation of 
apical Cl-/HCO3- AE activity in Calu-3 cell. 
 
 
        A                                                                       B 
 
 
 
 
 
Figure 3. 4: Apical Cl-/HCO3- AE activity is not affected by the Epac agonist 
8CPT-2Me-cAMP in Calu-3 cells. Summary of the impact of the Epac agonist on 
apical Cl-/HCO3- AE activity. Calu-3 cells were pre-treated with 10µM 8CPT-2Me-
cAMP-AM for 60 min. (A) mean alkalinisation in pHi in response to Cl- free solution. 
(B) the rate of reacidification upon Cl- readdition. No significant difference (P>0.05) 
compared to control responses, n=3 for each condition. Control cells run in parallel.  
 
However, in another series of experiments, Calu-3 cells were preincubated with 
the specific Epac inhibitor, ESI-09 (Almahariq et al., 2013), (Figure 3.5A). In 
the ESI-09 treated cells it was noted that the resting pHi was significantly 
reduced compared to untreated cells (6.90±0.04, n=6, compared to 7.45±0.03, 
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n=5, respectively; P <0.05). Surprisingly, Epac inhibition caused a partial, but 
significant, stimulation of apical Cl-/HCO3- AE activity in the absence of any 
cAMP agonist (Figure 3.5A,B and C), as well a marked stimulation in HCO3- 
efflux (Figure 3.5D), compared to untreated cells. Furthermore, Epac inhibition 
caused a significant decrease in Fsk stimulated apical Cl-/HCO3- AE activity 
(Figure 3.5B and C) as well as the rate of HCO3- efflux (Figure 3.5E). These 
results suggest that Fsk-induced stimulation of apical Cl-/HCO3- AE activity in 
Calu-3 cells is not only through PKA, but involves an Epac-dependent 
mechanism. They also suggest that keeping Epac active is essential to maintain 
apical Cl-/HCO3- AE activity under resting conditions. 
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Figure 3. 5: Effect of the Epac inhibitor, ESI-09, on the apical Cl-/HCO3- AE 
activity in Calu-3 cells. (A) pHi experimental trace showing the effect of preincubation 
of Calu-3 cells with 10µM Epac inhibitor ESI-09 for 60 min on the  apical Cl-/HCO3- 
AE activity after Cl- removing in the apical perfusate under basal and Fsk stimulated 
conditions. Summary of the effect of 10µM ESI-09 preincubation on mean 
alkalinisation in pHi in response to a Cl- free solution (B), and the rate of reacidification 
after Cl- readdition (C) in unstimulated and Fsk stimulated Calu-3 cells. (D) The rate of 
HCO3- flux during apical Cl- removal in control and +ESI-09 treated cells.  (E)  The rate 
of HCO3- flux during apical Cl- removal in control +Fsk and +FsK+ESI-09 treated cells.  
Data are shown as mean ±SEM. B, C, and E: *P<0.05 compared to control apical 0Cl- 
under basal and stimulated conditions, n=5 for control, n=6 for +ESI-09. D: *P<0.05, 
#P<0.01 compared to control apical 0Cl-, n=8 for apical 0Cl-, and n=5 for +ESI-09. 
Control cells run in parallel. 
 
 
Since apical Cl-/HCO3- exchange activity is markedly affected by CFTR (Ko et 
al., 2002), and our laboratory has recently found that CFTR knock-down, or the 
CFTR inhibitor, GlyH-101, reduced the rate of pendrin-mediated anion 
exchange in Calu-3 cells (Garnett et al., 2011), I wanted to investigate if the 
ESI-09-induced apical Cl-/HCO3- AE activity observed under basal conditions 
was also dependent on anion transport by CFTR. To do this, Calu-3 cells were 
preincubated with the Epac inhibitor and apical Cl-/HCO3- AE activity measured 
under basal conditions in the absence and presence of the CFTR pore blocker 
GlyH-101. Results showed that the apical Cl-/HCO3- AE activity induced by 
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Epac inhibition was completely abolished by GlyH-101 (Figure 3.6), suggesting 
that this apical Cl-/HCO3- AE activity was entirely dependent on CFTR anion 
transport, or that it was in fact due to CFTR itself.  
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Figure 3. 6: The ESI-09-induced apical Cl-/HCO3- AE activity is abolished by the 
CFTR pore blocker GlyH-101 under basal conditions in Calu-3 cells. (A) 
Representative pHi trace showing the effect of Cl- removal in the apical perfusate on 
pHi under basal condition in cells preincubated with Epac inhibitor, ESI-09, which was 
inhibited by the CFTR inhibitor GlyH-101. Calu-3 cells were pre-treated with 10µM 
ESI-09 for 60 min. (B) mean alkalinisation in pHi in response to Cl- free solution (C) 
the rate of reacidification.*P<0.05 compared to control apical 0Cl under basal 
condition. Data are shown as mean ±SEM, n=8 for Apical 0Cl-+ESI-09, and n=5 for 
+GlyH-101. 
 
 
It has been reported that, in addition to cAMP, cyclic 3',5'-guanosine 
monophosphate (cGMP) also plays an important role in regulating a variety of 
anion transporters (Barnes, 1995), and that both cGMP-dependent PKG I and 
PKG II regulate the activation of CFTR in Calu-3 cells (Chen et al., 2008), and 
stimulate anion secretion (Duszyk, 2001b). Also Wit et al, (1994) showed that 
compounds responsible for increasing cGMP and cAMP can act synergistically 
to relax microvascular smooth muscle in vivo (de Wit et al., 1994), and that a 
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combination of cAMP and cGMP plays an important role in increasing cilia beat 
frequency in bovine bronchial epithelial cells (Wyatt et al., 2005).  However, it 
was unknown whether cGMP was involved in the regulation of the apical Cl-
/HCO3- AE activity in Calu-3 cells. Thus, experiments were done to test the 
effect of 8-Bromo cyclic guanosine mono phosphate (8Br-cGMP), a membrane 
permeable cGMP agonist on apical Cl-/HCO3- AE activity. Results showed that a 
60 min preincubation of Calu-3 cells with 1mM 8Br-cGMP did not change 
apical Cl-/HCO3- AE activity under resting or after Fsk stimulation (Figure 3.7B 
and C). This suggests that cGMP dependent protein kinase is not involved in the 
regulation of the apical anion exchangers in Calu-3 cells.  
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Figure 3. 7: cGMP does not activate apical Cl-/HCO3- AE activity in Calu-3 cells. 
(A) Representative pHi trace showing the effect of Cl- removal in the apical perfusate 
on pHi before and after Fsk stimulation in 8Br-cGMP preincubated (1.0mM for 60 
mins) Calu-3 cells.  Summary of the impact of 8Br-cGMP  preincubation on mean pHi 
change (alkalinisation) caused by Cl- removal (B) and the rate of reacidification (C) 
following Cl- readdition, in the presence and absence of forskolin (5µM) in Calu-3 
cells. Data are shown as mean ±SEM (n=3). No significant difference (P>0.05) 
compared to apical 0Cl-. Control cells run   in parallel.  
 
 
 
3.3 Role of CFTR and basolateral transporter in the regulation of apical Cl-/HCO3- 
exchange activity  
Previous work by Garnett et al., (2011) showed that addition of the CFTR 
inhibitor, GlyH-101 during the alkalinisation caused by apical Cl- free exposure 
in fsk-stimulated Calu-3 cells, produced a very fast intracellular acidification 
which could be prevented by pre-exposing the cells to 500 µM basolateral 
H2DIDS. This result suggested two things; (1) that CFTR regulates apical anion 
exchange activity and (2) that a H2DIDS-sensitive basolateral HCO3-/H+ 
transporter also influences events at the apical membrane, and therefore could be 
involved in modulating transepithelial HCO3- secretion. In order to investigate 
the identity of the putative basolateral HCO3-/H+ transporter further, different 
concentrations of DIDS were applied to the basolateral side of Calu-3 cells and 
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the response to apical GlyH-101 measured. Figure 3.8 illustrates the effect of 
adding GlyH-101 on the alkalinisation produced by apical Cl- removal in fsk-
stimulated Calu-3 cells not exposed to basolateral DIDS. It can be seen that 
GlyH-101 significantly reduced the magnitude of the alkalinisation produced by 
Cl- removal (Figure 3.8A and B) and that the rate of the GlyH-101 induced 
‘acidification’ was 0.35 ± 0.03 pH unit min-1 (n=3), which is similar (not 
significantly different, P>0.05) to that observed when Cl- was reintroduced in 
control cells 0.45 ± 0.12 pH unit min-1 (n=3). These experiments were then 
repeated but cells were first exposed to different concentrations of DIDS in the 
basolateral perfusate prior to apical Cl- removal or GlyH-101 addition. Overall, 
it was found that only 100µM DIDS affected the magnitude of the GlyH-101 
induced acidification, which was inhibited by 70±20% (Figure 3.9B). In 
addition, only 100 µM DIDS affected the GlyH-101 induced rate of 
‘acidification’, which decreased from 0.35 ± 0.03 pH unit min-1 (n=3) in 
untreated cells to 0.04 ± 0.03 pH unit min-1 (P<0.05, n=5, Figure 3.9C) in DIDS-
treated cells., which equated to an 88.5±8.3% inhibition. Based on this limited 
dose-response to DIDS (and the data presented in Chapter 4) these results 
suggest that the basolateral anion exchanger SLC4A2 (or AE2) could be the 
transporter involved in modulating the pHi response to apical GlyH-101 
addition.  However, previous work by our group (Garnett et al., 2011), and result 
presented in chapter 4, showed that cAMP stimulation leads to the inhibition of 
a DIDS-sensitive basolateral Cl-/HCO3- AE, most probably AE2. 
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Figure 3. 8: CFTR inhibitor GlyH-101 reacidifies pHi following an apical Cl- free 
induced alkalinisation in Calu-3 cells. (A) Representative pHi trace illustrating the 
effect of adding the CFTR inhibitor GlyH-101 (10 µM) after cells were first exposed to 
a Cl- free solution. Note that the CFTR inhibitor caused pHi to rapidly acidify to a new 
steady-state. (B) Summary of the effect of CFTR pore blocker GlyH-101 on the mean 
alkalinisation in pHi following apical Cl- removal, in the absence and presence of 
GlyH-101, in Fsk stimulated Calu-3 cells. *P<0.05 compared to control. Data are 
shown as mean ±SEM, n=3, paired observations. 
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Figure 3. 9: Basolateral DIDS blocks the GlyH-101 induced intracellular 
acidification under apical Cl- free conditions in Fsk treated Calu-3 cells. (A) 
Representative pHi trace illustrating the effect of adding the CFTR inhibitor GlyH-101 
(10µM), in the presence of basolateral DIDS (100µM), after cells were first exposed to 
a Cl- free solution, under Fsk stimulated conditions. Summary of the effect of different 
concentrations of DIDS on the magnitude (B), and the rate of acidification caused by 
GlyH-101 (10 µM) in Cl- free conditions in the presence of Fsk compared to control 
response. Data shown as mean ± SEM, *P< 0.05 compared to control, n=3 for control 
and 10µM DIDS; n=4 for 30µM DIDS, and n=5 for 100 μM DIDS. 
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3.4 Role of intracellular and extracellular Ca2+ in the regulation of apical Cl-/HCO3- 
anion exchanger activity    
It has been demonstrated that both cAMP and Ca2+ play an important role in 
stimulation of HCO3- secretion in Calu-3 cells (Krouse et al., 2004). It has also 
been shown that an increase in intracellular Ca2+ [Ca2+]i in epithelial cells 
regulates a wide range of cellular process, such as the activation  of Ca2+ 
activated Cl-  channels and Cl- secretion,  (Paradiso et al., 1991; Grubb et al., 
1994), as well as  stimulation of CFTR dependent Cl-/HCO3- exchange activity 
in many CFTR-expressing epithelia cells (Namkung et al., 2003). Furthermore, 
a recent study has shown that elevation of intracellular cAMP caused activation 
of adenosine A2A receptors in human pulmonary epithelial cells and a 
subsequent increase in [Ca2+]i, which played a crucial role in mediating 
signalling pathways inside the cells (Ahmad et al., 2013). Also, an increase in 
[Ca2+]i plays an important role in stimulation of ciliary beat frequency in airway 
epithelial cells (Delmotte and Sanderson, 2006). Most recently, it has been 
suggested that cAMP and Ca2+ signaling are the most prominent regulators of 
HCO3- secretion in epithelial cells (Jung and Lee, 2014), and that there is a 
synergistic interaction between Ca2+ and cAMP signaling pathways to control 
electrolyte and fluid secretion (Lee et al., 2012). Therefore, it was possible that 
there was a cross-talk mechanism between cAMP and Ca2+ signaling pathways 
in the regulation of apical Cl-/HCO3- AE activity in Calu-3 cells. Thus, another 
series of experiments were done in order to assess the role of Ca2+ signalling in 
the regulation of apical Cl-/HCO3- AE activity in Calu-3 cells. 
 
3.4.1 Role of intracellular Ca2+  
In order to assess if intracellular Ca2+ modulates the cAMP-stimulated apical Cl-
/HCO3- AE activity, Calu-3 cells were pre-treated with BAPTA-AM, a chemical 
which has been widely used in studies to control intracellular Ca2+ signals that 
regulate many cellular functions (Bissonnette et al., 1994). Calu-3 cells were 
preincubated with 50µM BAPTA-AM (both apical and basolateral sides) for one 
hour and then the pHi response to apical Cl- free solution was measured after 
forskolin stimulation. As shown in Figure 3.10, BAPTA-AM significantly 
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reduced Fsk stimulated apical Cl-/HCO3- AE activity, and reduced both the mean 
change in pHi produced by apical Cl- removal, and the rate of reacidification 
upon readdition of Cl- to the apical side, compared to control cells not 
preincubated with BAPTA-AM. Note that the resting pHi was not significantly 
changed in BAPTA-AM treated cells (7.70±0.02, n=5 compared to control cells 
7.60±0.06, n=7, P>0.05). These results suggest that resting Ca2+ levels play an 
important role in regulating the cAMP stimulated apical Cl-/HCO3-AE activity in 
Calu-3 cells, and that intracellular chelation of Ca2+ by BAPTA-AM might 
disrupt the synergistic cross-talk mechanism between Ca2+ and cAMP, and 
thereby regulate Cl- and HCO3- transport in Calu-3 cells. 
 
 
 
               A                                              B 
 
 
 
 
 
 
 
Figure 3. 10: BAPTA-AM reduced apical Cl-/HCO3- AE activity in Calu-3 cells. 
Summary of the effect of the preincubation of Calu-3 cells with BAPTA-AM for 60 
min. on apical Cl-/HCO3- AE activity (A) mean alkalinisation in pHi in response to Cl- 
free solution (B) the rate of reacidification upon Cl- readdition in Fsk stimulated 
condition. *P<0.05 compared to control. Data are shown as mean ±SEM, n=7 for 
control, and n=5 for treated cell with BAPTA-AM. Control cells run in parallel. 
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Moreover, I have also used a Ca2+ agonist to investigate if an increase in resting 
Ca2+ could alter the cAMP stimulated apical Cl-/HCO3- AE activity,  because it 
has been shown that CFTR mediated Cl- current is stimulated by Ca2+ agonists 
through a Ca2+ dependent activation of adenylyl cyclase I (ACI) and 
cAMP/PKA signaling pathway in primary cultures of human bronchial epithelial 
cells (Namkung et al., 2010). Thus, I studied the effect of Ca2+ release from the 
endoplasmic reticulum (ER), by exposing Calu-3 cells to the selective SERCA 
pump inhibitor thapsigargin (Tg), which causes an increase in [Ca2+]i by 
inhibiting Ca2+ uptake via the Ca2+ ATPase, back into the ER (Thastrup et al., 
1990). Calu-3 cells were exposed to 200nM Tg for 5 mins, as previous work 
from our group has shown that this leads to calcium elevation in these cells 
(Garnett et al., 2011). Responses to apical Cl- removal were measured in the 
presence of Tg under Fsk stimulated conditions. Figure 3.11 shows that Tg 
caused a significant decrease in the mean change in intracellular pH and rate of 
reacidification in response to Cl- removal, suggesting that an increase in [Ca2+]i  
does play an important, but negative, role in the regulation of the apical 
transporter (CFTR/Pendrin) in Calu-3 cells. However, as shown in Figure 3.11, 
the effect of thapsigargin was not prevented by BAPTA-AM preincubation. 
Indeed, the presence of thapsigargin and BAPTA-AM caused a further, and 
significant, reduction in apical Cl-/HCO3- AE activity, under Fsk stimulated 
conditions. The percent inhibition of Fsk stimulated apical Cl-/HCO3- AE 
activity (as measured by the change in pHi) by thapsigargin alone (Figure 
3.12A) was significantly less than the percent inhibition produced by BAPTA-
AM and thapsigargin+BAPTA-AM. However, the percent inhibition of the rate 
of reacidification was not significantly different between the 3 treatments 
(Figure 3.12B).  
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Figure 3. 11: Thapsigargin reduced forskolin-stimulated apical Cl-/HCO3- AE 
activity in Calu-3. Summary of the effect of thapsigargin (200nM) on the Fsk-
stimulated apical Cl-/HCO3- AE activity measured in the absence and presence of 
BAPTA-AM. (A) Mean alkalinisation in pHi produced by apical Cl- removal and the 
rate of reacidification upon Cl- readdition (B) under Fsk stimulation. Data are shown as 
mean ±SEM. A: *P<0.05, compared to apical Cl-+Fsk, #P>0.05 compared to 
Fsk+Thaps. B: *P<0.01, #P<0.001 compared to apical Cl-+Fsk, #P>0.05 compared to 
Fsk+Thaps, n=12 for control; n=7 for Fsk+thapsigargin, and n=3 for 
Fsk+thapsigargin+BAPTA-AM.  
 
                          A                                           B 
 
 
 
 
 
 
Figure 3. 12: Percent inhibition of apical Cl-/HCO3- AE activity by thapsigargin 
and BAPTA-AM in Calu-3. Summary of the % inhibition of the apical Cl-/HCO3- AE 
activity caused by thapsigargin (200nM) and BAPTA-AM (50µM) exposure. (A) Effect 
on mean alkalinisation in pHi produced by apical Cl- removal and (B) the rate of 
reacidification upon Cl- readdition under Fsk stimulated conditions. Data are shown as 
mean ±SEM. A: *P<0.001 compared to +Fsk+BAPTA-AM and 
Fsk+thapsigargin+BAPTA-AM. B: no significant difference (P>0.05), n=5 for 
+Fsk+BAPTA-AM; n=7 for Fsk+thapsigargin, and n=3 for Fsk+thapsigargin+BAPTA-
AM.   
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3.4.2 Role of extracellular calcium concentration: 
My previous experiments showed that chelation of intracellular Ca2+ and Ca2+ 
store depletion both significantly reduced the apical Cl-/HCO3- AE activity in 
Calu-3 cells. To date, however, there were no available data on the effect of 
changing extracellular Ca2+ on the apical Cl-/HCO3- AE activity under Fsk 
stimulated conditions in Calu-3 cells. It has been demonstrated that changes in 
extracellular free calcium concentration can be  ‘sensed’  by the extracellular 
calcium-sensing receptor (CaSR), which is a G protein-coupled receptor 
expressed in many epithelial tissues, including human bronchial epithelial cells, 
where this receptor is linked to intracellular calcium signaling. Activation of 
CaSR by increases in extracellular Ca2+ ions also plays an important role in the 
regulation of intracellular cAMP signalling cascades (Ward, 2004; Milara et al., 
2010). In order to test the effect of changing extracellular Ca2+ on the apical Cl-
/HCO3- AE activity, cells were bilaterally perfused with  Ca2+ free Krebs prior to 
Fsk stimulation. Figure 3.13 shows that the absence of extracellular Ca2+ did not 
affect apical Cl-/HCO3- AE activity in Calu-3 cells, compared to the control 
response. This implies that extracellular Ca2+ is not involved in the regulation of 
apical Cl-/HCO3- AE activity in Calu-3 cells.  
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Figure 3. 13:  Removal of extracellular Ca2+ did not affect the Fsk stimulated 
apical Cl-/HCO3- AE activity in Calu-3 cells.  Summary of the effect of removal of 
extracellular Ca2+ on the mean alkalinisation in pHi in response to apical Cl- removal 
(A), and the rate of reacidification upon Cl- readdition (B) under Fsk stimulation. Data 
are shown as mean ±SEM. No significant difference (P>0.05) between control and 
treated cells, n=3 for each condition, paired observation. 
 
 
3.5 Role of calmodulin and Ca2+/calmodulin-dependent protein kinases  in the 
regulation of apical Cl-/HCO3-AE activity   
It has been shown that there is an extensive cross-talk between Ca2+/calmodulin 
(CaM)-dependent protein kinase (CaMK) and some cAMP-dependent protein 
kinases that could be involved in the regulation of signalling cascades inside the 
cytoplasm of cells (Soderling, 1999). In addition, it has been shown that the 
activity of calcium–activated Cl- channels was abolished by inhibition of the 
CaMK pathway (using STO-609, a CaMKK inhibitor) in Xenopus oocytes, 
while it did not affect CFTR activity (Faria D., 2012 PhD thesis, University of 
Lisbon). Moreover, it has been reported that adenylyl cyclase I (ACI), which is 
responsible for elevation of intracellular cAMP, is a Ca2+/calmodulin stimulated 
adenylyl cyclase that colocalized with CFTR in the apical membrane of human 
bronchial epithelial cells (Namkung et al., 2010). It has been found that CaMK 
75 
 
kinase (CaMKK) is an  upstream regulator of  CAMK (Soderling, 1999) which 
is a Ser/Thr kinase whose activation is through a Ca2+/CaM dependent 
mechanism (Swulius and Waxham, 2008). Moreover, CAMK kinase-alpha 
(CaMKK-α) and CAMK kinase-beta (CaMKK-β) have been purified and cloned 
from rat brain and shown to function as upstream regulators of both CaMKI and 
CaMKIV (Tokumitsu et al., 1997). Therefore, I tested whether the CaMKK 
pathway contributes to the regulation of the apical Cl-/HCO3- AE in Calu-3 cells.  
 
 
3.5.1 Inhibition of CaMKK 
Preincubation of cells with the CaMKK inhibitor STO-609 (inhibitor of 
CaMKK-α and CAMKK-β) for 60 min (Figure 3.14A) had no effect on basal 
AE activity, but did cause a small, but significant, reduction in intracellular 
alkalinisation produced by apical Cl- removal following Fsk stimulation (Figure 
3.14B). However, it did not affect the rate of reacidification compared to control 
cells (Figure 3.14 C). Also, inhibition of the CaMK pathway produced no 
significant effect, on the amount of secreted fluid that collected after 24 hours 
preincubation of Calu-3 cells with CaMKK inhibitor STO-609, and the pH of 
secreted fluid did not change (see Figure 3.22A and B). These results indicate 
that the CaMK pathway does not play a significant role in regulating the activity 
of the apical anion exchanger or fluid secretion in Calu-3 cells.      
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Figure 3. 14: CAMKK inhibitor, STO-609, reduced the apical Cl-/HCO3- AE 
activity in Calu-3 cells. (A) Representative pHi trace showing that STO-609 
preincubation (20μM) for 60 min modestly reduced the apical Cl-/HCO3- AE activity in 
Calu-3 cells. Summary of the effect of apical preincubation of STO-609 on (B) mean 
alkalinisation in pHi in response to Cl- free solution, and (C) the rate of reacidification 
under basal and stimulated condition. Data are shown as Mean±SEM.*P<0.05 
compared to control, n=3 for each condition. Control experiments were run in parallel. 
 
 
3.5.2 Inhibition of CaMKII 
Although my results showed that CaMKK inhibition did not markedly affect 
apical Cl-/HCO3- AE activity, it has been found that CaMKII plays an important 
role in the regulation of membrane Cl- permeability through Cl- channels in a 
variety of epithelial cells (Hartzell et al., 2005).  Therefore, in another series of 
experiments, Calu-3 cells were preincubated with 5µM CaMKII inhibitor, KN-
93, for 60 min, and then apical Cl-/HCO3- AE activity was measured in Cl- free 
solutions (Figure 3.15A). Similar to the results with CaMKK, inhibitor KN-93 
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had no effect on either basal or Fsk stimulated apical Cl-/HCO3- AE activity 
(Figure 3.15B and C). 
 
 
 
                          A                                                                             
 
 
 
 
 
            
 B                                                                               C 
 
 
 
 
 
 
Figure 3. 15: Inhibition of CaMKII had no effect the apical Cl-/HCO3- AE activity 
in Calu-3 cells. (A) Representative pHi trace showing that KN-93 preincubation (5µM) 
for 60 min did not affect the apical Cl-/HCO3- AE activity under basal and Fsk 
stimulated condition. Summary of the effect of apical preincubation of KN-93 on mean 
alkalinisation in pHi in response to Cl- free solution (B), and the rate of reacidification 
(C) under basal and stimulated condition. Data are shown as Mean±SEM. No 
significant difference (P>0.05) compared to control, n=3 for each condition. Control 
cells run in parallel. 
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3.5.3 Role of CaM in the regulation of apical Cl-/HCO3- exchange activity  
In order to further investigate the mechanism of regulation of the apical Cl-
/HCO3- AE activity by intracellular Ca2+, the role of CaM was tested under basal 
and cAMP stimulated conditions, because it has been found that binding of the 
Ca2+ /CaM complex enhances cAMP synthesis, via stimulation of membrane 
adenylyl cyclase activity (Ferguson and Storm, 2004). I therefore preincubated 
Calu-3 cells with N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide (J-8, 
50μM), which is a highly specific CaM inhibitor (Tian et al., 2011),  for 60 min 
and then apical Cl-/HCO3- AE activity was measured in Cl- free solutions (Figure 
3.16A). Results showed that CaM inhibition had little effect on apical Cl-/HCO3- 
AE activity under cAMP stimulated conditions, compared to untreated cells 
(Figure 3.16B and C). This suggests that CaM is not involved in the regulation 
of the apical Cl-/HCO3- AE activity, and is also consistent with the results 
obtained for CaMKK and CaMK inhibition. 
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Figure 3. 16: Calmodulin does not regulate the apical Cl-/HCO3- AE activity in 
Calu-3 cells. (A) Representative pHi trace showing the effect of calmodulin inhibition 
by preincubation with 50µM J-8 for 60 min, on the apical Cl-/HCO3- AE activity under 
basal and Fsk stimulated conditions. Summary of the effect of J-8 on the mean 
alkalinisation in pHi in response to Cl- free solution (B), and the rate of reacidification 
upon Cl- readdition (C) under basal and Fsk stimulated condition in Calu-3 cells. Data 
are shown as Mean±SEM. *P<0.05 compared to control, n=3. Control experiments run 
in parallel. 
 
 
 
3.6 Regulation of apical Cl-/HCO3- exchange activity by dynamin 
Dynamin is a GTPase and plays an essential role in the release of newly formed 
clathrin-coated vesicles during endocytosis, by causing scission of the neck of 
budding vesicle at the last stage of vesicle formation (Macia et al., 2006). 
Dynamin activity is enhanced by elevation of [Ca2+]i   (Liu et al., 1994). It has 
been reported that CFTR internalization from the cell surface is mediated by 
clathrin-coated vesicles  (Lukacs et al., 1997), and that siRNA knock down, and 
pharmacological inhibition of dynamin by the cell-permeable inhibitor, 
dynasore, increased CFTR accumulation on the surface of Hela cells by 
inhibiting CFTR endocytosis (Young et al., 2009). It has also been found that 
inhibition of dynamin, by dynasore, significantly increased the steady-state 
surface level of the apical Na+/K+/2Cl- cotransporter (NKCC2) by reducing 
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NKCC2 endocytosis in rat renal thick ascending limb epithelial cells (Ares and 
Ortiz, 2012). However, it was unknown whether dynamin regulates the surface 
levels the apical Cl-/HCO3- AE in Calu-3 cells. Thus, Calu-3 cells were 
preincubated with 80µM dynasore on the apical side, and then apical Cl-/HCO3- 
AE activity measured (Figure 3.17A). Interestingly, in dynamin treated cells, 
Fsk stimulation in high Cl- conditions caused a larger acidification in pHi 
(0.42±0.04 pH unit for dynasore treated, n=3 vs. control of 0.28±0.01 pH unit, 
n=4, P<0.05) which was also at faster but not significant rate (0.43±0.07 pHi 
min-1, n=3 for dynasore treated vs. control of 0.23±0.03 pHi min-1 n=4, P<0.05). 
Moreover, measuring apical Cl-/HCO3- AE activity in Cl- free solutions showed 
that dynamin inhibition had no effect on apical Cl-/HCO3- AE activity under 
resting conditions, but did induce a significant reduction in Fsk-stimulated 
apical Cl-/HCO3- AE activity. Both the magnitude of alkalinisation produced by 
apical Cl- removal, and the rate of reacidification upon Cl- readdition, were 
significantly lower compared to the control response (Figure 3.17C and D). In 
addition, the rate of HCO3- flux produced by Fsk stimulation was significantly 
decreased in dynasore treated Calu-3 cells compared to the control response 
(Figure 3.17E).  
 
In a separate set of experiments, the effect of dynamin inhibition on 
transepithelial electrical resistance (TEER) in Calu-3 cells was also determined 
to see if dynamin affects monolayer integrity. Thus, Calu-3 cells were treated 
with dynasore and then TEER was measured every 20 min in control and 
dynamin-treated cells. Figure 3.19 shows that dynamin inhibition did not affect 
TEER in Calu-3 cells, over the two hour period, suggesting that tight junction 
integrity in Calu-3 cells was not affected by dynamin inhibition.  
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Figure 3. 17: Dynamin inhibition reduces apical Cl-/HCO3- AE activity in Calu-3. 
(A) Representative pHi trace showing the effect of dynamin disruption on apical Cl-
/HCO3- AE activity in dynasore preincubated Calu-3 cells (for 60) min under basal and 
Fsk stimulated condition. Summary of the effect of dynamin disruption on mean 
alkalinisation in pHi in response to apical Cl- removal (B), and the rate of reacidification 
upon Cl- readdition(C), under resting and stimulated condition. (D) Summary of the rate 
of HCO3- flux produced by apical Fsk stimulation compared to control. *P<0.001 
compared to control. Data are shown as mean ±SEM, n=4 for control, and n=3 for 
+Dynasore.  Control cells run in parallel. 
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3.7 Role of actin-cytoskeleton disruption on apical Cl-/HCO3- exchange activity                              
Since dynamin has an actin binding domain that binds directly to actin filaments 
which has been shown to play a critical role in the regulation of the actin 
cytoskeleton in podocytes (Gu et al., 2010), I also assessed the role of the actin 
cytoskeleton in the regulation of apical Cl-/HCO3- AE activity under basal and 
cAMP-stimulated conditions in Calu-3 cells.  It has been shown that apical 
CFTR is confined within a macromolecular complex which forms a 
microdomain to enable efficient cAMP signalling transduction to CFTR 
(Guggino and Stanton, 2006). There is a physical interaction between CFTR and 
the protein scaffold NHERF1, which also helps place PKA close to CFTR via 
the protein kinase A anchoring protein known as AKAP ezrin (Sun et al., 2000), 
and this complex plays an essential role in the cAMP-induced activation of 
CFTR (Huang et al., 2001). Recently, the importance of actin-cytoskeleton 
integrity for cAMP compartmentalization and PKA activity in the regulation of 
CFTR activity has been shown in human bronchial epithelial cells (Monterisi et 
al., 2012). They found that pharmacological disruption of the actin cytoskeleton 
caused a defective accumulation of cAMP in the subcortical compartment, but 
also a high concentration of cytosolic cAMP, which was accompanied by 
reduced subcortical PKA activity and CFTR dependent Cl- efflux. 
Pharmacologically, the actin cytoskeleton can be disrupted by cytochalasin-D 
(CytoD) which is a widely used as an inhibitor of actin dynamics. CytoD 
disrupts the interaction between cofilin, which is a key regulator of actin 
filament dynamics, with G- and F-actin and causes a reduction in  the rate of 
both actin polymerization and depolymerisation, in intact cells (Shoji et al., 
2012). To assess the effect of actin cytoskeleton disruption on the apical Cl-
/HCO3- AE activity, Calu-3 cells were preincubated with 10μM cytochalasin D 
for one hour and then apical Cl-/HCO3- AE was measured in Cl- free solutions 
under basal and cAMP stimulated conditions.  Figure 3.18 shows that actin 
disruption had no significant effect on apical Cl-/HCO3- AE activity, under both 
basal and Fsk stimulated conditions compared to untreated cells (Figure 3.18B 
and C). I also tested if actin disruption led to changes in G-protein coupled 
receptor stimulation of apical Cl-/HCO3- AE activity by using ADO. As seen for 
Fsk, the ability of ADO to activate apical Cl-/HCO3- AE activity was also not 
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impaired (Fig 3.18. D and E). Taken together these results suggest that the actin 
cytoskeleton/cAMP compartmentalization is not essential for activation of apical 
anion exchange activity by cAMP in Calu-3 cells.   
To ensure that CytoD treatment had disrupted actin cytoskeleton integrity, 
confocal images of phalloidin-stained actin cytoskeleton (Figure 3.19A), were 
made. These images clearly show that CytoD caused a marked disruption of the 
cytoskeleton, which was more punctate and less organised (Figure 3.19A, Right 
panel), compared to the untreated cells (Figure 3.19A, left panel). In addition, 
CytoD caused a significant decrease in TEER in Calu-3 cells within the first 20 
mins of treatment that was maintained over a two hour period (Figure 3.19B).  
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Figure 3. 18: Cytochalasin-D did not affect apical Cl-/HCO3- AE activity in Calu-3. 
(A) Representative pHi trace showing the effect of Cl- removal in the apical perfusate 
on pHi under basal and stimulated conditions in cytochalalsin-D preincubated Calu-3 
cells. Summary of the impact of actin-cytoskeleton disruption on apical Cl-/HCO3- AE 
activity by preincubation of Calu-3 cells with cytochalasin-D for 60 min. on mean 
alkalinisation in pHi in response to apical Cl- free solution (B), and the rate of 
reacidification upon Cl- readdition (C) under basal and Fsk stimulated condition, n=4 
for control, and n=3 for cytochalasin-D preincubated. (D) Mean alkalinisation in pHi in 
response to Cl- free solution, (E) the rate of reacidification under basal and adenosine 
stimulated condition, n=6 for control, and n=9 for cytochalasin-D preincubated. Data 
are shown as mean ±SEM, no significant difference (P>0.05) between cytochalasin-D 
treated and untreated cells. 
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Figure 3. 19: The effect of dynamin inhibition and actin cytoskeleton disruption on 
transepithelial electrical resistance in control and treated Calu-3 cells. (A) shows 
Calu-3 cells that were untreated (left panel) compared to cells  incubated for one hour 
with 10μM CytoD (Right panel) and stained with 0.25% Texas-Red Phalloidin to 
visualize F-actin using confocal microscopy. I performed the actin staining of Calu-3 
cells with my colleague Mark Turner. (B) TEER was measured in Calu-3 cells before 
adding the inhibitors (time 0), and then cells were preincubated for two hours with 
10μM cytochalasin D or dynasore in 5% CO2. TEER measurements were made over the 
2 hour period every 20 or 30 mins, to see whether the effect of dynamin or actin 
skeleton disruption was time dependent. *P<0.05 compared to control and +Dynasore, 
n=3 for each condition. The actual values for TEER at time 0   (prior to adding 
inhibitors) were; 563.3±27.2 for control, 580±16 for Dynasore, and 925±57.9 for CytoD 
treated cells. 
Control Cytochalasin- D 
x-y x-y 
A 
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3.8 Regulation of apical Cl-/HCO3- exchange activity by CK2  
A previous study demonstrated that CK2 (formerly known as  casein kinase 2)is 
a very interesting kinase that plays an essential role in the regulation of CFTR 
biogenesis, trafficking and activity (Luz, 2008). It has also been shown that CK2 
colocalized with CFTR in the apical membrane of airway epithelial cells, and 
inhibition of CK2 decreased CFTR-dependent Cl- transport in CFTR over 
expressing, as well as in native pancreatic duct epithelial cells, which 
endogenously express CFTR. Moreover, coimmunoprecipitation studies 
suggested that there is a direct interaction between CK2 and CFTR, but not with 
F508del CFTR (Treharne et al., 2009). Furthermore, it has been found that 
application of the CK2 inhibitor TBB (4,5,6,7-tetrabromo-benzotriazole; 10μM) 
inhibited CFTR activity and significantly reduced the short-circuit current under 
cAMP stimulation, in both distal colonic and airway epithelial cell monolayers. 
The onset of the inhibition with TBB occurred at about 1μM which is highly 
specific for CK2 (Luz et al., 2011). TBB is a specific pharmacological agent and 
highly selective for CK2 as coexpression of a TBB-insensitive form of CK2 
eliminated the ability of TBB to inhibit cAMP/PKA-dependent CFTR activity 
(Treharne et al., 2009).  
To assess the role of CK2 in the regulation of apical Cl-/HCO3- AE activity, 
Calu-3 cells were preincubated with 10µM TBB for 60 min and then apical Cl-
/HCO3- AE activity was measured in Cl- free solutions, but in the continued 
presence of TBB (Figure 3.20A). Note that at the start of the experiment the 
resting pHi was significantly decreased in TBB preincubated cells (6.7±0.05, 
n=4, compared to untreated cells, 7.5±0.07, n=4, P<0.05), but this did partially 
recover over the first 5-10 mins of recording (despite the continued presence of 
TBB) to a new steady state pHi of (6.88±0.06, n=4). The apical Cl-/HCO3- AE 
activity was measured when pHi had partially recovered. Results showed that 
CK2 inhibition significantly reduced both the mean pHi change produced by 
apical Cl- removal (0.30±0.06, n=4, compared to control of 0.90±0.05, n=4, 
P<0.001), and the rate of reacidification following Cl- readdition (0.32±0.01, 
n=4, compared to control of 0.58±0.06, n=4, P<0.001), under Fsk stimulated 
conditions. However, it did not stimulate apical Cl-/HCO3- AE activity under 
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basal conditions, compared to the control response (Figure 3.20B and C). CK2 
inhibition also caused a significant decrease in the rate of HCO3- flux produced 
by apical Cl- removal under Fsk stimulation (Figure 3.20D). Also, as shown in 
Figure 3.22A, CK2 inhibition produced a marked decrease in the volume of Fsk-
stimulated fluid secretion (229±2.0µl/transwell, n=3, compared to the control 
response of 245±3.0 µl/transwell, n=3, P<0.05). However, the pH of the secreted 
fluid was not changed (See figure 3.22B). Therefore, these data imply that CK2 
plays an important role in the regulation of apical Cl-/HCO3- AE activity by 
cAMP, as well as fluid secretion in Calu-3 cells.   
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Figure 3. 20: Inhibition of apical Cl-/HCO3- AE activity by TBB in Calu-3 cells. (A) 
Raw pHi trace showing the effect of TBB preincubation and perfusion (10µM) on apical 
Cl-/HCO3- AE activity under basal and Fsk stimulated conditions in Calu-3 cells. 
Summary of the effect of CK2 inhibition  on (B) mean alkalinisation (pHi) produced by 
apical Cl- removal, (C) the rate of reacidification upon Cl- readdition, (D) the rate of 
HCO3- flux resulting from apical Cl- removal in the presence of Fsk in control and TBB 
treated Calu-3 cells. Data are shown as Mean±SEM. *P<0.001, #P<0.05 compared to 
control, n=4 for each condition. Control experiments were run in parallel. 
 
 
 
 
To further investigate the temporal effects of CK2 inhibition on apical Cl-
/HCO3-  activity, in a separate series of experiments Calu-3 cells were acutely 
exposed to 10μM TBB for several mins (both apical and basolateral perfusates) 
and then AE activity measured (Figure 3.21A). Results showed that in TBB-
treated cells, forskolin addition caused a larger intracellular acidification 
compared to untreated cells (0.53±0.03 compared to 0.25±0.02 pH units, 
P<0.05). However, TBB had no  effect on either the Fsk stimulated apical Cl-
/HCO3- AE activity, nor the rate of HCO3- flux produced by apical Cl- removal 
under Fsk stimulation (Figure 3.21B, C and D). This suggests that TBB needs 
time to cause inhibition of CK2 and exert its effect on the apical Cl-/HCO3- AE 
activity in Calu-3 cells. 
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Figure 3. 21: Effect of acute bilateral TBB exposure on the apical Cl-/HCO3- AE 
activity in Calu-3 cells. (A) Representative pHi trace showing the effect of acute 
bilateral TBB exposure (10μM) on Fsk stimulated apical Cl-/HCO3- AE activity in Calu-
3 cells. Summary of the effect of acute TBB exposure (10μM) on the mean 
alkalinisation (pHi) produced by apical Cl- removal (B), and the rate of reacidification 
upon Cl- readdition (C) in control and TBB treated Calu-3 cells. Rate of HCO3- flux 
resulting from forskolin stimulated apical Cl- removal in control and TBB treated Calu-
3 cells (D). No significant difference (P>0.05) compared to control response. Data are 
shown as Mean±SEM. n=4 for each condition, paired observations.  
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Figure 3. 22: Summary of the effect of STO-609, Dynasore and TBB on rates of 
Fsk-stimulated fluid secretion and pH in Calu-3 cells. Cells were stimulated with 
5μM forskolin and incubated for 24 hours in 5% CO2 (v/v) in high Cl- Krebs solution at 
37˚C. (A) Shows the effect of Fsk and different inhibitors on the volume of fluid 
secreted over 24 hours; *= P<0.05 significant effect of forskolin stimulation compared 
to unstimulated control cells, #=P<0.05 significant effect of forskolin stimulation 
compared to +Fsk+TBB and Fsk+Dynasore. (B) Shows the pH of Fsk-stimulated 
secreted fluid compared to unstimulated control cells under different reatments as 
indicated. Data represents mean ± S.E.M.; n = 3 for each condition.  
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3.9 Discussion 
 
3.9.1 The effect of cAMP and cGMP in the regulation of apical Cl-/HCO3- AE activity 
Using pHi measurements from polarised cultures of Calu-3 cells my results have 
shown that in the absence of cAMP stimulation these model human serous 
airway cells exhibit little Cl-/HCO3- anion exchange activity at the apical 
membrane. In contrast, stimulation of Calu-3 cells with several different cAMP 
agonists (ADO, Fsk, IBMX and dbcAMP) reversed this situation, with the cells 
showing robust anion exchange activity at the apical membrane as evidenced by 
the magnitude of the alkalinisation following apical Cl- removal and the 
subsequent rate of reacidification upon Cl- readdition. However, stimulation of 
Calu-3 cells with Fsk caused a significantly larger increase in apical Cl-/HCO3- 
AE activity, compared to ADO stimulated cells. One potential explanation for 
this difference could be that ADO might produce a smaller  increase in [cAMP]i 
compared to Fsk, which is consistent with studies by Huang et al. (2001) who 
demonstrated that stimulation of Calu-3 cells with adenosine produced very little 
increase in [cAMP]i, compared to forskolin  (Huang et al., 2001).  
Although a previous study by Illek et al., (1997) concluded that CFTR functions 
as a Cl- and HCO3- channel (Illek et al., 1997), which was supported by studies 
performed on Calu-3 cells that showed CFTR to possess both an apical Cl- and 
HCO3- conductance (Shan et al., 2012), my studies are also consistent with the 
most recent work obtained by Garnett et al., 2011 and 2013 (Garnett et al., 
2011; Garnett et al., 2013) that apical Cl-/HCO3- AE directly regulates HCO3- 
transport in Calu-3 cells. In the Garnett study the apical Cl-/HCO3-  AE was 
identified as SLC26A4, also known as pendrin, a member of the SLC26A 
transporter family (Mount and Romero, 2004).  The cAMP-induced activation of 
apical Cl-/HCO3- AE activity that I have described was markedly inhibited by 
two different PKA inhibitors, H-89 and RpcAMP, as well as by the Epac 
inhibitor ESI-09, which clearly indicates that stimulation of apical Cl-/HCO3- AE 
activity is through cAMP/PKA/Epac-dependent mechanisms. Furthermore, Epac 
inhibition enhanced apical Cl-/HCO3- AE activity under resting conditions, 
which was potentially CFTR dependent. Either way these results suggest that 
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Epac plays two distinct roles in Calu-3 cells. Under resting conditions, where 
cAMP levels are likely to be low, Epac appears to inhibit apical Cl-/HCO3- AE 
activity. In contrast, when cells are strongly stimulated by Fsk, Epac appears to 
be required to maintain maximal Cl-/HCO3- AE activity. Exactly how Epac is 
able to play these distinct roles requires further investigation, but it is possible 
that under resting conditions Epac could help keep cAMP levels sufficiently low 
to prevent PKA activation, by acting as a cAMP ‘buffer’.  In contrast to cAMP, 
although it has been previously shown in some cells that there is a synergistic 
interaction between the two intracellular second messengers, cAMP and cGMP, 
(de Wit et al., 1994), my results showed that cGMP is not involved in the 
regulation of the apical Cl-/HCO3- AE activity in Calu-3 cells, under both basal 
and cAMP stimulated conditions. 
Furthermore, cAMP stimulation of apical Cl-/HCO3- AE activity in Calu-3 cells 
was significantly reduced by CFTR inhibition, using the CFTR pore blocker 
GlyH-101, which produced a very fast intracellular acidification, suggesting that 
anion transport by CFTR modulated the apical Cl-/HCO3- AE activity. However, 
the GlyH-101 induced acidification was prevented by addition of basolateral 
DIDS, in a dose-dependent manner, with 100µM DIDS completely blocking the 
acidification. This result suggests that a DIDS-sensitive basolateral transporter 
appears to regulate apical Cl-/HCO3- AE activity in Calu-3 cells. This is 
consistent with the previous finding that 500µM H2DIDS abolished the CFTR 
inhibitor-induced acidification under 0Cl- conditions (J Garnett PhD thesis, 
2010). My experiments have not uncovered the exact identity of the basolateral 
HCO3- transporter so future experiments will be required to do this. However, 
because I have shown that cAMP stimulation inhibits the basolateral anion 
exchanger in Calu-3 cells, it is unlikely that this protein is involved, although at 
this stage it cannot be ruled out. Another possibility is that the basolateral NBC 
could be involved as GlyH-101 prevents anion efflux through CFTR and this 
could therefore lead to a hyperpolarisation of the membrane potential, which 
could be large enough to reverse the electrogenic basolateral NBC, thereby 
causing HCO3- efflux rather than entry, and so [HCO3-]i decreases. However, 
previous results showed that GlyH-101 induced acidification was independent of 
membrane potential (J Garnett PhD thesis, 2010).  
93 
 
3.9.2 Intracellular Ca2+ signaling plays a significant role in the regulation of apical Cl-
/HCO3- AE activity 
The mechanism by which cAMP induced activation of apical Cl-/HCO3- AE was 
assessed by changing the concentration of intracellular and extracellular Ca2+, 
because it has been shown that there is a synergistic interaction between cAMP 
and Ca2+ in stimulation of HCO3- secretion in Calu-3 cells  (Krouse et al., 2004). 
Consistent with this, my results showed that decreasing intracellular Ca2+ 
concentration, by BAPTA-AM, significantly reduced the cAMP-induced 
intracellular alkalinisation and rate of reacidification produced by apical Cl- 
removal. These data imply that normal (resting) concentration of [Ca2+]i is 
required for  cAMP to stimulate apical Cl-/HCO3- AE activity in Calu-3 cells.  
However, an increase in [Ca2+]i concentration, using thapsigargin,  significantly 
reduced the cAMP stimulated apical Cl-/HCO3- AE activity which was not 
blocked by treating the cells with BAPTA-AM; instead this caused a further 
significant reduction in apical Cl-/HCO3- AE activity. This indicates that the 
effect of an increase [Ca2+]i is independent of BAPTA-AM; which potentially 
could be through a PKA-dependent mechanism because it has been shown that 
an increase in [Ca2+]i enhances calcineurin, a serine-threonine protein 
phosphatase, which inhibits PKA activity via dephosphorylation of PKA 
effectors (Santana et al., 2002) or even direct inhibition of PKA itself (Orie et 
al., 2009). Thus, even in the presence of BAPTA-AM, thapsigargin might 
produce some increase in [Ca2+]i to affect the PKA-dependent apical Cl-/HCO3- 
AE activity. Consistent with this, my colleague, Waseema Patel, has measured 
intracellular Ca2+ in HEK293T cells (using the Ca2+ sensitive dye, Fura2-AM), 
in the presence of BAPTA-AM and thapsigargin, and her results showed that 
there is still a small increase in [Ca2+]i.  On the other hand, removing 
extracellular Ca2+ did not affect the cAMP-induced activation of apical Cl-
/HCO3- AE activity. These data collectively suggest that BAPTA-AM might 
disrupt the synergistic cross-talk between cAMP and Ca2+ to maintain apical Cl-
/HCO3- AE activity under cAMP stimulation, while an increase in [Ca2+]i exerts 
its effect via PKA inhibition, independently of intracellular Ca2+ chelation by 
BAPTA-AM. Also extracellular Ca2+ is not involved in intracellular cAMP 
signalling cascades in the regulation of Fsk stimulated apical Cl-/HCO3- AE 
activity. Future experiment would be of interest to measure the PKA activity in 
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the presence of BAPTA-AM and thapsigargin to establish whether a decrease or 
an increase in [Ca2+]i  affects PKA activity in forskolin-stimulated Calu-3 cells, 
which could involve performing ELISA assays. 
Based on the fact that cAMP stimulated apical Cl-/HCO3- AE activity needs 
normal (resting) [Ca2+]i  to maintain the apical Cl-/HCO3- AE activity, I 
investigated further the relationship between cAMP and Ca2+/calmodulin 
dependent protein kinase (CaMK) in the regulation of cAMP stimulated apical 
Cl-/HCO3- AE activity, because extensive cross-talk has been found between 
CaMK and some cAMP-dependent protein kinases, that could be involved in the 
regulation of signalling cascades inside the cells (Soderling, 1999). Results 
showed that preincubation of cells with the CaMKK inhibitor STO-609 (which 
inhibits CaMKI and CaMKIV), did not stimulate basal AE activity, but did 
produce a significant reduction in intracellular alkalinisation upon apical Cl- 
removal, following Fsk stimulation, in STO-609 treated cells, but did not affect 
the rate of reacidification compared to control cells.  A possible mechanism for 
this might be that inhibition of CaMK interferes with the ability of AC1 to 
generate cAMP, in a Ca2+-dependent manner, as AC1, which colocalizes with 
CFTR, is a Ca2+/calmodulin stimulated enzyme in the apical membrane of 
human bronchial epithelial cells (Namkung et al., 2010). However, CaMKII 
inhibition had no effect on the apical Cl-/HCO3- AE activity, suggesting that this 
Ca2+/calmodulin dependent kinase is not involved in the regulation of apical Cl-
/HCO3- AE activity in Calu-3 cells. Furthermore, in order to obtain an insight 
into the role of CaM in the regulation of apical Cl-/HCO3- AE activity, Calu-3 
cells were treated with a CaM inhibitor and results revealed that CaM did not 
contribute to the regulation of apical Cl-/HCO3- AE activity under basal and 
cAMP stimulated condition. This is consistent with the lack of a role for 
CaMKK and CaMK in the regulation of the apical Cl-/HCO3- AE activity in 
Calu-3 cells. Also, another Ca2+-dependent protein kinase, PKC, has also been 
shown not to be involved in the regulation of the apical Cl-/HCO3- AE activity 
under basal and stimulated conditions (J Garnett, PhD thesis, 2010).  
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3.9.3 The effect of dynamin on apical Cl-/HCO3- AE activity and fluid secretion 
There is a strong relationship between intracellular Ca2+ and dynamin as it has 
been shown that relocation of dynamin from the cytoplasm to the plasma 
membrane is enhanced by an elevation of intracellular Ca2+ (Liu et al., 1994) 
which could be via direct binding of Ca2+ to dynamin, or indirectly, by 
dephosphorylation of dynamin through its binding with a Ca2+-sensitive 
phosphatase, known as calcineurin (Bauerfeind et al., 1997; Hens et al., 1998; 
Marks and McMahon, 1998). Dynamin also plays an important role in the 
formation of a transport vesicle derived from the trans Golgi network, which 
travels to the plasma membrane (Nabi and Le, 2003; Abazeed et al., 2005; Cao 
et al., 2005). It has also been shown that dynamin plays a key role in the 
expansion of the fusion pore within milliseconds of granule fusion, and also 
regulates the topological fate of the released granules after fusion and spreading 
of membrane proteins into the plasma membrane (Anantharam et al., 2011). 
Thus, I also investigated the role of dynamin in the regulation of apical Cl-
/HCO3- AE activity in Calu-3 cells since increasing [Ca2+]i markedly reduced the 
cAMP stimulated apical Cl-/HCO3- AE activity, which could be potentially by 
enhancing dynamin mediated endocytosis of the AE.  
Dynamin was inhibited via treating cells with dynasore, and this caused a 
significant decrease in cAMP stimulated apical Cl-/HCO3- AE activity, but had 
no effect on the apical Cl-/HCO3- AE activity under basal conditions. However, 
dynamin inhibition did not affect the pH of secreted fluid, but it did reduce the 
amount of fluid secreted over a 24 h period, compared to control responses. One 
possible explanation for these apparent discrepant results could be that dynamin 
inhibition may have reduced surface levels of CFTR, which would decrease Cl- 
efflux, and thereby reduce the driving force for fluid secretion by Calu-3 cells. 
However, the residual CFTR activity may have been enough to maintain 
sufficient apical Cl-/HCO3- AE activity to ensure that the pH of secreted fluid 
was alkalinised over a 24 h period. This would be consistent with previous 
results from our group which showed that both CFTR KD, or treatment of cells 
with CFTR blockers, also reduced the amount of fluid secreted over 24 h but not 
the final pH of the secreted fluid (Garnett et al., 2011). Another possible 
explanation could be that apical AE activity in dynamin treated cells for 24 
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hours may not reflect the acute exposure of dynamin in pHi experiments. Thus, 
it would be worth to measure apical AE activity in dynasore treated Calu-3 cells 
following 24 hour preincubation, under both resting and Fsk-stimulated 
conditions. However, how dynamin inhibition could reduce levels of CFTR is 
not clear and needs further investigation.  Note that dynamin inhibition could 
also reduce the expression level of the apical Cl-/HCO3- AE and subsequently 
reduce the Cl-/HCO3- exchange activity. However, previous work from our lab 
(Garnett et al., 2011), showed that while pendrin KD in Calu-3 cells caused a 
reduction in apical anion exchange activity, it had modest effects on fluid 
secretion, but markedly reduced the pH of the secreted fluid. Thus the results 
from dynamin inhibition do not match those from pendrin KD cells.   Overall, 
my results imply that dynamin plays a role in the regulation of apical Cl-/HCO3- 
AE activity, and this may be via a change in surface levels of CFTR in Calu-3 
cells.  
 
3.9.4 Role of the actin-cytoskeleton in the regulation of apical Cl-/HCO3- AE activity 
I also have assessed the dependency of apical Cl-/HCO3- AE activity on an intact 
cytoskeleton and cAMP compartmentalization. The pharmacological agent, 
CytoD, was used to disrupt F-actin polymerization and thus actin cytoskeleton 
organization, which was appeared much more punctuate and disorganised by 
phalloidin staining. Treatment was found to significantly reduce TEER in Calu-
3 cells suggesting that CytoD affected the organization of the actin cytoskeleton 
to modulate tight junction properties. However, CytoD did not affect either the 
basal or the cAMP stimulated apical Cl-/HCO3- AE activity under Fsk and ADO 
stimulated conditions. Given that forskolin or ADO still provoked apical Cl-
/HCO3- AE activity suggested that cAMP compartmentalization wasn’t 
necessary in order to produce this response. This is somewhat surprising because 
Monterisi et al. (2012) has demonstrated that actin-cytoskeleton disruption in 
human bronchial epithelial cells (HBE) significantly decreased cAMP-
stimulated CFTR activity. This  potentially suggests that (i) there is an important 
difference between Calu-3 and HBE cells in actin cytoskeleton organization or 
(ii) forskolin or ADO were still able to increase [cAMP]i to some extent, that 
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even a reduction in a specific cAMP microdomain, was not sufficient to reduce 
the activity of cAMP-stimulated apical Cl-/HCO3- AE in Calu-3 cells.  Further 
investigations into the effects of cytoskeleton disruption on cAMP 
compartmentalization and [cAMP]i at specific microdomains in cAMP 
stimulated Calu-3 cells are required, which could involve performing  FRET 
analysis with cAMP or PKA sensors, which is an accurate method for the 
analysis and interpretation of changes in [cAMP]i detected at different 
subcellular regions (Salonikidis et al., 2008).   
 
3.9.5 CK2 exhibits a significant role in regulating apical Cl-/HCO3- AE activity  
To further understand the mechanism of apical Cl-/HCO3- AE activation by 
cAMP signalling, Calu-3 cells were treated with two different CK2 inhibitors 
(TBB or CX4945), because CK2 inhibition has been shown to reduce CFTR 
channel activity and reduce the Cl- conductance of airway cells. CK2 co-
immunoprecipitated and colocalized with WT-CFTR in the apical membrane of 
human airway epithelial cells (Treharne et al., 2009). Here, researchers also 
demonstrated that CK2 is absent in the apical membrane of CF nasal epithelia 
which makes CFTR unable to traffic to the apical membrane. It has  also been 
shown that CK2 inhibition blocked the cAMP-dependent PKA activation of 
CFTR (Mehta, 2008). My results demonstrated for the first time that CK2 
inhibition caused a significant decrease in cAMP stimulated apical Cl-/HCO3- 
AE activity in Calu-3 cells, but it did not affect the basal AE activity. Also, CK2 
inhibition caused a significant reduction in the cAMP stimulated HCO3- flux by 
the apical Cl-/HCO3- exchanger. This is consistent with the previous finding that 
CK2 can modulate cAMP-dependent HCO3- secretion in pancreatic duct 
epithelial cells (Treharne et al., 2009). My findings also provide further support 
for an interaction between CK2 and CFTR, as CK2 inhibition would potentially 
reduce CFTR anion transport function, and subsequently reduce cAMP-
stimulated apical Cl-/HCO3- AE activity. This is consistent with previous finding 
from our laboratory, which showed that knocking down CFTR in Calu-3 cells 
decreased the rate of cAMP-stimulated apical Cl-/HCO3- AE activity (Garnett et 
al., 2011). However, I found that CK2 inhibition produced a significant decrease 
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in the amount of secreted fluid collected after 24 h preincubation of Calu-3 cells 
with TBB, but it did not change the pH of secreted fluid. This paradoxical effect 
of CK2 inhibition could be explained by a similar mechanism described for 
dynamin inhibition, namely a selective reduction in CFTR expression/activity 
(see section 3.83).  Further investigation could involve testing the effect of CK2 
inhibition on the apical Cl-/HCO3- AE activity in CFTR-KD Calu-3 cells. 
The exact mechanisms involved in the regulation of apical Cl-/HCO3- AE 
activity by CK2 under cAMP stimulated condition are not clear. However, CK2 
is known to be the main, if not the only, protein kinase that can phosphorylate 
CaM in living cells (Arrigoni et al., 2004). Since I have shown that CaM is not 
involved in the regulation of apical Cl-/HCO3- AE activity, this suggests that 
CK2 exerts its effect on the apical Cl-/HCO3- AE activity through a CaM-
independent mechanism, possibly via direct phosphorylation of CFTR and/or the 
apical AE itself. 
 
 
The main findings of this chapter are summarized below (see Figure 3.23): 
 
• cAMP agonists stimulate CFTR dependent apical Cl-/HCO3- AE activity in 
Calu-3 cells through PKA and Epac-dependent mechanisms. 
• cGMP is not involved in the regulation of the apical Cl-/HCO3- AE activity in 
Calu-3 cells. 
• Epac inhibition stimulates CFTR-dependent apical Cl-/HCO3- AE activity under 
basal conditions. 
• A decrease in [Ca2+]i significantly attenuated cAMP stimulated apical Cl-/HCO3- 
AE activity in Calu-3 cells potentially via inhibiting the synergistic interaction 
between Ca2+ and cAMP.  
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• cAMP stimulated apical Cl-/HCO3- AE activity was significantly reduced by 
intracellular elevation of Ca2+,  perhaps through PKA inhibition.  
CaMKI, CaMKII and CaMKIV were not significantly involved in the regulation 
of apical Cl-/HCO3- AE activity in Calu-3 cells. 
• Dynamin inhibition caused a significant reduction in cAMP stimulated apical Cl-
/HCO3- AE activity, as well as the amount, but not the pH, of the secreted fluid.   
• An intact actin-cytoskeleton was not required for cAMP-induced apical Cl-
/HCO3- AE activity in Calu-3 cells. 
• CK2 plays an essential role in the regulation of cAMP stimulated apical Cl-
/HCO3- AE activity through a CaM-independent mechanism in Calu-3 cells.  
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Figure 3. 23: Schematic illustration of intracellular signaling pathways that 
regulate CFTR and apical Cl-/HCO3- AE activity in Calu-3 cells. Adenylyl cyclase 
(tmAC) activators (forskolin or adenosine), and the membrane permeable cAMP 
analogue ,dibutyryl cAMP, or the phosphodiesterase inhibitor, IBMX, cause a rise in 
cAMP, which is a key event in PKA and Epac-dependent stimulation of CFTR and 
apical Cl-/HCO3- AE activity. Chelation of intracellular Ca2+ by BAPTA-AM, or 
elevation of [Ca2+]i by thapsigargin, reduced cAMP stimulated CFTR and pendrin 
activity, through a different mechanism. CK2 and dynamin play a critical role in the 
regulation of cAMP stimulated CFTR and pendrin activity. (-) denotes inhibition, (+) 
denotes stimulation, and (X) denotes not contribute. 
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Chapter 4 Basolateral Cl-/HCO3- anion exchange activity in Calu-3 cells 
4.1 Introduction 
A previous immunofluorescence study (Loffing et al., 2000), and recent results 
by Garnett et al, have demonstrated that there is a functional Cl-/HCO3- anion 
exchanger at the basolateral membrane of Calu-3 cells which is active under 
resting conditions (Garnett et al., 2011; Garnett et al., 2013) and which was 
originally proposed to be a housekeeping Cl-/HCO3- exchanger (Alper et al., 
1999). This transporter is most likely AE2 or SLC4A2, which is one of the eight 
members of the SLC4 family of solute transporters that encode proteins that are 
involved in transmembrane HCO3- transport (Romero et al., 2004). 
Immunohistochemical analysis has shown that AE2 is present in airway 
epithelial cells with a similar level of mRNA expression from the trachea down 
to the small bronchi (Al-Bazzaz et al., 2001). The basolateral Cl-/HCO3- AE is 
thought to play an important role in the regulation of intracellular pH (pHi) by 
participating in base efflux, and it can  also work in concert with the sodium-
potassium chloride cotransporter, NKCC1, to facilitate the inward movement, 
and accumulation, of Cl- across the basolateral membrane (Loffing et al., 2000; 
Inglis et al., 2002). In most epithelial cells the  basolateral Cl-/HCO3- AE plays a 
critical role in the regulation of intracellular pH during intracellular 
alkalinisation, as well as in cell volume control, by regulating the Cl-  
concentration inside the cells (Stewart et al., 2002). However, it has recently 
been proposed that the basolateral Cl-/HCO3- AE also plays an essential role in 
cAMP-stimulated transepithelial Cl- secretion in Calu-3 cells, through coupling 
of its transport activity with that of the electrogenic sodium-bicarbonate 
cotransporter (NBC). In this novel ‘tertiary’ active process, Cl- is effectively 
accumulated within Calu-3 cells through the combined activity of the two 
basolateral transporters (driven by the inward directed Na+ gradient maintained 
by the Na+-K+ ATPase), with HCO3- cycling across the basolateral membrane 
(Huang et al., 2012; Shan et al., 2012). The study by Shan et al, 2012 also 
demonstrated that Fsk stimulation of Calu-3 cells led to an increase  in 
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basolateral Cl- loading and HCO3- influx by stimulation of the basolateral Cl-
/HCO3- AE and NBC activity, respectively, thereby enhancing fluid secretion 
across the apical membrane (Shan et al., 2012). Furthermore, a recent pHi study 
by Kim et al., (2014) revealed that  although the basolateral Cl-/HCO3- AE 
appeared to be almost completely inhibited in Fsk stimulated Calu-3 cells,  it 
could in fact be shown to be active (unmasked) if  CFTR was  inhibited (in the 
presence of Fsk), suggesting that cAMP stimulation was not inhibiting the 
basolateral anion exchanger, it was simply being ‘masked’ by the more 
dominant apical anion exchanger activity (Kim et al., 2014). This result is 
consistent with our own studies where it was found that knocking down CFTR 
expression, or blocking its activity with GlyH-101, led to incomplete inhibition 
of the basolateral Cl-/HCO3- AE  by cAMP in Calu-3 cells (Garnett et al., 2013).  
However, we also found that the basolateral anion exchanger was still inhibited 
in cells treated with both Fsk as well as the PKA inhibitor, H-89, which reduced 
apical anion exchanger activity by ~ 85%. This latter result is not compatible 
with the observations of Kim et al., (2014), and furthermore suggested that an 
increase in intracellular cAMP inhibited basolateral Cl-/HCO3- AE activity 
through a novel PKA-independent mechanism (Garnett et al., 2013).  The reason 
for these differing results/interpretations is not resolved.  
 
However, since human airway serous cells from SMGs play an important role in 
regulating the magnitude and pH of the ASL that lines the surface of the 
conducting airways (Ballard and Inglis, 2004; Tarran et al., 2006; Garnett et al., 
2011), which  is essential for the innate defence mechanisms of the lung to 
function adequately  (Pezzulo et al., 2012b) and inhibition of the basolateral Cl-
/HCO3- anion exchanger could theoretically provide additional HCO3- to be 
transported by the apical AE in Calu-3 cells, the molecular mechanism that 
regulates the basolateral Cl-/HCO3- AE under resting, as well as cAMP 
stimulated conditions, is an important area of research. In this chapter I have 
characterised in more detail the cellular signalling mechanisms that regulate the 
basolateral anion exchanger, and provide additional support that a rise in 
cytosolic cAMP inhibits AE2 activity, through a PKA-independent mechanism. 
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4.2 Cl- and HCO3- dependence of the basolateral Cl-/HCO3- anion exchanger 
As shown in Figure 4.1, and previously reported by Garnett et al., (2011); 
Garnett et al., (2013), Calu-3 cells exhibit a basolateral Cl-/HCO3- AE activity 
under resting situations. In HCO3-/KREBS condition, basolateral Cl- removal 
produced an alkalinisation in pHi of 0.36±0.02 pH units (n=6). It was noticeable 
that the alkalinisation caused by basolateral Cl- removal was monophasic, with a 
fast initial increase in pHi to a new plateau level (Figure 4.1A), in contrast to the 
alkalinisation produced by apical Cl- removal under cAMP-stimulated 
conditions, which was biphasic (see Chapter 3). To investigate the anion 
transport properties of this basolateral anion exchanger in more detail, the Cl- 
and HCO3--dependence was assessed by removing Cl- and HCO3- from the 
perfusate and replacing with HEPES buffer, under resting conditions. Acute 
exposure of the basolateral membrane to a HCO3- free (but Cl- rich) HEPES 
buffered solution failed to produce any intracellular alkalinisation, but instead 
produced a large, and significant, intracellular acidification of 0.40±0.01 pH 
units (n=3, P<0.001; Figure 4.1A & B), which may be due to HCO3- efflux via 
the basolateral Cl-/HCO3- AE activity in exchange with extracellular Cl- or more 
likely due to inhibition of the NBC. This suggests that the basolateral Cl-/HCO3- 
AE cannot transport significant amounts of OH- anions. Addition of a HCO3- 
and Cl- free HEPES solution to the basolateral compartment did not produce any 
change in pHi, which was significantly different to the control response and the 
response to HCO3--free, Cl--rich HEPES conditions (n=6, P<0.001; Figure 4.1), 
suggesting that Cl--dependent HCO3- transportation was responsible for the 
obvious intracellular pH changes.  
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Figure 4. 1: Cl- and HCO3- dependence of the basolateral Cl-/HCO3- AE in Calu-3 
cells. (A) Representative pHi trace showing the basolateral Cl-/HCO3- AE activity in 
HCO3- and Cl- free HEPES buffer solution in Calu-3 cells. (B) mean change in pHi 
produced by basolateral Cl-/HCO3- AE activity in HCO3-/KREBS solution compared to 
HCO3- free and HCO3-+Cl- free HEPES solution respectively. *P<0.001 compared to 
control response, #P<0.001 compared to Na-HEPES. Data are shown as mean ±SEM, 
n=6 for control, n=3 for +Na-HEPES, and n=6 for Cl- free HEPES.  
 
 
4.3 DIDS sensitivity of the basolateral Cl-/HCO3- anion exchanger  
To investigate the pharmacological properties of the basolateral anion exchanger 
the response to a basolateral Cl- free solution was evaluated in the presence of 
the anion exchange inhibitor 4-4-Diisothiocyanatostilbene-2,2′-Disulfonic Acid 
(DIDS). Figure 4.2A shows that basolateral Cl- removal produced an 
alkalinisation in pHi of 0.33±0.05 pH unit, which recovered following Cl- 
readdition at a rate of 0.57±0.07 pHi min-1 (n=8). This response was not affected 
by 0.01µM DIDS, (0.34±0.01 pH units, and the rate of reacidification following 
Cl- readdition of 0.57±0.01 pHi min-1, n=4); however, the response to a Cl- free 
solution was completely abolished by 500µM DIDS (P<0.05, paired 
observation; n=3). There was a concentration-dependent inhibition of basolateral 
Cl-/HCO3- AE activity by DIDS. Results showed that there was a significant 
reduction in the mean pHi when perfused with Cl- free solution containing 30µM 
(0.10 ± 0.01 pH units, n=5, P<0.05) and 100 µM DIDS (0.05 ± 0.02 pH units, 
n=3, P<0.05) and a marked change in the rate of reacidification upon readdition 
105 
 
6.8
7.0
7.2
7.4
7.6
7.8
8.0
Baso 0Cl- Baso 0Cl-
           KREBS/HCO3- +
            0.01µM DIDS           KREBS/HCO3
-
240s
Baso 0Cl-
           KREBS/HCO3- +
            500µM DIDS
           KREBS/
             HCO3-
pH
i
-8 -7 -6 -5 -4 -3
0
10
20
30
40
50
60
70
80
90
100
Log [DIDS, M]
Pe
rc
en
t I
nh
ib
iti
on
 o
f M
ea
n 
ch
an
ge
 in
 p
H
i
-8 -7 -6 -5 -4 -3
0
10
20
30
40
50
60
70
80
90
100
Log [DIDS, M]
Pe
rc
en
t I
nh
ib
iti
on
 o
f r
at
e 
of
re
ac
id
ifi
ca
tio
n 
(p
H
i m
in
-1
)
of high Cl- solution. The percent inhibition of the basolateral AE activity is 
shown in Figure 4.2B and C, and from these data an IC50 value 16.5 ± 1.3 µM 
was obtained for DIDS inhibition of the mean change in pHi. The IC50 value for 
inhibition of the rate of reacidification was 7.5 ± 1.2 µM. These results are 
consistent with the presence of a basolateral DIDS-sensitive Cl-/HCO3-  anion 
exchanger (SLC4A2), as previously been reported in Calu-3 cells (Loffing et al., 
2000). Taken together, these data imply that the basolateral Cl-/HCO3- AE 
activity is clearly a Cl- and HCO3--dependent, DIDS-sensitive, anion exchanger 
in Calu-3 cells.  
 
        A 
 
 
 
 
 
 
 
                  B                                                                           C 
 
 
 
 
 
 
 
Figure 4. 2: Inhibitory effect of DIDS on basolateral Cl-/HCO3- AE activity. (A) 
Representative pHi traces showing the effect of  DIDS (0.01 µM and 500µM) on pHi changes 
after perfusion of basolateral Cl- free solution in Calu-3 cells. DIDS dose response curve for 
inhibition of the basolateral Cl-/HCO3- anion exchanger. Plot of percent inhibition of the mean 
change in pHi caused by basolateral Cl- removal (B), and the rate of reacidification upon Cl- 
readdition (C) at different DIDS concentrations. Non-linear regression fit to the data, n=8 for 
control; n=4 for 0.01µM and 500µM DIDS; n=5 for 10µM, 30µM, and n=3 for 0.1µM; 1µM; 
100µM DIDS. 
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Note that because the inhibitory effect of DIDS on the basolateral AE was not 
fully reversible for concentrations above 10 µM, (as shown in Figure 4.3), dose-
response experiments had to be done on separate cultured monolayers.  
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Figure 4. 3: Recovery of basolateral Cl-/HCO3- AE activity after DIDS inhibition. 
(A) Representative pHi trace showing the effect of DIDS (100µM) on pHi changes after 
perfusion of basolateral Cl- free solution in Calu-3 cells. Summary of the effect of 
100µM DIDS on mean pHi changes (B), and the rate of reacidification after Cl- 
readdition (C).  DIDS inhibition of the basolateral Cl-/HCO3- exchanger was partially 
reversible after 8 min of wash off in high Cl- solution. Data are shown as mean± SEM 
*P<0.05 compared to control, paired observation, n=3 for each condition. 
 
 
In the DIDS experiments, DMSO was used as the vehicle to dissolve the 
inhibitor. In order to test if DMSO alone had any effect on basolateral Cl-/HCO3- 
AE activity, Calu-3 cells were acutely exposed to 0.25% DMSO (~5min) and 
then basolateral Cl-/HCO3- AE activity was measured in the presence of DMSO. 
Results showed that basolateral Cl- removal in the presence of 0.25% DMSO did 
not affect the basolateral Cl-/HCO3- AE activity compared to control responses, 
for both the mean change in pHi produced by basolateral Cl- removal 
(0.30±0.01, for controls and 0.34±0.02 for DMSO treated responses, n=5, 
P>0.05) and the rate of reacidification following Cl- readdition (0.77±0.09, n=5 
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for controls and 0.88±0.08 for DMSO treated responses, n=5, P>0.05). This 
suggests that DMSO is not involved in producing any changes in the basolateral 
Cl-/HCO3- AE activity in Calu-3 cells. 
Previous work from our group has shown that in the absence of cAMP 
stimulation, Calu-3 cells secrete an isotonic solution with a pH of ~ 7.4 (Garnett 
et al., 2011). I therefore investigated the effect of blocking the basolateral anion 
exchanger with DIDS on transepithelial fluid and HCO3- secretion. Although 
complete inhibition of the basolateral Cl-/HCO3-AE by 500µM DIDS did not 
affect the amount of secreted fluid, the pH of the secreted fluid was significantly 
increased after 24 h incubation of cells with DIDS, in a high Cl- Krebs solution 
at 37˚C in 5% CO2 (Figure 4.4A and B). These results provide support that 
changes in basolateral Cl-/HCO3-AE activity can modulate transepithelial HCO3- 
secretion, as inhibition of the basolateral Cl-/HCO3- AE activity should cause 
accumulation of HCO3- inside the cells, and thereby increase the driving force 
for HCO3- secretion, by apical AE and/or CFTR activity. 
 
           
 
           A                                   B 
 
 
 
 
 
Figure 4. 4: Summary of the effect of DIDS (500µM) on fluid secretion in Calu-3 
cells. Cells were incubated with 500µM DIDS for 24 hours in 5% CO2 (v/v) in air in 
high Cl- Krebs solution at 37˚C. Summary shows the effect of DIDS on the volume (A) 
and pH (B) of the secreted fluid after 24 h; *P<0.05 significant effect compared to 
control cells, n=3. 
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4.4 Role of cyclic nucleotides (cAMP and cGMP) in the regulation of basolateral Cl-
/HCO3- anion exchange activity  
4.4.1 cAMP agonists: 
Adenosine 3′,5′ cyclic monophosphate (cAMP) is one of the ubiquitous 
intracellular secondary messengers that plays an important role in the  regulation 
of various cellular functions, and its intracellular concentration is controlled by 
enzymes such as adenylyl cyclase and phosphodiesterases (Fantidis, 2010). As 
shown in Figure 4.5A,  the basolateral Cl-/HCO3- anion exchange activity was 
nearly completely abolished by the addition of the cAMP agonist Fsk, which 
reduced the magnitude of alkalinisation induced by basolateral Cl- removal by 
85.2±2.6% and the rate of reacidification by 98.4±1.6%. The basolateral Cl-
/HCO3- exchange activity was also inhibited by bilateral addition of 10µM 
adenosine (ADO), which was as effective as Fsk in reducing the basolateral AE 
activity. ADO reduced the magnitude of alkalinisation by 73.9±4.8% and the 
rate of reacidification by 81.8± 5.1% (Figure 4.5D and E). The results for ADO 
inhibition are also of interest since it was shown in Chapter 3 (section 3.2.1), 
that ADO was much less effective at activating apical AE activity compared to 
Fsk. Overall, these results suggest that intracellular increases of cAMP were 
responsible for the inhibition of the basolateral Cl-/HCO3- exchange activity in 
Calu-3 cells. 
 
     A                                                                        B                                   C   
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Figure 4. 5: Forskolin and adenosine reduced basolateral Cl-/HCO3- AE activity in Calu-3 
cells. (A) Representative pHi trace showing the effect of Fsk (5µM) on pHi changes after 
perfusion of basolateral Cl- free solution in Calu-3 cells. Summary of the impact of cAMP 
agonist forskolin on the basolateral Cl-/HCO3- AE activity in Calu-3 cells, (B) mean pHi change 
(alkalinisation) caused by Cl- removal, and the rate of reacidification (C) following Cl- 
readdition, under resting and forskolin (5µM) stimulated condition.  *P<0.05 compared to Baso 
0Cl-.  Data are shown as mean ±SEM, n=10 for each condition. (D) Impact of ADO on mean pHi 
change (alkalinisation) caused by Cl- removal, and the rate of reacidification following Cl- 
readdition (E), under resting and adenosine (10µM) stimulated conditions. *P<0.05 compared to 
Baso 0Cl-.  Data are shown as mean ±SEM, n=3 for each condition, paired observations. 
 
 
Another way to increase cAMP inside cells, aside from Fsk and ADO, and 
downstream of tmAC was to use the phosphodiesterase (PDE) inhibitor, IBMX 
(1mM added apically only), or to treat cells with a membrane permeable 
analogue of cAMP, db-cAMP, (added bilaterally at a concentration of 800µM) 
to further clarify the role of cAMP in mediating the inhibition of basolateral AE 
activity. It has been shown that inhibitions of PDEs, which are responsible for 
cAMP breakdown, are accompanied by an increase of intracellular cAMP, and 
CFTR activation in Calu-3 cells (Cobb et al., 2003). As shown in Figure 4.6A, 
stimulation of Calu-3 cells with IBMX completely abolished the basolateral AE 
activity compared to the control response, and which was fully reversed after 5 
min washing off the IBMX. The PDE inhibitor caused a significant decrease in 
both mean change in pHi, produced by basolateral Cl- removal, and the rate of 
reacidification, upon Cl- readdition, compared to control response (Figure 4.6B 
and C). Moreover, db-cAMP significantly reduced the activity of the basolateral 
Cl-/HCO3- anion exchanger, as  both the magnitude of alkalinisation produced 
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by basolateral Cl- removal, as well as  the rate of reacidification following Cl- 
readdition were significantly decreased (Figure 4.6D and E). Note that the effect 
of dbcAMP was not readily reversible. Therefore, these data provide further 
strong support that an increase of intracellular cAMP is clearly responsible for 
abolishing basolateral Cl-/HCO3- AE activity.  
 
 
 
                       A                                                                                               
 
 
 
 
 
               B                                    C                                    D                                  E 
 
 
 
 
 
Figure 4. 6: IBMX and dbcAMP inhibit basolateral Cl-/HCO3- AE activity in Calu-3 cells. 
(A) Representative pHi trace showing that IBMX inhibits the activity of the basolateral AE 
activity in Calu-3 cells.  Summary of the impact of IBMX on the basolateral Cl-/HCO3- AE 
activity for both mean pHi change (alkalinisation) caused by Cl- removal (B), and the rate of 
reacidification after Cl- readdition (C) under resting and stimulated condition with cAMP 
agonists (IBMX), .*P<0.05, n=6 for each condition. (D) Mean pHi change (alkalinisation) 
caused by Cl- removal, (E) the rate of reacidification after Cl- readdition under resting and 
stimulated condition with dbcAMP (800µM) in Calu-3 cells. Data are shown as Mean±SEM. 
*P<0.05, n=3 for each condition, paired observations. 
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4.4.2 The role of Multidrug Resistance Proteins 
 
The multidrug resistance proteins (MRP) are also members of the ABC 
transporter family,  and have been shown to transport cyclic nucleotides from 
inside to outside of cells (Dean et al., 2001). It has been demonstrated that a 
functional MRP1 is expressed on the basolateral membrane of Calu-3 cells 
(Hamilton et al., 2001). MRP4 has been shown to be expressed in epithelial cells 
lining lung, kidney, intestine, etc., on both the apical (van Aubel et al., 2002) 
and basolateral membranes (Lai and Tan, 2002) of polarized cells. MRP4 plays 
an essential role as a high affinity cAMP efflux pump (Chen et al., 2001; van 
Aubel et al., 2002). Moreover, it has been reported that MRP4 is physically and 
functionally linked to CFTR in  gut epithelial cells, and that MK571 an inhibitor 
of MRP4, potentiates the CFTR mediated Cl- conductance at the apical 
membrane of gut epithelial cells (Li et al., 2007). Our hypothesis was that 
inhibition of these transporters should cause cAMP accumulation inside the 
cells, and reduce the basolateral Cl-/HCO3- AE activity. Therefore, in order to 
investigate the role of these MRP transporters in the regulation of basolateral Cl-
/HCO3- AE activity, Calu-3 cell cells were preincubated with the MRP4 
inhibitor, MK-571, (10µM apically) for 60 min and then basolateral AE activity 
was measured in Cl- free solutions under resting (i.e. non-cAMP stimulated) 
conditions. Results showed that MRP inhibition caused a significant reduction in 
basolateral Cl-/HCO3- AE activity, and both the mean change in pHi produced by 
basolateral Cl- removal, and the rate of reacidification following Cl- readdition, 
were significantly reduced compared to control responses (Figure 4.7A and B). 
This implies that inhibition of the cAMP efflux pump caused an increase in 
intracellular cAMP and inhibition of the basolateral Cl-/HCO3- activity in Calu-3 
cells, which further reinforces the fact that cAMP is responsible for inhibition of 
the basolateral AE activity. These results also indicate that under ‘resting 
‘conditions, Calu-3 cells must have a basal turnover of cAMP in the absence of 
an external cAMP agonist, and the transport activity of the MRP transporters 
helps maintain a low intracellular level of cAMP, which has been found in other 
epithelial cells (van Aubel et al., 2002).  
 
112 
 
-Ba
so 
0C
l
+M
K5
71
0.0
0.1
0.2
0.3
0.4
0.5
*
M
ea
n 
ch
an
ge
 in
 p
H
i
-
Ba
so 
0C
l
+M
K5
71
0.0
0.1
0.2
0.3
0.4
0.5
0.6
*
R
at
e 
of
 r
ea
ci
di
fic
at
io
n 
(p
H
i m
in
-1
)
 
                A                                              B 
 
 
 
 
 
 
Figure 4. 7: Inhibition of the MRP transporter reduced the basolateral Cl-/HCO3- AE 
activity in Calu-3 cells. Summary of the effect of the MRP inhibitor, MK571 (10µM), on mean 
pHi change (alkalinisation) caused by Cl- removal (A), and the rate of reacidification (B) 
following Cl- readdition under resting condition in Cau-3 cells. Data are shown as 
Mean±SEM.*P<0.05, n=3 for each condition. Control cells run in parallel. 
 
 
4.4.3 cGMP 
As mentioned in chapter 3 (section 3.2.2) cGMP plays an important role in the 
activation of CFTR and anion secretion in many epithelial cells. Although my 
results suggested it did not regulate CFTR-dependent pendrin activity in Calu-3 
cells, it was still of interest to gain an insight into the role of cGMP in the 
regulation of the basolateral anion exchanger in Calu-3 cells, and to see whether 
cGMP influences the cAMP-dependent inhibition of this exchanger. Thus, Calu-
3 cells were preincubated with the cGMP agonist, 8Br-cGMP, for 60 min and 
then basolateral Cl-/HCO3- AE activity measured in response to Cl- free 
solutions. My results showed that, similar to the lack of effect on apical anion 
exchange activity, cGMP stimulation had no effect on either the magnitude of 
alkalinisation produced by basolateral Cl- removal, or the rate of reacidification, 
under resting conditions, nor did it alter the subsequent Fsk-induced inhibition 
of the basolateral Cl-/HCO3- anion exchanger (Figure 4.8A and B). This suggests 
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that that cGMP dependent protein kinase is not involved in the regulation of 
basolateral Cl-/HCO3- AE activity in Calu-3 cells.  
 
 
 
    A                                                                   B 
 
 
 
 
 
Figure 4. 8: cGMP agonist, 8Br-cGMP, did not affect the basolateral Cl-/HCO3- AE activity 
in Calu-3 cells. Summary of the effect of the cGMP agonist on basolateral Cl-/HCO3- AE 
activity. Calu-3 cells were preincubated apically with 1mM 8Br-cGMP for 60 min. (A) mean 
alkalinisation in pHi in response to Cl- free solution, (B) the rate of reacidification upon Cl- 
readdition. Data are shown as Mean±SEM, no significant difference (P>0.05) compared to 
control, n=3 for each condition, control cells run in parallel. 
 
 
Overall, my results demonstrate that raising intracellular levels of cAMP, using 
cAMP agonists or inhibiting cAMP efflux, was clearly responsible for the 
marked reduction in basolateral Cl-/HCO3- AE activity in Calu-3 cells. However, 
it was not clear whether cAMP directly or indirectly inhibited the basolateral 
exchanger. Therefore, my next experiments focused on identifying the role of 
downstream targets of cAMP in the regulation of the basolateral Cl-/HCO3- AE 
activity in Calu-3 cells.  
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4.5 Regulation of basolateral Cl-/HCO3- anion exchanger activity by downstream 
targets of cAMP 
To investigate the mechanisms behind the cAMP-induced inhibition of the 
basolateral Cl-/HCO3- AE activity in more detail, I next assessed the potential 
downstream targets of cAMP. There are three major  intracellular targets for 
cAMP which include PKA, Epac and cyclic nucleotide-gated ion channels 
(CNGCs), which are non-selective cation channels that are particularly 
important in the olfactory and visual system (Craven and Zagotta, 2006). 
Moreover, it has been reported by Kim et al., (2010) that intracellular elevation 
of cAMP can lead to the activation of the mammalian target of rapamycin 
complex 1 (mTORC1) signaling pathway through a PKA-independent 
mechanism  (Kim et al., 2010).  
 
4.5.1 Role of PKA 
 
H-89, which is a competitive inhibitor of PKA, was tested on the basolateral 
response to Cl- free KREBS solution, in Calu-3 cells pre-incubated with H-89 
for 60 min, and then exposed to Fsk. Note that previous data from our group 
showed that H-89 had no effect on the resting basolateral Cl-/HCO3- AE activity 
in Calu-3 cells using similar conditions (J Garnett PhD thesis, 2010).  As shown 
in Figure 4.9, the inhibitory effect of Fsk on basolateral AE activity was not 
changed in the presence of H-89.  Furthermore, normal basolateral AE activity 
returned after ~ 15 mins of washing off the H-89 (with high Cl- KREBS 
solution), which was completely inhibited by subsequent addition of Fsk. This is 
despite the fact that H-89 (50μM) significantly decreased the Fsk stimulated 
apical AE activity in Calu-3 cells (see chapter 3, figure 3.3). As H-89 is a non-
specific inhibitor of PKA, an alternative PKA inhibitor, Rp-adenosine-3',5'-
cyclic monophosphorothioate (RpcAMP) was used. RpcAMP has a different 
structure to H-89, and acts as a specific competitive antagonist of the cyclic 
nucleotide–binding domains on PKA (de Wit et al., 1984). Calu-3 cells were 
preincubated with 1mM RpcAMP on the apical side for one hour, and then the 
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basolateral response to Cl- removal in the presence of Fsk assessed. Results 
showed that the basolateral AE activity was completely abolished in RpcAMP 
pretreated cells, which was completely recovered after 10 min washing off of the 
inhibitor. A representative pHi trace from RpcAMP treated cells is shown in 
Figure 4.9B. The effect of both H-89 and RpcAMP are summarized in Figure 
4.9C and D. As can be seen, the PKA inhibitor had no effect on the inhibitory 
effect of Fsk on the basolateral AE activity, suggesting that PKA is not involved 
in the cAMP-dependent inhibition of the basolateral AE activity in Calu-3 cells.  
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Figure 4. 9: PKA inhibitors, H-89 and RpcAMP, had no effect on the cAMP 
induced inhibition of the basolateral Cl-/HCO3- AE activity in Calu-3 cells. (A) and 
(B) pHi traces showing that inhibition of PKA by either  50µM H-89 , or 1mM 
RpcAMP (both inhibitors preincubated with cells for 60 min), did not affect the Fsk 
induced inhibition of the basolateral AE in Calu-3 cells. Summary of the effect of both 
PKA inhibitors, H-89 and RpcAMP, on mean pHi change (alkalinisation) caused by Cl- 
removal (C), and the rate of reacidification after Cl readdition (D) in Calu-3 cells. Data 
are shown as Mean±SEM.*P<0.05 compared to control, n=3 for each, except for 
control n=6, which were run in parallel. 
 
 
4.5.2 Exchange protein directly activated by cAMP (Epac) 
It has been demonstrated that Epac is a novel cAMP target which has properties 
independent of PKA (Schmidt et al., 2013). Therefore, Calu-3 cells were 
preincubated with the Epac agonist (8CPT-2Me-cAMP-AM) for 60 min, and 
basolateral Cl-/HCO3- AE activity measured in response to Cl- free solutions 
under both resting and cAMP stimulated conditions. Results showed that Epac 
stimulation did not alter basolateral Cl-/HCO3- AE activity (Figure 4.10A and 
B), nor did it alter Fsk-induced inhibition of the basolateral anion exchanger. 
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Figure 4. 10: Epac agonist, 8CPT-2Me-cAMP-AM, did not affect the basolateral 
Cl-/HCO3- AE activity in Calu-3 cells. Summary of the effect of the Epac agonist 
(8CPT-2Me-cAMP-AM) 10µM preincubation for 60 min on the mean alkalinisation in 
pHi in response to Cl- free solution (A) and the rate of reacidification upon Cl- 
readdition (B) in the presence and absence of Fsk in Calu-3 cells. Data are shown as 
Mean±SEM. No significant difference (P>0.05) compared to control, n=3 for each 
condition. Control cells run in parallel. 
 
 
Although the experiments using the Epac agonist showed that Epac appeared not 
to be involved in regulating basolateral AE activity, inhibition of Epac by 
preincubation of Calu-3 cells with the Epac inhibitor (ESI-09), which is a novel 
and specific Epac inhibitor  (Almahariq et al., 2013), resulted in a marked 
reduction in the basolateral Cl-/HCO3- AE activity under resting conditions, both 
in the mean change in pHi (alkalinisation) produced by basolateral Cl- removal, 
and the rate of reacidification upon Cl- readdition, compared to control 
responses. However, the residual basolateral AE activity could still be inhibited 
by Fsk (Figure 4.11A, B and C). The rate of HCO3- flux was also significantly 
reduced in ESI-09 treated cells compared to control cells (Figure 4.11F).  The 
effect of Epac inhibition on the basolateral Cl-/HCO3- AE activity was 
significantly recovered after washing off the inhibitor (Figure 4.11D and E). 
This result clearly implies that (1) Epac appears to be required to maintain the 
basolateral Cl-/HCO3- AE activity under resting conditions, and (2) the Fsk- 
induced inhibition of the basolateral Cl-/HCO3- AE activity is through an Epac-
independent mechanism. 
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Figure 4. 11: The Epac inhibitor, ESI-09, reduced the basolateral Cl-/HCO3- AE 
activity in Calu-3 cells under resting conditions. (A) pHi trace showing that 
inhibition of Epac by preincubation of Calu-3 cells with 10µM ESI-09 for 60 min 
reduced the basolateral Cl-/HCO3- AE activity which was recovered after washing off 
the inhibitor. Summary of the effect of ESI-09 on the mean alkalinisation in pHi in 
response to Cl- free solution (B) and the rate of reacidification after Cl- readdition (C) 
under resting and Fsk stimulated condition. The basolateral AE activity was recovered 
after washing off the Epac inhibitor for both mean change in pHi (D) and the rate of 
reacidification (E). (F) The rate of HCO3- flux in control and ESI-09 treated cells. Data 
are shown as Mean±SEM, *P<0.05, #P<0.01 compared to control, paired observation, 
n=4 for each condition.  
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4.5.3 Role of cyclic nucleotide-gated cation (CNG) channels  
It has been shown that CNG channels are stimulated by cAMP and increase 
transepithelial sodium and calcium absorption in rat colon (Qiu et al., 2000b). It 
has also been demonstrated that mRNA for CNG channels are expressed in 
human bronchial airway cells, which contribute to both sodium and calcium 
absorption in the adult lung (Qiu et al., 2000a). Since CNG channels are voltage 
gated ion channels (Kaupp and Seifert, 2002), and mediate membrane 
depolarization in neurons (Zufall et al., 1994; Finn et al., 1996), and there is no 
specific CNG channel inhibitor, I investigated the effect of depolarising the 
membrane potential by perfusing Calu-3 cells with a high K+ HCO3-/KREBS 
solution, which should  inhibit the CNG channels (Figure 4.12A). Results 
showed that depolarising cell did not prevent the inhibitory effect of cAMP on 
the basolateral Cl-/HCO3- AE activity, although the mean pHi change and rate of 
reacidification were affected under resting conditions (Figure 4.12B and C). 
This suggested that CNG channels are not involved in the cAMP-induced 
inhibition of the basolateral Cl-/HCO3- AE activity in Calu-3 cells. The enhanced 
alkalinisation seen under zero Cl- conditions in the presence of high K+ (Figure 
2.12B), might be due to stimulation of the electrogenic basolateral NBC by 
membrane depolarisation, which would provide more HCO3- influx across the 
basolateral membrane into the cells. However, under Fsk-stimulated conditions, 
in depolarized cells, where the basolateral anion exchanger is inhibited, there 
was a marked acidification observed upon zero Cl- perfusion (Figure 4.12A). 
This pHi data could be explained by the presence of an electrogenic anion 
exchanger, or alternatively an anion channel on the basolateral membrane, 
which is active under cAMP stimulated conditions (see Chapter 3).  
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Figure 4. 12: Depolarization of Calu-3 cells did not affect the cAMP induced 
inhibition of the basolateral Cl-/HCO3- AE activity. pHi trace showing the effect of 
high K+ KREBS solution on the basolateral AE activity. Calu-3 cells were perfused 
with bilateral high K+ Krebs solution to depolarize cell membrane potential, and inhibit 
CNG channel. Summary of mean pHi change (alkalinisation) caused by Cl- removal (A) 
and the rate of reacidification upon Cl- readdition (B) under resting and Fsk stimulated 
condition in depolarized Calu-3 cells. Data are shown as Mean±SEM.*P<0.05 
compared to control, paired observation, n=3 for each condition.  
 
 
 
 
121 
 
-Ba
so 
0C
l
+Fs
k
0.0
0.1
0.2
0.3
0.4 Control
+Rapamycin
M
ea
n 
ch
an
ge
 in
 p
H
i
-
Ba
so 
0C
l
+Fs
k
0.0
0.1
0.2
0.3
0.4 Control
+Rapamycin
R
at
e 
of
 r
ea
ci
di
fic
at
io
n 
(p
H
i m
in
-1
)
4.5.4 Mammalian target of rapamycin (mTOR) kinase 
In order to assess the role of the cAMP-dependent protein kinase, mTOR, in the 
regulation of the basolateral Cl-/HCO3- AE activity, Calu-3 cells were 
preincubated for 60 mins with rapamycin, which is selective blocker of mTOR 
protein kinase (Ballou and Lin, 2008). Results showed that inhibition of mTOR 
kinase did not produce any changes in either the magnitude of alkalinisation 
produced by basolateral Cl- removal or the rate of reacidification following Cl- 
readdition, and did not affect the cAMP induced inhibition of the basolateral Cl-
/HCO3- AE activity (Figure 4.13A and B). This suggests that mTOR kinase is 
not involved in the regulation of the basolateral Cl-/HCO3- AE activity under 
both resting and cAMP stimulated conditions. 
 
 
 
                 A                                                                          B 
 
 
 
 
 
Figure 4. 13: mTOR inhibition did not affect the basolateral Cl-/HCO3- AE activity 
in Calu-3 cells. Summary of mean pHi change (alkalinisation) caused by Cl- removal 
(A) and the rate of reacidification upon Cl- readdition (B) in Calu-3 cells, preincubated 
for 60 min and perfused with 100nM rapamycin, under resting and Fsk stimulated 
condition. Data are shown as Mean±SEM. No significant difference (P>0.05) compared 
to control response, n=4 for control, and n=3 for +Rapamycin. Controls run in parallel. 
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4.6 Role of Ca2+ in the regulation of basolateral Cl-/HCO3- anion exchanger activity    
It has been found that changes in [Ca2+]i can alter cAMP levels (either by 
stimulation or inhibition of cAMP production), through a number of Ca2+-
sensitive isoforms of AC (Willoughby and Cooper, 2007). Evidence has also 
shown that there is a direct link between the ER-Ca2+-store operated signaling 
pathway and cAMP production by ACs, which is independent of changes in 
cytosolic Ca2+ concentration (see Chapter 3). This response requires the 
translocation of the transmembrane ER Ca2+-sensor protein, STIM1, into a large 
immobile aggregate under the plasma membrane and activation of AC 
(Lefkimmiatis et al., 2009). Therefore, I investigated the role of Ca2+ in the 
regulation of the basolateral Cl-/HCO3- AE activity under both resting and 
cAMP stimulated conditions. 
 
 
4.6.1 Intracellular Ca2+ 
 
4.6.1.1 Effect of increases in [Ca2+]i on anion exchange activity   
 
It has been found that elevation of [Ca2+]i by thapsigargin and muscarinic 
receptor (M3) stimulation, markedly enhanced basolateral Cl-/HCO3- AE activity 
in mouse salivary acinar cells  (Nguyen et al., 2004). Moreover, it has been 
shown that intracellular elevation of Ca2+, using Ca2+ agonists, plays an 
important role in the stimulation of adenylyl cyclase and elevation of cAMP 
(Namkung et al., 2010). A well-known synergistic interaction between cAMP 
and Ca2+ signals has also been reported in human airway epithelial cells, which 
plays a critical role in HCO3- and fluid secretion, in response to carbachol and 
vasoactive intestinal peptide (VIP), which is absent in CF  cells (Choi et al., 
2007). Therefore it was important to test whether increasing [Ca2+]i  could affect 
the activity of the basolateral Cl-/HCO3- anion exchanger. I used two different 
methods to investigate this which involved studying the effects of Ca2+ release 
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from IP3-sensitive ER stores by the muscarinic agonist carbachol (Cch) 
(Mayerhofer et al., 1992), and by using the selective SERCA pump inhibitor 
thapsigargin (Thastrup et al., 1990). 
 
4.6.1.1.1 Effect of carbachol on basolateral AE activity 
 
It has been shown that Cch induces intracellular cAMP elevation in a dose 
dependent manner in rat pancreatic islets (Tian and Laychock, 2001). However, 
it has not been investigated whether Cch application could influence basolateral 
Cl-/HCO3- AE activity in Calu-3 cells. Thus, Calu-3 cells were exposed to either 
unilateral (Figure 4.14A, C, D, E & F) or bilateral Cch (Figure 4.14G & H), and 
results showed that Cch did not affect the basolateral AE activity under resting 
or Fsk stimulated conditions, compared to the control response (Figure 4.14A-C-
F). However, a transient acidification was produced by basolateral Cl- removal 
in Fsk stimulated cells compared to the control response, when Cch was applied 
only basolaterally, (Figure 4.14A, red trace). This transient acidification might 
be due to a change in membrane potential, as an increase in [Ca2+]i could 
stimulate Ca2+-sensitive K+ channels in the basolateral membrane. This would 
cause hyperpolarisation, which would inhibit NBC activity, reduce HCO3- influx 
into the cells, and thereby produce a transient acidification. In order to 
investigate whether this acidification was Ca2+-dependent, cells were 
preincubated with the Ca2+ chelator BAPTA-AM (50μM) for 1hr. Results 
showed that BAPTA-AM abolished the carbachol-induced transient acidification 
(Figure 4.14B, n=3), suggesting that this acidification was Ca2+ dependent.   
Note that BAPTA-AM loading significantly reduced basolateral AE activity, 
which is discussed in more detail in section 4.6.1.2. 
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Figure 4. 14: Carbachol (Cch) did not affect the activity of the basolateral Cl-
/HCO3- AE activity in Calu-3 cells. (A) Representative pHi trace showing lack of 
effect of Cch (20µM), applied basolaterally, on basolateral AE activity under resting 
condition, while carbachol induced a transient acidification in pHi when applied with 
Fsk stimulation in Calu-3 cells. (B) Representative pHi trace showing that BAPTA-AM 
loading abolished the transient acidification caused by Cch. Summary of the effect of 
basolateral carbachol on the basolateral AE activity on mean pHi changes after 
basolateral Cl- removal (C), and the rate of reacidification upon Cl- readdition (D), 
paired observation, n=3 for each condition. Perfusion of apical carbachol did not affect 
mean pHi change (alkalinisation) following Cl- removal (E) and rate of reacidification 
after readdition of Cl- (F) in forskolin stimulated and non-stimulated condition in Calu-
3 cells,  n=10 for control, n=7 +apical carbachol, n=6 +Fsk, and n=3 +Fsk+apical 
carbachol. Bilateral carbachol did not affect mean pHi change following Cl- removal (G) 
and the rate of reacidification after readdition of Cl- (H) in Calu-3 cells, n=3 for each 
condition. Data are shown as Mean±SEM.*P<0.05 compared to control.               
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Furthermore, in order to test whether the effect of Cch, under Fsk stimulation, 
was produced via muscarinic or nicotinic receptor stimulation, Calu-3 cell were 
perfused simultaneously with atropine and Cch, and then basolateral AE activity 
was measured under resting and Fsk stimulated conditions (Figure 4.15A). 
Application of atropine and Cch did not change the basolateral Cl-/HCO3- AE 
activity under resting conditions, and did not abolish the Fsk induced inhibition 
of the basolateral AE activity (Figure 4.15B and C). However, the Cch induced 
transient acidification, under Fsk stimulation, was completely eliminated by 
atropine, verifying that Cch signaling pathway was through muscarinic 
cholinergic receptors. These  results suggest that intracellular elevation of Ca2+, 
by stimulation of muscarinic receptors, does not regulate basolateral Cl-/HCO3- 
AE activity in Calu-3 cells under both resting and Fsk stimulated conditions. 
 
 
 
       A 
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Figure 4. 15: Atropine blocked the transient acidification induced by carbachol in 
forskolin stimulated Calu-3 cells. (A) Representative pHi trace showing that apical 
atropine (10µM), blocked the acidification induced by carbachol, but did not affect the 
basolateral Cl-/HCO3- AE activity, under resting and Fsk stimulated conditions in Calu-
3 cells. Summary of the effect of carbachol and atropine on mean pHi changes after 
basolateral Cl- removal (C), and the rate of reacidification upon Cl- readdition (D) under 
resting and Fsk stimulation condition in Calu-3 cells. Data are shown as Mean±SEM, 
No significant difference (P>0.05) compared to control response, n=7 for control, n=4 
for +carbachol+atropine, n=3 for +Fsk and Fsk+carbachol+atropine.  
 
 
 
4.6.1.1.2  Thapsigargin 
 
A recent study showed that ER [Ca2+] depletion caused adenylyl cyclase-
dependent cAMP production through a Ca2+ sensor, STIM-dependent pathway 
(Maiellaro et al., 2012). In order to assess the effects of Ca2+ release from the 
ER on the basolateral Cl-/HCO3- AE activity, Calu-3 cells were first exposed to 
200nM thapsigargin for 5 mins (Figure 4.16A), which previous work from our 
group has shown that leads to calcium elevation in Calu-3 cells (Garnett et al., 
2011). The basolateral Cl-/HCO3- AE response to Cl- free KREBS solution 
revealed no significant effect of thapsigargin on mean pHi change produced by 
basolateral Cl- removal, or rate of reacidification upon Cl- readdition, compared 
to control Calu-3 cells. In addition, the inhibitory effect of Fsk on basolateral Cl-
/HCO3- AE activity was also not changed (Figure 4.16B and C). This suggests 
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that ER Ca2+-store depletion does not generate sufficient cAMP in Calu-3 cells 
to inhibit the basolateral anion exchanger. 
 
 
 
 
            A                                                                                            
 
 
 
 
 
           
    B                                                      C 
 
 
 
 
 
 
Figure 4. 16: Thapsigargin did not affect the basolateral Cl-/HCO3- AE activity in 
Calu-3 cells. (A) Representative pHi traces showing the effect of thapsigargin on the 
basolateral Cl-/HCO3- AE activity under resting and stimulated condition. Summary of 
the effect of thapsigargin (200nM) on the mean change in pHi following basolateral Cl-  
removal (B) and the rate of reacidification upon readdition of Cl- (C) under resting and 
Fsk stimulated condition in Calu-3 cells. Data are shown as Mean±SEM, no significant 
difference (P>0.05) compared to control, n=10 for Baso 0 Cl-, and n=7 for +Fsk.  
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4.6.1.2  Effect of a decrease in [Ca2+]i on basolateral anion exchange activity, using 
BAPTA-AM   
 
As mentioned in chapter 3 (section 3.6) since there is a synergistic interaction 
between Ca2+ and cAMP for controlling fluid and electrolyte secretion by 
epithelial cells, another series of experiments were performed in order to assess 
the effect of  intracellular Ca2+ depletion on the resting and the cAMP-induced 
inhibition of the basolateral Cl-/HCO3- AE activity. For these experiments, Calu-
3 cells were preincubated with 50µM BAPTA-AM (both apical and basolateral 
sides) for one hour and then the basolateral Cl-/HCO3- AE response to Cl- free 
solution were measured under resting and cAMP stimulated conditions (Figure 
4.17B) and compared to control responses (Figure 4.17A). As shown in Figure 
4.18C and D, BAPTA-AM significantly reduced resting basolateral AE activity 
by 65.1±2.8% (n=8) in the mean pHi change in response to basolateral Cl- free 
solution. It was also noticeable that BAPTA-AM significantly reduced the rate 
of reacidification, caused by readdition of Cl- to the basolateral side, by 
57.1±8.1% (n=8) compared to control cells, not preincubated with BAPTA-AM. 
However, BAPTA-AM loaded cells still showed normal forskolin-induced 
inhibition of the basolateral AE. These results suggest that decreasing 
intracellular Ca2+ plays an important role in regulating the resting level of 
basolateral Cl-/HCO3- AE activity, but it is not involved in the cAMP-induced 
inhibition of the basolateral Cl-/HCO3- AE activity in Calu-3 cells.   
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Figure 4. 17: BAPTA-AM induced changes in the basolateral Cl-/HCO3- AE 
activity in Calu-3 cells. pHi experimental trace showing the effect of BAPTA-AM 
(50µM) preincubation on changes in pHi following the removal of basolateral Cl- in 
Calu-3 cells in the absence and presence of forskolin (B), compared to control response 
(A). Summary of the effect of BAPTA-AM on mean alkalinisation produced by Cl- 
removal (C), and the rate of reacidification upon chloride readdition (D) under resting 
and stimulated conditions. Data are shown as Mean±SEM, *P<0.05 compared to 
control. n= 8 for each condition. Control cells run in parallel. 
 
 
Interestingly, in another set of experiments, perfusion of cells with 200nM 
thapsigargin in BAPTA-AM treated Calu-3 cells (Figure 4.19A), partially 
reversed  the inhibitory effect of BAPTA-AM on the mean pHi change in 
response to Cl- free perfusion under resting conditions, although the rate of 
reacidification was still significantly reduced (Figure 4.19B and C). This implies 
that thapsigargin may be capable of causing a small increase in [Ca2+]i from a 
thapsigargin-sensitive store in BAPTA-AM treated cells that was capable of 
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partially reversing the BAPTA-AM-induced inhibition of the basolateral AE 
activity. This result reinforces the fact that the normal resting [Ca2+]i plays an 
important role in the regulation of the basolateral AE activity in Calu-3 cells. 
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Figure 4. 18: The Effect of thapsigargin and BAPTA-AM on the basolateral Cl-
/HCO3- AE activity in Calu-3 cells. (A) Representative pHi traces showing the effect 
of thapsigargin and BAPTA-AM on the basolateral Cl-/HCO3- AE activity under resting 
and Fsk stimulated condition in Calu-3 cells. Summary of the effect of BAPTA-AM 
(50μM) and thapsigargin (200nM) on mean pHi change (alkalinisation) following 
basolateral Cl- removal (B) and the rate of reacidification after readdition of Cl- (B),  
under resting and forskolin stimulated conditions in Calu-3 cells. Data are shown as 
Mean±SEM.*P<0.05 compared to control.  n=3 for each, except for control n=10. 
Control cells run in parallel. 
 
 
In order to test whether cAMP and Ca2+ exert their effects on the basolateral Cl-
/HCO3- AE activity through the same pathway, Calu-3 cells were pretreated with 
the cAMP efflux pump inhibitor, MK571, simultaneously with BAPTA-AM, for 
60 min, and then basolateral AE activity measured under both resting and cAMP 
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stimulated conditions (Figure 4.19A). Results showed that there was a further 
reduction in basolateral Cl-/HCO3- AE activity under resting conditions, both in 
the magnitude of alkalinisation produced by basolateral Cl- removal, and the rate 
of reacidification upon Cl- readdition (Figure 4.19B and C) compared to 
BAPTA-AM on its own (4.17C and D). However, the cAMP-induced inhibition 
of the basolateral Cl-/HCO3- AE activity was not changed. As shown in Figure 
4.20A and B, preincubation of Calu-3 cells with BAPTA-AM and MRP 
inhibitor, MK571, caused a marked reduction in the rate of reacidification 
produced by basolateral Cl- readdition compared to BAPTA-AM treated only, or 
MK-571 treated only cells, although the mean pHi changes showed no-
significant change. These data imply that both intracellular elevation of cAMP 
and decreasing [Ca2+]i produced their effects on the basolateral Cl-/HCO3- AE 
activity via distinct mechanisms. 
 
 
 
 
              A 
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Figure 4. 19: BAPTA-AM+MK571 almost completely inhibited the basolateral Cl-
/HCO3- AE activity in Calu-3 cells. (A) Experimental pHi trace showing the effect of 
BAPTA-AM (50µM) preincubation and perfusion of MK571 on changes in pHi 
following the removal of basolateral Cl- in Calu-3 cells in the absence and presence of 
forskolin. Summary of the effect of BAPTA-AM+MK571 on mean alkalinisation 
produced by chloride removal (B), and the rate of reacidification upon chloride 
readdition (C). Data are shown as Mean±SEM, *P<0.001 compared to control, n=5 for 
each condition. Control cells run in parallel. 
 
 
                   A                                                                B 
 
 
 
 
 
 
Figure 4. 20: Summary of the effect of BAPTA-AM and MK571 on the basolateral 
Cl-/HCO3- AE activity in Calu-3 cells. Mean alkalinisation (pHi) produced by chloride 
removal (A), and the rate of reacidification upon chloride readdition (B). *P<0.001 
compared to control, # =Significant difference (P<0.001) compared to MK571, and 
BAPTA-AM. Data are shown as mean ±SEM. n= 5 for control, n=7 for BAPTA-AM, 
n=3 for +MK571 and n=5 for BAPTA-AM+MK571. 
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4.6.2 Effect of changing extracellular Ca2+ concentration 
The extracellular Ca2+ sensing receptor (CaSR) is a G-protein coupled receptor 
whose main physiological ligand is extracellular Ca2+ (Magno et al., 2011). 
Since it has been found that CaSR plays an important role in the regulation of 
anion and fluid secretion in human pancreatic ducts (Racz et al., 2002), it was of 
interest to assess whether  extracellular Ca2+ mediated signaling pathway 
regulates the basolateral Cl-/HCO3- AE activity under resting and cAMP 
stimulated conditions. It has been shown that a decrease in extracellular Ca2+ 
concentration reduces the activity of the CaSR (Brown, 2007). Thus, Calu-3 
cells were exposed to Ca2+-free extracellular solution and anion exchange 
activity measured. 
 
4.6.2.1  Effect of unilateral Ca2+ free solutions: 
Apical or basolateral perfusion of extracellular Ca2+ free HCO3-/KREBS 
solution, in which CaCl2  was replaced with MgCl2  and 0.5mM EGTA added to 
chelate any remaining Ca2+, did not produce any changes in basolateral AE 
activity. Also the cAMP-induced inhibition of the basolateral Cl-/HCO3- 
exchanger was not affected (Figure 4.21A-D). This suggest that neither apical or 
basolateral CaSR mediated signaling pathways were involved in the regulation 
of the basolateral Cl-/HCO3- AE activity in Calu-3 cells. 
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Figure 4. 21: Unilateral Ca2+ free solutions did not affect the basolateral Cl-/HCO3- 
AE activity in Calu-3 cells. Summary of the effect of apical Ca2+ free solution on the 
basolateral Cl-/HCO3- AE activity on mean pHi changes produced by basolateral Cl- 
removal (A), and rate of reacidification upon Cl- readdition (B). Data are shown as 
Mean ±SEM.*P<0.05 compared to Baso 0Cl-, n=4, paired observation. Basolateral Ca2+ 
free solution on the mean pHi change caused by basolateral Cl- free solution (C), and 
the rate of re acidification (D) in Calu-3 cells. Data are shown as Mean±SEM. No 
significant difference (P>0.05) compared to control, n=5, paired observations. 
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4.6.2.2  Effect of bilateral Ca2+ free solutions: 
 
To further investigate the possibility of cross-talk between apical and basolateral 
CaSR mediated signaling  that might affect the activity of the basolateral Cl-
/HCO3- AE, Calu-3 cells were perfused bilaterally with a Ca2+ free HCO3-
/KREBS solution (Figure 4.22A). Although resting AE activity was not altered 
under these conditions there was a significant relief in the cAMP-induced 
inhibition of the basolateral Cl-/HCO3-AE activity, when mean pHi changes were 
compared to the ‘control’ Fsk stimulated response. However, although the rate 
of reacidification was partially recovered under cAMP stimulated conditions in 
treated cells, it was not significant compared to control responses (Figure 4.22B 
and C) in Ca2+ free conditions. This indicates that, to some extent, there is a 
cross-talk between apical and basolateral CaSR-mediated signaling pathways 
that regulate the basolateral Cl-/HCO3- AE activity under cAMP stimulated 
condition in Calu-3 cells. Note that the effect of bilateral Ca2+ free conditions on 
basolateral AE activity did not mirror the response seen in BAPTA-AM treated 
cells (Figure 4.17), suggesting that the bilateral removal of extracellular Ca2+ 
was not exerting an effect on basolateral AE activity simply by reducing 
intracellular Ca2+ levels.  
 
               A 
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Figure 4. 22: Impact of bilateral Ca2+ free solutions on the activity of the 
basolateral Cl-/HCO3- AE activity in Calu-3 cells. (A) Representative pHi experiment 
showing the effect of bilateral perfusion of Ca2+ free Krebs solution on the basolateral 
Cl-/HCO3- AE activity. Summary of the effect of bilateral Ca2+ free Krebs solution on 
mean pHi changes produced by basolateral Cl- removal (B), and the rate of 
reacidification upon Cl- readdition (C), in non-stimulated and Fsk stimulated condition 
in Calu-3 cells. Data are shown as Mean ±SEM.*P<0.05 compared to +Fsk, n=4 for 
each condition, paired observation.  
 
 
 
Although the resting basolateral Cl-/HCO3- AE activity was not significantly 
changed in the absence of extracellular Ca2+, it has been found that there is 
intracellular cAMP production, through stimulation of AC (independent of 
PDEs), by ER Ca2+-store depletion in the absence of extracellular Ca2+, via the 
ER potential Ca2+-sensor STIMI, that  couples ER-Ca2+ to cAMP production 
(Lefkimmiatis et al., 2009). Thus, I performed a set of experiments in Calu-3 
cells to assess the activity of the basolateral Cl-/HCO3- AE in the absence of 
extracellular Ca2+-, but after ER Ca2+-store depletion. ER stores were depleted 
using thapsigargin and basolateral AE activity was measured, under resting and 
cAMP stimulated conditions. As shown in Figure 4.23A, basolateral Cl-/HCO3- 
AE was significantly decreased, both the magnitude of alkalinisation produced 
by basolateral Cl- removal, and the rate of reacidification following Cl- 
readdition, compared to the control response (Figure 4.23B and C). This result is 
consistent with my previous results which clearly showed that an increase in 
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[cAMP]i is responsible for inhibition of the basolateral AE activity in Calu-3 
cells. This suggest that ER Ca2+-store depletion and removal of extracellular 
Ca2+ leads to an increase in [cAMP]i. Interestingly, a transient intracellular 
acidification was produced following removal of extracellular Ca2+ and ER 
Ca2+-store depletion (Figure 4.23A, red trace), which might be due to an 
elevation of intracellular cAMP and stimulation of CFTR/Pendrin activity, 
which would lead to HCO3- efflux across the apical membrane. Although 
removal of extracellular Ca2+ partially reduced the cAMP-induced inhibition of 
the basolateral Cl-/HCO3- AE (see Figure 4.22A and B), the cAMP-induced 
inhibition was not changed when ER Ca2+-store depletion occurred in the 
absence of extracellular Ca2+ (Figure 4.23). This might be due to the absence of 
extracellular Ca2+ alone, which could affect the rate of intracellular cAMP 
production by AC compared to complete inhibition of the basolateral Cl-/HCO3- 
AE by cAMP under both ER Ca2+-store depleted and extracellular Ca2+ free 
conditions. 
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Figure 4. 23: Bilateral Ca2+ free solution and thapsigargin reduced the basolateral 
Cl-/HCO3- AE activity in Calu-3 cells. (A) Representative pHi experiment shows 
impact of bilateral perfusion of Ca2+ free Krebs solution on the basolateral Cl-/HCO3- 
AE activity in the presence of 200nM thapsigargin. Summary of the effect of bilateral 
Ca2+ free Krebs solution and 200nM thapsigargin on mean pHi changes produced by 
basolateral Cl- removal (B), and the rate of reacidification upon Cl- readdition (C), 
under resting and Fsk stimulated Calu-3 cells. Data are shown as Mean ±SEM.*P<0.05, 
#P<0.001 compared to Baso 0Cl-, n=4 for each condition, paired observations. 
 
4.7 Role of CaM and Ca2+/CaM-dependent protein kinases in the regulation of 
basolateral Cl-/HCO3- AE activity  
Intracellular changes in Ca2+ are often decoded by the cell through Ca2+ binding 
proteins such as calmodulin (CaM), which play an important role in signal 
transduction and regulation of a wide range of cellular responses. Ca2+ and CaM 
modulate the activity of several intracellular serine/threonine protein kinase 
cascades, including CaM-kinase kinase (CaMKK), CaMKI and CaMKIV. 
Moreover, it has been shown that binding of Ca2+/CaM complex enhances 
membrane adenylyl cyclase activity, which is accompanied by elevation of 
intracellular cAMP (Ferguson and Storm, 2004). According to sequence analysis 
of SLC4A2, there are a number of putative Ca2+/calmodulin-dependent protein 
kinase (CaMKI, CaMKII and CaMKIV) phosphorylation sites present. Since it 
is unknown whether these kinases could be involved in the regulation of the 
basolateral Cl-/HCO3- AE activity under resting and cAMP stimulated 
conditions, another set of experiments were done to test the impact of these 
kinases on basolateral AE activity.    
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4.7.1.1 Role of calmodulin (CaM) in the regulation of basolateral Cl-/HCO3- AE 
activity  
To focus on the mechanism of regulation of the basolateral AE activity by a 
decrease in intracellular Ca2+, the role of CaM was tested. For these experiments 
Calu-3 cells were preincubated apically for 60 min with  N-(8-aminooctyl)-5-
iodonaphthalene-1-sulfonamide (J-8, 50μM), which is a highly specific CaM 
inhibitor (Tian et al., 2011), and then the basolateral Cl-/HCO3- AE activity was 
assessed using Cl- free solutions under resting conditions. Interestingly, CaM 
inhibition caused a marked reduction in both the mean pHi alkalinisation 
produced by basolateral Cl- removal and the rate of reacidification following Cl- 
readdition, compared to control cells, while the cAMP-induced inhibition of the 
basolateral Cl-/HCO3- AE activity was not affected (Figure 4.24A and B). CaM 
inhibition also significantly decreased the rate of HCO3- flux produced by 
basolateral Cl- removal, compared to untreated cells (Figure 4.24C). This 
implies that CaM plays an important role in the regulation of the basolateral Cl-
/HCO3- AE activity under resting conditions in Calu-3 cells.  
 
     A                                                        B                                                      C                                                              
 
 
 
 
 
 
Figure 4. 24: Calmodulin inhibitor, J-8, inhibited basolateral Cl-/HCO3- AE 
activity in Calu-3 cells under resting conditions.  Summary of the effect of apical 
preincubation of 50μM J-8 for 60 min on mean alkalinisation in pHi in response to 
basolateral Cl- removal (A) and the rate of reacidification upon Cl- readdition (B) under 
resting and Fsk stimulated conditions. (C) The rate of HCO3- flux during Cl-  readdition 
in Calu-3 cells. Data are shown as Mean±SEM.*P<0.01, #P<0.05 compared to control, 
n=3 for each condition, experiments run in parallel. 
141 
 
6.6
6.8
7.0
7.2
7.4
7.6
7.8
8.0
 KREBS/HCO3-  +MK571  KREBS/HCO3- +Fsk+MK571
Baso 0Cl-
Baso 0Cl-
240s
p
H
i
7.0
7.2
7.4
7.6
7.8
8.0
8.2
 KREBS/HCO3-
Baso 0Cl-
 KREBS/HCO3- +Fsk
240s
Baso 0Cl-
 KREBS/
   HCO3-
pH
i
To further investigate whether the inhibitory impact of CaM inhibition on 
basolateral AE activity could be changed under conditions where intracellular 
cAMP was elevated, Calu-3 cells were preincubated with J-8 and then perfused 
with the cAMP efflux inhibitor, MK571, and basolateral Cl-/HCO3- AE activity 
was measured with and without cAMP stimulation  (Figure 4.25A). Compared 
to untreated cells (Figure 4.25B), results showed that J-8 and MK571 caused a 
very significant inhibition of the basolateral Cl-/HCO3- AE activity under resting 
conditions, but did not change the subsequent Fsk-induced inhibition of the 
remaining basolateral Cl-/HCO3- AE activity (Figure 4.25A, C and D). As shown 
in Figure 4.26B, treatment of Calu-3 cells with J-8 and MK572 simultaneously 
caused a marked decrease in the rate of reacidification produced by basolateral 
Cl-/HCO3- AE activity, which was nearly abolished, compared to Calu-3 cells 
treated with MK571 or J-8 alone. However, the mean pHi change produced by 
basolateral Cl- removal, and cAMP-induced inhibition of the basolateral Cl-
/HCO3- AE activity was not changed (Figure 4.26A and B). This suggests that 
CaM and cAMP control the basolateral Cl-/HCO3- AE activity via separate 
regulatory mechanisms. 
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Figure 4. 25: Impact of J-8+MK571 on the basolateral Cl-/HCO3- AE activity in 
Calu-3 cells.  (A) Representative pHi trace showing the effect of J-8 and MK571 on the 
basolateral Cl-/HCO3- AE activity compared to control response (B) under resting and 
Fsk stimulated condition. Summary of the effect of apical perfusion of MRP inhibitor, 
MK572 in Calu-3 cells preincubated with 50μM J-8 for 60 min on mean change in pHi 
in response to basolateral Cl- removal (C) and the rate of reacidification upon Cl- 
readdition (D) under resting and Fsk stimulated conditions. Data are shown as 
Mean±SEM.*P<0.001 compared to control, n=5 for control, and n=4 for J-8+MK571.  
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Figure 4. 26: Impact of MK571, J-8 and J-8+MK571 on the basolateral Cl-/HCO3- 
AE activity in Calu-3 cells.  (A) Mean alkalinisation in pHi in response to basolateral 
Cl- free solution, (B) the rate of reacidification upon Cl- readdition under resting and Fsk 
stimulated conditions. Data are shown as Mean±SEM.*P<0.001, †P<0.01 compared to 
MK571 and †P<0.05 compared to +J-8, n=10 for control, n=3 +K571, n=4 for +J-8, and 
n= 4 J-8+K571. 
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4.7.1.2 Inhibition of CaMKK by STO-609 
 
It has been shown that the activity of calcium–activated Cl- channels was 
abolished by inhibition of the CAMK pathway (using the CAMKK inhibitor 
STO-609) in Xenopus oocytes, while it did not affect CFTR activity (Faria D., 
2012 PhD thesis, University of Lisbon). In order to test the role of CaMKK in 
the regulation of the basolateral Cl-/HCO3- AE activity, Calu-3 cells were 
preincubated with 20μM STO-609 for 60 min, and then basolateral Cl-/HCO3- 
AE activity was measured in response to basolateral Cl- removal under resting 
and cAMP stimulated conditions. As shown in Figure 4.27A and B, inhibition of 
the CaMKK mediated signaling pathway did not affect the resting basolateral Cl-
/HCO3- AE activity, and did not abolish the cAMP-induced inhibition of the 
basolateral Cl-/HCO3- AE activity. This suggests that CaMKI and CaMKIV are 
not involved in the regulation of the basolateral Cl-/HCO3- AE activity in Calu-3 
cells. 
 
 
        A                                                                        B 
 
 
 
 
 
Figure 4. 27: CAMKK inhibitor, STO-609, did not affect the basolateral Cl-/HCO3- 
AE activity in Calu-3 cells.  Summary of the effect of apical preincubation of 20μM 
STO-609 for 60 min on mean alkalinisation in pHi in response to basolateral Cl- 
removal (A) and the rate of reacidification upon Cl- readdition under resting and Fsk 
stimulated conditions (B).  Data are shown as Mean±SEM. No significant difference 
(P>0.05) compared to Baso 0Cl-, n=3 for each, experiments run in parallel. 
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4.7.1.3 Inhibition of CaMKII by KN-93 
It has also been found that CAMKII plays an important role in the regulation of 
membrane Cl- permeability through Cl- channels in a variety of epithelial cells 
(Hartzell et al., 2005). To further investigate the mechanism of CaM-dependent 
regulation of the basolateral Cl-/HCO3- AE, Calu-3 cells were preincubated with 
KN-93 (5μM), a CaMKII-specific inhibitor (Namkung et al., 2010). Results 
showed that CaMKII inhibition did not affect the resting basolateral Cl-/HCO3- 
AE activity, nor affect the cAMP-induced inhibition of the basolateral AE, 
although the rate of reacidification was increased in treated cells, compared to 
control cells (Figure 4.28A and B). These data indicate that CAMKII was not 
significantly involved in maintaining resting activity, nor was it involved in the 
cAMP-induced inhibition of the basolateral Cl-/HCO3- AE activity in Calu-3 
cells. Together, the above data imply that inhibition of the basolateral Cl-/HCO3- 
AE activity by decreasing [Ca2+]i is through a CaM dependent, but CaMK-
independent, signaling pathway in Calu-3 cells. 
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Figure 4. 28: No impact of the CaMKII inhibitor, KN-93, on the basolateral Cl-
/HCO3- AE activity in Calu-3 cells.  Summary of the effect of apical preincubation of 
5μM KN-93 for 60 min. (A) mean alkalinisation in pHi in response to basolateral Cl- 
removal, and the rate of reacidification following Cl- readdition (B), under resting and 
Fsk stimulated condition. Data are shown as Mean±SEM.*P<0.05 compared to control, 
n=3 for each condition. Control cells run in parallel. 
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4.8 Regulation of basolateral Cl-/HCO3- anion exchanger activity by dynamin  
In order to further investigate the mechanism of Ca2+/CaM-mediated regulation 
of the basolateral AE activity in Calu-3 cells, the role of dynamin was assessed, 
because there is a Ca2+-sensing mechanism that regulates dynamin mediated 
endocytosis (Lai et al., 1999). My previous results showed that inhibition of 
dynamin, using dynasore, significantly reduced the activity of the apical Cl-
/HCO3- AE in Calu-3 cells (see chapter 3, section 3.7). Also, experimental 
evidence has shown that dynamin plays a critical role in membrane fission of 
Golgi-derived vesicles in the trans-face of the Golgi network, through an actin-
dependent mechanism, and interference with dynamin function inhibits post 
Golgi protein transportation (Kerkhoff et al., 2001; Carreno et al., 2004; Kessels 
and Qualmann, 2004; Praefcke and McMahon, 2004; Cao et al., 2005; Kessels 
et al., 2006). However, it is unknown whether dynamin is involved in the 
regulation of the basolateral anion exchanger. Thus, Calu-3 cells were 
preincubated with dynasore for 60 min, and then basolateral Cl-/HCO3- AE 
activity was measured in Cl- free solutions. As shown in Figure 4.29A and B, 
dynamin inhibition caused a marked reduction in the activity of the basolateral 
Cl-/HCO3- AE activity, both in the magnitude of alkalinisation produced by 
basolateral Cl- removal, as well as the rate of reacidification following Cl- 
readdition, compared to control cells. However, dynamin inhibition did not alter 
the Fsk-induced inhibition of the remaining basolateral AE activity. This 
suggests that dynamin plays an important role in the regulation of the basolateral 
Cl-/HCO3- AE activity in Calu-3 cells under resting conditions, but probably not 
in the cAMP-induced inhibition of AE activity.        
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Figure 4. 29: Inhibition of dynamin reduced basolateral Cl-/HCO3- AE activity in 
Calu-3 cells. Summary of the effect of  dynamin disruption, by preincubation of cells 
with 80µM dynasore for 60 min, on mean alkalinisation in pHi in response to 
basolateral Cl- free removal (A) and the rate of reacidification following Cl- readdition 
(B) under resting and Fsk stimulated conditions in Calu-3 cells. Data are shown as mean 
±SEM, *P<0.001 compared to control, n=5 for Control, and n=4 for +Dynasore. Control 
cells run in parallel. 
 
 
4.9 Role of the actin-cytoskeleton in the regulation of basolateral Cl-/HCO3- anion 
exchanger activity 
Since the actin cytoskeleton can bind directly to dynamin, through its actin 
binding domain (Gu et al., 2010), and dynamin inhibition significantly reduced 
the basolateral Cl-/HCO3- AE activity (see Figure 4.29), my hypothesis was that 
an intact actin cytoskeleton would be essential for maintaining basolateral Cl-
/HCO3- AE activity. My hypothesis was further corroborated by the most recent 
finding that actin filaments participate in trafficking pathways of the secretory 
membrane vesicles from trans-Golgi network to the plasma membrane, and play 
an important role in the regulation of some ion pumps/channels (Egea et al., 
2015). To test this hypothesis, Calu-3 cells were preincubated with CytoD for 60 
min, and then basolateral Cl-/HCO3- AE activity was measured in response to 
basolateral Cl- free solutions. Results showed that disruption of the actin 
cytoskeleton by CytoD significantly decreased the activity of the basolateral Cl-
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/HCO3- AE, both in the magnitude of alkalinisation produced by basolateral Cl- 
removal, as well as the rate of reacidification following Cl- readdition, compared 
to untreated cells. However, CytoD did not affect the cAMP-induced inhibition 
of the basolateral Cl-/HCO3- AE activity after Fsk stimulation (Figure 4.30A and 
B). This implies that an intact actin-cytoskeleton plays an essential role in the 
resting activity of the basolateral Cl-/HCO3- AE in Calu-3 cells, but like 
dynamin, not in the cAMP-induced inhibition of AE activity. 
   
 
         A                    B 
 
 
 
 
 
Figure 4. 30: Cytochalasin-D reduced basolateral Cl-/HCO3- AE activity in Calu-3 
cells. Summary of the effect of actin disruption, by preincubation of Calu-3 cells with 
20µM CytoD for 60 min, on mean pHi change (alkalinisation) caused by basolateral Cl- 
removal (A) and the rate of reacidification upon Cl- readdition (B) under resting and 
Fsk stimulated conditions. Data are shown as Mean±SEM. *P<0.001, #P<0.01 
compared to Baso 0Cl-, n=10 for control Baso 0Cl-, n=12 for Baso 0Cl-+Cytochalasin-
D, and n=4 for Control +Fsk. 
 
 
4.10 Regulation of basolateral Cl-/HCO3- anion exchanger activity by CK2  
In order to further investigate the mechanism behind Ca2+/CaM regulation of the 
basolateral Cl-/HCO3- AE activity under resting conditions, another set of 
experiments were performed to assess the impact of CK2 on the basolateral AE 
activity as it has been reported that CK2 is the main serine/threonine kinase both 
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in vivo and in vitro that can phosphorylate CaM (Arrigoni et al., 2004). Also, a 
recent study by Kang et al., (2014) has shown that phosphorylation of CaM by 
CK2 strengthens binding of CaM with the M-type potassium channel (Kang et 
al., 2014). According to sequence analysis of SLC4A2 (see appendix), there are 
a number of potential CK2 phosphorylation sites present. It has been shown that 
CK2 plays an important role in the regulation of ion channels such as CFTR, 
and experimental evidence revealed that if CK2 is inhibited, PKA cannot 
activate CFTR (Mehta, 2008). My previous results showed that CK2 inhibition 
significantly reduced the apical Cl-/HCO3- AE in Calu-3 cells (Chapter 3, Figure 
3.19); however, it was unknown whether CK2 regulates the basolateral Cl-
/HCO3- AE activity under resting and/or cAMP stimulated conditions.  
 
4.10.1 Effect of the CK2 inhibitor TBB: 
In order to define the role of CK2 in the Ca2+/CaM mediated regulation of the 
basolateral Cl-/HCO3- AE activity, I first assessed the effect of CK2 inhibition, 
using TBB, on the mean pHi change following Cl- removal from the basolateral 
side of Calu-3 cells. For these experiments, cells were preincubated with 10μM 
TBB in both apical and basolateral compartments, for 60 min, and then perfused 
with KREBS solution containing TBB (Figure 4.31A). TBB caused a significant 
decrease in resting pHi (6.8+0.08, P<0.05, n=5) compared to control untreated 
cells (7.5±0.07, P<0.05, n=6), which was recovered after washing off of the 
TBB. Results showed that CK2 inhibition caused a significant reduction in the 
magnitude of alkalinisation produced by basolateral Cl- removal, and the rate of 
reacidification following Cl- readdition, compared to control cells, while it did 
not affect the cAMP-induced inhibition of the basolateral Cl-/HCO3- AE activity 
(Figure 4.31B and C). Inhibition of the basolateral AE activity, caused by CK2 
inhibition, completely recovered after 25 min of washing off the TBB (Figure 
4.31D and E), and was not significantly different to untreated cells. Also, CK2 
inhibition caused a marked reduction in the rate of HCO3- flux produced by 
basolateral Cl- removal AE activity compared to control untreated cells (Figure 
4.31F). 
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Figure 4. 31: Inhibition of basolateral Cl-/HCO3- AE activity by TBB in Calu-3 
cells. (A) Raw pHi trace showing the effect of TBB preincubation and perfusion on the 
basolateral Cl-/HCO3- AE activity in Calu-3 cells under resting and cAMP stimulated 
conditions. The inhibitory effect of TBB was recovered after 25 min washing off. 
Summary of the effect of CK2 inhibitor TBB (10µM preincubation and perfusion) on 
the basolateral AE activity on mean alkalinisation (pHi) produced by basolateral Cl- 
removal (B) and the rate of reacidification upon Cl- readdition (C) under resting and Fsk 
stimulated conditions. Recovery of TBB-induced inhibition of the basolateral AE 
activity, both in the mean alkalinisation (D), and the rate of reacidification (E), in Calu-
3 cells. (F) The rate of HCO3- flux in control and TBB treated cells. Data are shown as 
Mean±SEM. *P<0.001, #P<0.05 compared to control, n=6 for control, and n=5 for 
+TBB. Control cells run in parallel. 
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To further investigate the temporal effects of TBB-induced inhibition of the 
basolateral Cl-/HCO3- AE activity, Calu-3 cells were instead acutely exposed to 
KREBS/HCO3- solution containing 10μM TBB to both the apical and 
basolateral compartments, and then basolateral Cl-/HCO3- AE activity measured 
in response to Cl- free solutions (Figure 4.32.A). Acute TBB exposure caused an 
intracellular acidification (Figure 4.32A, red trace) and mean pHi was 
significantly decreased from 7.59±0.02 to 7.49±0.01 (P<0.05, n=6) after TBB 
exposure. In addition there was a significant decrease in both the magnitude of 
alkalinisation produced by basolateral Cl- removal, and the rate of reacidification 
upon Cl- readdition compared by TBB exposure compared to control responses. 
Inhibition of the basolateral AE activity, caused by CK2 inhibition, completely 
recovered after 25 min washing off of the TBB (Figure 4.32B and C). Since the 
mean pHi was within the normal range after TBB exposure, it was unlikely that 
pHi itself caused the decrease in basolateral AE activity. CK2 inhibition also led 
to a marked reduction in the rate of HCO3- flux, compared to control untreated 
cells (Figure 4.32D). This suggests that CK2 is important to maintain the 
activity of the basolateral Cl-/HCO3- AE under resting conditions.   
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Figure 4. 32: Inhibition of basolateral Cl-/HCO3- AE activity by acute exposure to 
TBB in Calu-3 cells. (A) Representative pHi trace showing the effect of acute bilateral 
TBB exposure (10µM) on the basolateral Cl-/HCO3- AE activity under resting 
conditions in Calu-3 cells. Note that washing off the inhibitor led to recovery of the 
basolateral Cl-/HCO3- AE activity. Summary of the effect of acute exposure to TBB 
(10μM) on the mean alkalinisation (pHi) produced by basolateral Cl- removal (B) and 
the rate of reacidification upon Cl- readdition (C) in control and TBB treated Calu-3 
cells. (D) HCO3- efflux in control and TBB treated cells, basolateral Cl-/HCO3- AE 
activity reversed after 25 min washing off the CK2 inhibitor. Data are shown as 
Mean±SEM.*P<0.001 compared to control and recovery, n=6 for each condition, paired 
observations. 
 
In order to further investigate whether CK2 regulation of the basolateral Cl-
/HCO3- AE activity was direct or through CaM, in another series of experiments, 
Calu-3 cells were preincubated with the CaM inhibitor J-8 for 60 min, and then 
acutely exposed to bilateral TBB, and then the basolateral Cl-/HCO3- AE activity 
was measured in response to Cl- free solutions (Figure 4.33A). As shown in 
Figure 4.33B and C, TBB did not further decrease the activity of the basolateral 
AE in the presence of CaM inhibitor, with respect to both magnitude of 
alkalinisation produced by basolateral Cl- removal, or the rate of reacidification 
following Cl- readdition, compared to control responses. Also, TBB did not 
cause a further reduction in the % inhibition in the rate of reacidification in the 
presence of CaM inhibitor, but did it further reduce the % inhibition in mean pHi 
change (Figure 4.33D and E). These results suggest that CK2 potentially 
controls the resting activity of the basolateral Cl-/HCO3- AE through the 
downstream target CaM, in Calu-3 cells. 
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Figure 4. 33: Inhibition of basolateral Cl-/HCO3- AE activity by J-8 preincubation 
and acute TBB exposure in Calu-3 cells. (A) Representative pHi trace showing the 
effect of acute bilateral TBB exposure on the basolateral Cl-/HCO3- AE activity in 
preincubated cells with J-8 under resting condition in Calu-3 cells. Summary of the 
effect of acute TBB exposure in J-8 preincubated Calu-3 cells on mean alkalinisation 
(pHi) produced by basolateral Cl- removal (B), and the rate of reacidification upon Cl- 
readdition (C). % inhibition in mean pHi change (D), and the rate of reacidification (E), 
in Calu-3 cells treated with TBB or J-8 alone, compared to J-8 and TBB treated cells. 
Data are shown as Mean±SEM.*P<0.001 compared to control, n=9 for control, n=6 for 
TBB and +J-8, and n=3 for TBB+J-8. 
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4.10.2 Effect of the CK2 inhibitor CX4945 
 
In order to further investigate the role of CK2 in the regulation of basolateral Cl-
/HCO3- AE activity in Calu-3 cells, I used another CK2 inhibitor, 5-(3-
chlorophenylamino) benzo[c][2,6]naphthyridine-8-carboxylic acid (CX4945), 
which has recently been shown to be a potent and selective  ATP-competitive 
inhibitor of CK2 (Pierre et al., 2011). Calu-3 cells were preincubated with 
bilateral 10μM CX4945 for 60 min, and then perfused with CX4945 containing 
KREBS solution (Figure 4.34A). CX4945 also caused a significant decrease in 
mean pHi (6.8±0.05, n=3) compared to untreated cells (7.4±0.02, n=3, P<0.001). 
As shown in Figure 4.34B and C, CX4945 produced a significant decrease in the 
mean pHi change produced by basolateral Cl- removal, and the rate of 
reacidification following Cl- readdition compared to control cells. However, it 
did not affect the subsequent Fsk-induced inhibition of the remaining basolateral 
Cl-/HCO3- AE activity (Figure 4.34B and C). Inhibition of the basolateral Cl-
/HCO3- AE activity by CX4945 completely recovered after 25 min washing off 
of the inhibitor, as did the pHi (7.5±0.06). HCO3- flux was also significantly 
reduced by CX4945, compared to untreated cells (Figure 4.34F).  
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Figure 4. 34: Inhibition of basolateral Cl-/HCO3- AE activity by CX4945 in Calu-3 
cells. (A) Raw pHi trace showing the effect of CX4945 preincubation and perfusion 
(10µM) on the basolateral Cl-/HCO3- AE activity in Calu-3 cells under resting and Fsk 
stimulated conditions. The inhibitory effect of CX4945 was reversed after ~ 25 mins 
wash off. Summary of the effect of CK2 inhibitor CX4945 (10µM preincubation and 
perfusion) on the basolateral Cl-/HCO3- AE activity on mean alkalinisation (pHi) 
produced by basolateral Cl- removal (B) and the rate of reacidification upon Cl- 
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readdition (C), recovery of CX4945-induced inhibition of basolateral Cl-/HCO3- AE in 
both mean alkalinisation (D) and the rate of reacidification (E) in Calu-3 cells. (F) 
HCO3- efflux in control and TBB treated cells. Data are shown as Mean±SEM. 
*P<0.001, #P<0.05 compared to control, n=3 for each condition. 
 
 
Similarly, in another set of experiments, acute bilateral exposure to 10μM 
CX4945 nearly abolished the basolateral Cl-/HCO3- AE activity in Calu-3 cells 
(Figure 4.35A). CX4945 caused a significant decrease in basolateral Cl-/HCO3- 
AE activity in both the magnitude of alkalinisation produced by basolateral Cl- 
removal, and the rate of reacidification upon Cl- readdition compared to control 
responses (Figure 4.35B and C). Also, CK2 inhibition by CX4945 produced a 
significant decrease in the rate of HCO3- efflux compared to untreated cells 
(Figure 4.35D). However, unlike TBB, CX4945 did not produce an intracellular 
acidification, but like TBB, the effect of CX4945 was fully reversible on 
washing away the inhibitor (Figure 4.35B-D).  Taken together, the above data 
clearly indicate that CK2 plays an essential, and novel, role in the regulation of 
the basolateral Cl-/HCO3-AE activity under resting conditions in Calu-3 cells. 
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Figure 4. 35: Inhibition of basolateral Cl-/HCO3- AE activity by acute exposure to CX4945 
in Calu-3 cells. (A) Representative pHi trace showing the effect of acute bilateral exposure of 
CX4945 on the basolateral Cl-/HCO3- AE activity under resting condition in Calu-3 cells. 
Washing off CX4945 recovered the basolateral Cl-/HCO3- AE activity. Summary of the effect of 
acute bilateral exposure of CX4945 (10μM) on the mean alkalinisation (pHi) produced by 
basolateral Cl- removal (B) and the rate of reacidification upon Cl- readdition (C), HCO3- flux 
produced by basolateral Cl removal AE activity (D) in control response compared to CX4945 
treated and recovery in Calu-3 cells. Data are shown as Mean±SEM. B and C: *P<0.001 
compared to control and recovery, #P<0.05 compared to recovery. D: *P<0.05 to Baso 0Cl-, 
*P<0.001 to recovery, #P<0.05 compared to Baso 0Cl-, n=6 for each condition, except for 
recovery n=5. 
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4.11 Regulation of the basolateral Cl-/HCO3- anion exchanger by protein phosphatase 
(PP1/PP2A) activity  
Recently, it was shown that regulation of M-type potassium channels by CK2-
mediated phosphorylation of CaM depends on CK2 and PP1 anchored to the M-
type potassium channel (Kang et al., 2014). In order to assess whether 
PP1/PP2A could be involved in the regulation of the basolateral Cl-/HCO3- AE 
activity by CK2 and CaM, I performed another series of experiments where 
Calu-3 cells were preincubated with 100nM okadaic acid (OA) and perfused 
with KREBS/HCO3- solution containing OA, and then basolateral Cl-/HCO3- AE 
activity measured in response to Cl- free solutions (Figure 4.36A). My results 
showed that 100nM OA significantly inhibited the basolateral Cl-/HCO3- AE 
activity, both in the mean pHi change in response to basolateral Cl- free solution, 
and the rate of reacidification upon Cl- readdition under resting condition 
compared to untreated Calu-3 (Figure 4.36B and C). This is consistent with the 
recent finding by Garnett et al., (2013) that PP1 inhibition by OA (but not 
PP2A), mimicked the cAMP-induced inhibition of the basolateral AE activity in 
Calu-3 cells (Garnett et al., 2013). These results suggest that PP1/2A keeps the 
basolateral anion exchanger active under resting conditions by 
dephosphorylating the exchanger, or an accessory/regulatory protein. The 
inhibition of the basolateral Cl-/HCO3- AE activity by OA was only seen when 
Calu-3 cells were pretreated with OA and then perfused with OA containing 
KREBS solution, as perfusion of OA alone failed to produce any significant 
effect on AE activity. This suggests that OA needs time to produce its inhibitory 
effect on the basolateral Cl-/HCO3- AE activity (Figure 4.36D, E and F). 
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Figure 4. 36: Effect of okadaic acid (OA) on the activity of the basolateral anion 
exchanger. (A) Representative pHi traces showing that OA preincubation and perfusion 
(100nM) reduced the activity of the basolateral anion exchanger in Calu-3 cells. 
Summary of the effect of OA preincubation and perfusion (100nM) on mean change in 
pHi produced by basolateral Cl- removal (B), and the rate of reacidification upon Cl- 
readdition (C) compared to control responses. *P<0.05 compared to Baso 0Cl-, n=8 for 
control, and n=5 for OA treated cells. (D) Representative pHi trace showing that acute 
OA exposure had no effect on the basolateral Cl-/HCO3- AE activity. Summary of the 
effect of acute OA exposure on mean pHi change (E), and the rate of reacidification (F), 
compared to control response in Calu-3 cells. Data are shown as mean ±SEM, no 
significant difference, n=3, paired observation.   
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4.12 Discussion 
 
4.12.1 Inhibition of the basolateral AE activity by DIDS 
Using real-time measurements of pHi from polarised cultures of Calu-3 cells my 
results show that in the absence of cAMP stimulation these model human serous 
airway cells have a functional Cl-/HCO3- anion exchanger on the basolateral 
membrane. The basic properties of this exchanger were consistent with 
SLC4A2, a Cl-/HCO3- exchanger commonly referred to as AE2, which has 
previously been shown to be expressed at the basolateral membrane in Calu-3 
cells by immunofluorescence (Loffing et al., 2000). One of the goals of my 
project was to investigate the functional properties of the basolateral anion 
exchanger in more detail and its potential role in transepithelial HCO3- secretion. 
My results showed that the basolateral Cl-/HCO3- AE activity was inhibited by 
the disulphonic stilbene DIDS, and that DIDS caused an increased amount of 
HCO3- to be secreted across the apical membrane without affecting the amount 
of fluid secreted over a 24 hr period. Therefore, these results suggest that 
inhibition of the basolateral Cl-/HCO3- AE activity provides more HCO3- to 
accumulate inside the cells and this in turns increases the driving force for 
HCO3- secretion across the apical membrane in Calu-3 cells. The IC50  for DIDS 
inhibition of the basolateral anion exchanger was about 17 µM, which  is in very 
good agreement with Humphreys et al., 1994 (Humphreys et al., 1994) who 
obtained an IC50 of ~ 13 µM for DIDS block of human basolateral AE2 
heterologously expressed in Xenopus oocytes. However, these authors 
(Humphreys et al., 1994) found that 200 µM DIDS nearly abolished AE2 
activity, whereas I found that a higher concentration (500 µM) was required to 
achieve complete inhibition. This suggests that other DIDS-sensitive base 
transporters in the basolateral membrane of Calu-3 cells may be present, along 
with AE2. These could be other members of the SLC4 family, or even the 
SLC26 family,  since HCO3- transportation  across the basolateral membrane of 
gastric parietal cells (Petrovic et al., 2003) and intercalated cells of the outer 
medullary collecting duct (Petrovic et al., 2004) are thought to be mediated by 
SLC26A7 (Rossmann et al., 2001), which is expressed in Calu-3 cells and is 
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also sensitive to DIDS.  However, based on the dose response for  DIDS 
inhibition of the basolateral Cl-/HCO3- AE activity in Calu-3 cells, a much lower 
concentration of DIDS was needed to block the basolateral AE activity, 
compared to DIDS inhibition of the SLC26A7, with an IC50 of 126 µM (Petrovic 
et al., 2003). Also my results showed that the basolateral Cl-/HCO3- AE activity 
is Cl- and HCO3- dependent, in contrast to SLC26A7, which is  impermeable to 
HCO3-, as the magnitude of Cl- current in SLC26A7 transfected Xenopus 
oocytes and HEK cells was unaffected by HCO3- (Kim et al., 2005). Therefore, 
based on my pharmacological data and the Cl- and HCO3- dependency, my 
results are consistent with the functional expression of AE2 on the basolateral 
membrane of Calu-3 cells.   
Although the exact role of AE2 in Calu-3 cells still needs to be determined, it is 
likely to be important in regulating resting intracellular pH via its ability to 
transport HCO3- across the basolateral membrane, as shown in my studies and 
by others (Inglis et al., 2002; Garnett et al., 2011). Also the study by Huang et 
al., (2012) showed that intracellular alkalinisation produced by basolateral Cl- 
removal was decreased by 80% in AE2 knock down Calu-3 cells (Huang et al., 
2012). In addition, through its transport activity under resting conditions, it will 
also act to accumulate Cl- inside the cell, particularly when working in parallel 
with NKCC1 that facilitates the influx of Na+, K+ and 2Cl- ions across the 
basolateral membrane of Calu-3 cells (Liedtke et al., 2001). This is likely to be 
beneficial for transepithelial Cl- secretion, prior to stimulation by cAMP 
agonists, where the activity of the basolateral Cl-/HCO3- AE exchanger is 
subsequently reduced. As discussed in the introduction, AE2 may also have a 
role in accumulating Cl- via coupled transport with the basolateral NBC, as 
recently suggested (Huang et al., 2012; Shan et al., 2012). However, my results 
which showed no effect of DIDS on fluid secretion, suggests this mode of 
coupling is not that important under resting conditions at least.  
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4.12.2 Role of cAMP and cGMP in the regulation of the basolateral AE activity 
 
A recent study by Kim et al., (2014) demonstrated that apical HCO3- efflux via 
CFTR interferes with measuring basolateral AE2 activity, using pHi methods, in 
Fsk stimulated Calu-3 cells.  In this study, exposing cells to the apical CFTR 
inhibitor, CFTRinh-172 after cAMP stimulation, unmasked basolateral AE2 
activity such that basolateral Cl- substitution caused a significant alkalinisation 
(Kim et al., 2014). While I haven’t specifically tested the effect of adding a 
CFTR inhibitor to the apical membrane on basolateral AE activity, I have used 
several PKA inhibitors to block apical AE/CFTR activity and failed to show any 
basolateral AE2 activity, in Fsk stimulated Calu-3 cells. Moreover, it has 
recently been shown that the basolateral Cl-/HCO3- AE activity is not abolished 
by an increase of intracellular cAMP (using Fsk) in Calu-3 cells (Huang et al., 
2012). However, a study by Ishiguro et al., (2002) demonstrated that the 
basolateral Cl-/HCO3- AE activity is abolished by intracellular elevation of 
cAMP following stimulation of guinea pig pancreatic duct cells with Fsk 
(Ishiguro et al., 2002). My results showed that stimulation of Calu-3 cells by 
addition of cAMP agonists Fsk, ADO, dbcAMP or IBMX all inhibited the 
activity of the basolateral Cl-/HCO3- AE activity. Further evidence that the 
activity of the basolateral Cl-/HCO3- AE was affected by an increase of 
intracellular cAMP, comes from the finding that inhibition of the cAMP efflux 
transporter, most likely MRP4, mimicked the effect of cAMP agonists on 
basolateral Cl-/HCO3- AE activity in Calu-3 cells.  
Additionally, I have also shown that intracellular elevation of cGMP did not 
affect either the basolateral Cl-/HCO3- AE activity under resting and cAMP 
stimulated conditions. This suggests that intracellular elevation of cAMP blocks 
the basolateral Cl-/HCO3- AE activity in Calu-3 cells, consistent with the study 
by Garnett et al., (2013). Furthermore, the mechanism by which cAMP blocks 
the basolateral Cl-/HCO3- AE activity was assessed in more detail by inhibition 
of the downstream targets of cAMP. My results showed that inhibition of PKA, 
Epac, CNG channels and mTOR kinase, failed to overcome the cAMP-induced 
inhibition of the basolateral Cl-/HCO3- AE activity. This clearly suggests that 
cAMP-induced inhibition of the basolateral Cl-/HCO3- AE activity is through a 
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PKA, Epac, CNG channel, and mTOR-independent mechanism. Although Epac 
inhibition did not remove the cAMP-induced inhibition of the basolateral Cl-
/HCO3- AE activity, it significantly reduced the resting activity of the basolateral 
Cl-/HCO3- AE, suggesting, for the first time, that Epac plays an essential role in 
maintaining the resting basolateral Cl-/HCO3-AE activity in Calu-3 cells. Since 
Epac plays an important role in Ca2+ release in cardiac myocytes (Oestreich et 
al., 2009), the effect of Epac inhibition on the basolateral Cl-/HCO3- AE activity 
might be through an intracellular Ca2+ signaling pathway as it has been shown 
that Epac regulation of human intestinal Cl- secretion was completely abolished 
by BAPTA-AM (Kazi Mirajul Hoque, 2009). Future experiments should test 
these conditions on the basolateral AE activity in Calu-3 cells. 
 
 
4.12.3 Role of Ca2+ in the regulation of the basolateral AE activity 
 
4.12.3.1  Intracellular Ca2+     
To focus on the mechanism of cAMP-induced inhibition of the basolateral Cl-
/HCO3- AE activity in Calu-3 cells, the potential role of intracellular and 
extracellular Ca2+ was assessed under resting and cAMP stimulated conditions, 
as it has been shown that changes in intracellular Ca2+ concentration affect 
cAMP production, either through inhibition or stimulation of Ca2+-sensitive ACs 
(Willoughby and Cooper, 2007). Calu-3 cells were stimulated with the Ca2+ 
agonists Cch and thapsigargin that increase [Ca2+]i by releasing Ca2+ from ER 
stores into the cytosol (Thastrup et al., 1990; Mayerhofer et al., 1992). Results 
showed that basolateral Cl-/HCO3- AE activity was not changed by elevation of 
intracellular Ca2+ under both resting and cAMP-stimulated conditions. However, 
under Fsk stimulation basolateral Cl- removal in the presence of Cch produced a 
transient acidification in pHi in a Ca2+-dependent manner, and BAPTA-AM 
abolished the Cch-induced transient acidification. This suggests that elevation of 
intracellular Ca2+ does not play a critical role in the regulation of basolateral Cl-
/HCO3- AE activity in Calu-3 cells.  
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Although it has been shown that cAMP and Ca2+ cooperate to simulate HCO3- 
secretion, my results showed that intracellular depletion of Ca2+, using BAPTA-
AM, did not alter the cAMP-induced inhibition of basolateral Cl-/HCO3- AE 
activity suggesting that intracellular Ca2+ is not involved in the cAMP-mediated 
inhibition of the basolateral Cl-/HCO3- AE activity. However, a decrease in 
[Ca2+]i caused a marked reduction in basolateral Cl-/HCO3- AE activity, 
highlighting the potential importance of maintaining normal [Ca2+]i levels for 
optimal basolateral Cl-/HCO3- AE activity under resting conditions in Calu-3 
cells. Consistent with this, perfusion of thapsigargin in BAPTA-AM loaded 
Calu-3 cells, partially removed the inhibitory effect of BAPTA-AM on the 
basolateral Cl-/HCO3- AE activity, suggesting that thapsigargin caused a small 
increase in intracellular Ca2+ even in the presence of Ca2+ chelator, BAPTA-
AM. Furthermore, elevating cAMP and decreasing [Ca2+]i simultaneously, 
produced a further reduction in the activity of the  basolateral Cl-/HCO3- AE, 
indicating that cAMP and Ca2+ regulate the basolateral Cl-/HCO3- AE activity 
via different signaling pathways, which is  an interesting area for further 
investigation. This could involve determining the Ca2+ sensitive protein that 
regulates the basolateral Cl-/HCO3- AE activity under cAMP stimulated 
conditions in Calu-3 cells. 
 
4.12.3.2 Extracellular Ca2+  
 
Extracellular Ca2+ sensing receptor (CaSR) plays an important role in the 
regulation of anion and fluid secretion in human epithelial cells (Racz et al., 
2002). It has been shown that a decrease in extracellular Ca2+ concentration 
reduces the CaSR activity (Brown, 2007). In Calu-3 cells, removing of 
extracellular Ca2+ concentration, either apically or basolaterally, failed to inhibit 
basolateral Cl-/HCO3- AE activity, or overcome the cAMP-induced inhibition of 
the basolateral anion exchanger, suggesting that apical or basolateral 
extracellular Ca2+ sensing receptor alone is not involved in the regulation of the 
basolateral Cl-/HCO3- AE activity in Calu-3 cells. However, bilateral removal of 
extracellular Ca2+ significantly reduced the cAMP-induced inhibition of the 
basolateral anion exchanger, although the resting activity did not change. This 
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suggests that bilateral Ca2+ removal alters CaSR which somehow alters cAMP 
signaling and changes basolateral Cl-/HCO3- AE activity in Calu-3 cells. This 
might be because in the absence of extracellular Ca2+, CaSR interferes with 
cAMP production, thereby partially overcoming the cAMP-induced inhibition of 
the basolateral anion exchanger. Consistent with this, it has been shown that 
cAMP production is decreased in the absence of extracellular Ca2+ concentration 
(Ferreira et al., 1998). Although removing extracellular Ca2+ alone did not affect 
the resting basolateral Cl-/HCO3- AE activity, my results showed that in the 
absence of extracellular Ca2+, ER Ca2+-store depletion (induced by 
thapsigargin), caused a significant inhibition of basolateral Cl-/HCO3- AE 
activity, and interestingly produced a transient intracellular acidification, 
potentially through stimulation of the apical AE activity. However, cAMP-
induced inhibition of the basolateral Cl-/HCO3- AE activity was not changed. 
Thus, a possible explanation would be that a combination of extracellular Ca2+ 
removal combined with ER Ca2+-store depletion, increased intracellular cAMP 
levels and thereby blocked the basolateral Cl-/HCO3- AE activity in Calu-3 cells. 
It has been reported that ER Ca2+-store depletion and absence of extracellular 
Ca2+ enhance AC and increase [cAMP]i through the ER Ca2+-sensor STIM, 
which couples ER Ca2+ level to cAMP production (Lefkimmiatis et al., 2009). 
Future experiments could involve measuring [Ca2+]i and ER [Ca2+] in the 
absence of extracellular Ca2+ to support the role of Ca2+ in the regulation of the 
basolateral Cl-/HCO3- AE activity. 
 
4.12.4 Role of CaM and CaMK in the regulation of the basolateral AE activity 
 
Since depletion of [Ca2+]i significantly reduced the basolateral Cl-/HCO3- AE 
activity in Calu-3 cells, suggested that an intracellular calcium-sensor was 
involved, and therefore the role of CaM was assessed, because it has been shown 
that there is a strong relationship between CaM activation and intracellular 
Ca2+concentration (Keller et al., 2008). CaM inhibition caused a marked 
reduction in the basolateral Cl-/HCO3- AE activity under resting conditions, but 
it did not prevent the remaining activity to be inhibited by Fsk. Although there is 
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well described cross-talk between Ca2+/Calmodulin dependent protein kinase 
(CaMK) and some cAMP dependent signaling pathways (Soderling, 1999), and 
normal intracellular Ca2+ concentration is also required to maintain the resting 
activity of the basolateral Cl-/HCO3- AE, inhibition of CaMK (CaMKI, CaMKII 
and CaMKIV) produced  little effect on  basolateral Cl-/HCO3- AE activity,  and 
did not  prevent the cAMP-mediated inhibition of the basolateral Cl-/HCO3- AE 
activity. This suggests that CaM-dependent kinases were not involved in the 
regulation of the basolateral Cl-/HCO3- AE activity under resting and cAMP 
stimulated conditions in Calu-3 cells. These data indicate that although CaM is 
not involved in cAMP-mediated inhibition of the basolateral Cl-/HCO3- AE 
activity, it does play an important role in regulating the resting activity, through 
a CaMK-independent mechanism. This is further supported by the effect of 
BAPTA-AM, which also reduced the basolateral Cl-/HCO3- AE activity (see 
section 4.6.1.2, figure 4.18). Taken together, decreasing [Ca2+]i potentially 
blocks the basolateral Cl-/HCO3- AE activity through a CaM dependent pathway 
in Calu-3 cells. Consistent with this, it has been reported that CaM plays an 
essential role in transduction of Ca2+-mediated signaling pathways in all 
eukaryotic cells (O'Day, 2003). Interestingly, in the presence of a CaM inhibitor,  
elevating cAMP (by inhibition of MRP4), did  cause a further reduction in the 
resting activity of the basolateral Cl-/HCO3- AE, suggesting that both CaM and 
cAMP induce their effects via separate regulatory mechanism. 
 
 
4.12.5 How does actin-cytoskeleton disruption and dynamin inhibition lead to the 
marked decrease in the basolateral AE activity  
 
Another hypothesis to explain the effect of [Ca2+]i depletion on resting 
basolateral Cl-/HCO3- AE activity could be provided by an effect on dynamin 
mediated endocytosis, as it has been reported that this process is controlled via a 
Ca2+-sensing mechanism (Lai et al., 1999). Although blocking dynamin in Calu-
3 cells did not affect the cAMP-induced inhibition of the basolateral Cl-/HCO3- 
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AE activity, the resting basolateral Cl-/HCO3- AE activity was significantly 
decreased, which could potentially be through inhibition of supply of new 
proteins from the trans-face of Golgi complex, as dynamin plays an important 
role in the fission of newly formed vesicles, and regulates the kinetics of 
released protein to the plasma membrane (Anantharam et al., 2011). This 
highlights the importance of dynamin in the regulation of the basolateral Cl-
/HCO3- AE under resting conditions in Calu-3 cells. However, exactly how this 
occurs is unclear, but one possible explanation could be via the actin 
cytoskeleton, since there is a direct interaction between dynamin and the actin 
cytoskeleton (Gu et al., 2010), and recent findings showed that actin filaments 
plays a vital role in transferring secretory vesicles from the trans-Golgi network 
to the plasma membrane, and thereby regulation of some ion transporter activity 
((Egea et al., 2015), see Figure 4.37). Consistent with this, I showed that 
disruption of the actin cytoskeleton in Calu-3 cells produced a marked reduction 
in the basolateral Cl-/HCO3- AE activity under resting conditions, but it did not 
overcome the cAMP-induced inhibition. Taken together, the above data imply 
that both an intact actin cytoskeleton and dynamin are required to maintain the 
normal resting activity of the basolateral Cl-/HCO3- AE in Calu-3 cells, 
potentially through a Ca2+-dependent mechanism.  
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Figure 4. 37: Schematic illustration of actin participation in the trafficking 
pathway of secretory vesicles from the Golgi complex to the plasma membrane.  
Actin polymerization plays a vital role in scission (1), pulling (2), and forward 
movement (3) of carrier vesicles, and regulation of ion transporter function (4), and/or 
being part of cytoskeleton (6), and keeping the Golgi extended (5).  Diagram taken from 
(Egea et al., 2015). 
 
 
4.12.6 Role of CK2 in the regulation of the basolateral anion exchanger  
 
To further understand the mechanism of CaM-induced inhibition of the 
basolateral Cl-/HCO3- AE activity in Calu-3 cells under resting conditions, the 
role of CK2 was assessed since there are a number of putative CK2 
phosphorylation sites in SLC4A2 (see appendix), and it has been shown that 
CK2 is the main kinase that can phosphorylate CaM (Arrigoni et al., 2004) via 
three physiological CK2-phosphorylation acceptor sites in CaM (Quadroni et 
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al., 1994; Arrigoni et al., 2004). Interestingly, treatment of Calu-3 cells with two 
different selective CK2 inhibitors, TBB and CX4945, either by preincubation or 
acute exposure of cells with the inhibitors, caused a significant decrease in the 
basolateral Cl-/HCO3- AE activity under resting conditions, while CK2 inhibition 
failed to overcome the cAMP-induced inhibition of the basolateral Cl-/HCO3- 
AE activity. This clearly indicates that CK2 plays an important role in the 
regulation of the basolateral Cl-/HCO3- AE activity under resting conditions, and 
also implies that CK2 regulates the basolateral AE activity potentially through a 
CaM-dependent mechanism, based on the fact that CaM is a known downstream 
target of CK2. This is further supported by my results when Calu-3 cells were 
treated simultaneously with a J-8 as well as TBB, which did not produce a 
further decrease in the basolateral Cl-/HCO3- AE activity, compared to the 
presence of CaM inhibitor or CK2 inhibitor alone. My results are also consistent 
with recent findings that showed CK2-mediated phosphorylation of CaM plays 
an important role in the regulation of K+-channels by strengthening CaM 
binding to the K-channels, which was shown to regulate channel trafficking and 
stabilize its activity in HEK293A cells (Kang et al., 2014).   
 
 
4.12.7 Impact of PP1 on the regulation of the basolateral AE activity 
 
It has been previously reported from our group that PP1 inhibition leads to 
stimulation of apical AE activity and inhibition of the basolateral Cl-/HCO3- AE 
activity, in Calu-3 cells (Garnett et al., 2013). I also showed that PP1 inhibition 
by OA markedly decreased the basolateral Cl-/HCO3- AE activity under resting 
conditions, suggesting that dephosphorylation of the basolateral Cl-/HCO3- AE, 
or other regulatory proteins might be responsible for maintaining the resting 
activity of the basolateral Cl-/HCO3- AE in Calu-3 cells. The exact mechanism as 
to how PP1 regulates basolateral Cl-/HCO3- AE activity is still unclear; however, 
it has been shown that CK2 can phosphorylate and activate PP1 (Van Eynde et 
al., 1994), suggesting there exists a link between active PP1 and CK2. My 
results are consistent with this as I showed that CK2 inhibition markedly 
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reduced basolateral Cl-/HCO3- AE activity, similar to PP1 inhibition. A possible 
explanation could involve CK2 phosphorylation of PP1, which would help 
maintain the resting activity of the basolateral anion exchanger, while blocking 
the apical AE activity, under resting conditions. A recent study demonstrated 
that regulation of K+-channel activity by CK2-mediated phosphorylation of CaM 
in HEK293A cells, depends on the binding of CK2 and PP1 to the K+ channels 
(Kang et al., 2014). In accordance with this, my results showed that inhibition of 
CK2, CaM and PP1 all significantly reduced the resting activity of the 
basolateral Cl-/HCO3- AE; therefore, regulation of the basolateral Cl-/HCO3- AE 
activity via CK2-mediated phosphorylation of CaM might need a physical 
interaction between CK2 and PP1 and the basolateral Cl-/HCO3- AE in Calu-3 
cells. Taken together, this suggests that under normal condition CK2 mediated 
phosphorylation of PP1 is potentially responsible for keeping the basolateral Cl-
/HCO3- AE active under resting condition, while inhibiting apical AE activity in 
Calu-3 cells. Future experiments could involve measuring basolateral Cl-/HCO3- 
AE activity in Calu-3 cells treated with CaM and PP1 inhibitors simultaneously, 
to test whether CaM is involved in the potential CK2-mediated phosphorylation 
of PP1. It could also look at binding of CK2/PP1 to AE2 by co-
immunoprecipitation. 
 
 
The key findings of this chapter are summarized below (see Figure 4.38):  
 
• DIDS inhibits the basolateral Cl-/HCO3- AE activity with an IC50 of 17µM, 
which is consistent with SLC4A2 underlying this anion exchange activity. 
• Intracellular elevation of cAMP is responsible for abolishing the basolateral Cl-
/HCO3- AE activity in Calu-3 cells through a mechanism that is independent of 
direct downstream targets of cAMP. 
• Changes in the levels of [cGMP] not involved in the regulation of the basolateral 
Cl-/HCO3- AE activity. 
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• Inhibition of Epac protein markedly decreased the resting activity of the 
basolateral Cl-/HCO3- AE in Calu-3 cells. 
• Decreasing intracellular Ca2+ concentration by BAPTA-AM loading, 
significantly reduced the basolateral Cl-/HCO3- AE activity, which was 
dependent on CaM, but independent of several CaMKs.  
• Acute increase in [Ca2+]i did not affect the basolateral Cl-/HCO3- AE activity. 
• An intact actin cytoskeleton and active dynamin are essential in maintaining the 
activity of the basolateral Cl-/HCO3- AE in Calu-3 cells. 
• I have identified a novel role for CK2 in regulating the basolateral Cl-/HCO3- AE 
activity in Calu-3 cells, potentially through a CaM and PP1-dependent 
mechanism. 
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Figure 4. 38: Diagram to show which signaling pathway regulate the basolateral 
AE activity under resting and stimulated conditions in Calu-3 cells. Under resting 
conditions: CK2 showed a novel role in the regulation of the basolateral AE activity 
potentially through a CaM and PP1 dependent mechanism. Decreasing [Ca2+]i also 
significantly reduced the basolateral AE activity but through CaMK independent 
mechanisms. Under cAMP stimulated conditions; increasing [cAMP]i by adenylyl 
cyclase (tmAC) activators, forskolin or adenosine, and the membrane permeable cAMP 
analogue, dibutyryl cAMP or the phosphodiesterase inhibitor, IBMX, significantly 
inhibited basolateral AE activity, but this did not involve  several well-known 
downstream targets of cAMP. Chelation of intracellular Ca2+ by BAPTA-AM, or 
elevation of [Ca2+]i by thapsigargin had no effect on basolateral AE activity. Blocking 
CK2 and CaMK failed to overcome the cAMP-induced inhibition of the basolateral AE 
activity. (-) denotes inhibition, (+) denotes stimulation, and (X) denotes not contribute. 
cAMP Stimulated: 
Lumen 
Blood 
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Chapter 5 Regulation of heterologously expressed mouse AE2 in 
transiently transfected HEK-293T cells 
5.1  Introduction 
 
My results described in Chapter 4 showed for the first time that the activity of 
the basolateral anion exchanger in polarised cultures of Calu-3 cells was 
regulated by a number of intracellular messengers and signalling pathways, 
including cAMP/PKA/Epac, resting calcium concentration and calmodulin, as 
well as via a novel CK2-dependent pathway. I also showed that CFTR appeared 
to be involved in regulating AE activity, consistent with previous results from 
our lab (Garnett et al., 2011). Although at this stage I cannot be certain about the 
molecular identity of the basolateral AE activity in Calu-3 cells, my own results, 
and those of others (Loffing et al., 2000; Al-Bazzaz et al., 2001; Romero et al., 
2004; Garnett et al., 2011; Huang et al., 2012; Shan et al., 2012; Garnett et al., 
2013; Kim et al., 2014) provide strong support that the anion exchanger is AE2 
(SLC4A2). In order to provide further evidence that these various signaling 
pathways were capable of regulating AE2 activity, I have transiently transfected 
Human Embryonic Kidney-293T cells (HEK293T) cells with cDNA for mouse 
AE2 (mAE2; slc4A2) and studied the effect of altering the same signaling 
messengers/pathways on mAE2 mediated anion transport. I have also 
investigated the potential role of CFTR in regulating anion exchange activity by 
cotransfecting HEK-293T cells with mAE2 and human CFTR. I used mouse 
AE2, rather than human AE2, for these studies as I was not able to obtain full-
length human AE2. Nonetheless, based on the amino acid sequence of mAE2, 
this protein shows a great deal of sequence homology to human AE2, and in 
particular contains many potential CK2 phosphorylation sites similar to human 
AE2 (see appendix). The HEK-293 cell line has been commonly used to 
overexpress many different types of proteins to study their function and 
molecular regulation (Domingue et al., 2014). HEK-293 cells have a wide range 
of advantages, such as high transfection yields and adaptation to growth in 
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serum-free media and suspension culture (Graham, 1987; Garnier et al., 1994). 
The HEK-293T cells are derived from the HEK-293 parent (Kim et al., 1997) 
and have been extensively used   in electrophysiological studies of 
heterologously expressed  ion channels (Senatore et al., 2011). Heterologous 
transfection and expression of cDNA in cells, over a short period of time, is 
known as “transient expression” (Kaufman, 1997), which can be detected for 1-4 
days after transfection. (Colosimo et al., 2000). This transient expression system 
has also been used  to study the function of anion exchangers (AEs)  (Lee et al., 
1991). It has been reported that HEK293 cells have a low level of endogenous 
Cl-/HCO3- AE activity (Sterling et al., 2002). Immunofluorescence and pulse-
chase labelling experiments demonstrated that transient expression of murine 
AE2 can be detected both at the cell surface and in intracellular compartments, 
potentially the ER, of transfected HEK cells (Ruetz et al., 1993). Here, they also 
found that transient expression of murine AE2 in HEK cells, functions as a 
plasma membrane anion exchanger, by producing a significant increase in Cl--
driven SO4- efflux, which was inhibited by 200µM DIDS. Moreover, it has been 
shown that transient transfection of rat AE2 showed a high level of expression 
and Cl-/HCO3- transport activity, in HEK-293 cells, which was also inhibited by 
DIDS, with an IC50 of 142µM (Fujinaga et al., 2003). Domingo et al., (2014) 
used HEK-293 cells as a useful model to overexpress CFTR, to study the 
signaling pathway that regulate CFTR activity, as HEK-293 cells neither express 
CFTR mRNA nor protein (Domingue et al., 2014). Therefore, in this chapter I 
have further investigated the role of cAMP, cytosolic calcium, CFTR and CK2 
in the regulation of mouse AE2 (mAE2) activity, which was studied after being 
transiently transfected into HEK-293T cells. 
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5.2  Properties of mAE2 expressed in HEK-293T cells 
 
To characterise the biophysical properties of mAE2, I have performed a series of 
experiments in HEK-293T cells transiently transfected with mAE2 cDNA, and 
compared the results to control, non-transfected, HEK293T cells. pHi 
measurement in control cells showed that these cells possessed an endogenous 
Cl-/HCO3- exchange activity based on the results from the standard Cl- 
removal/readdition protocol employed in chapters 3 and 4. However, my results 
showed that Cl-/HCO3- exchange activity was significantly increased in mAE2 
transfected HEK-293T cells after two days of transfection, both in the 
magnitude of alkalinisation in response to Cl- free solution (0.68±0.02, n=10, 
compared to control cells, 0.42±0.02, n=10, P<0.05), and the rate of 
reacidification upon Cl- readdition (0.56±0.06, n=10, compared to control cells, 
0.24±0.02, n=10, P<0.05). Also, I performed immunocytochemistry on HEK-
293T transfected with HA-tagged mAE2 to confirm the successful transfection 
and expression of mAE2 in these cells. mAE2 expression was detected using an 
anti-HA antibody that was FITC-conjugated, and therefore produces a green 
colour when  visualized by confocal microscopy. Results showed that mAE2 
transfected cells exhibit  strong green fluorescence, both at the plasma 
membrane and within the cells (Figure 5.1A and B), compared to control non-
transfected cells (Figure 5.1D). Moreover, I further investigated  mAE2 
localization in transfected cells by staining the plasma membrane with wheat 
germ agglutinin (WGA), a red plasma membrane marker (Yacoub et al., 2006). 
mAE2 was shown to be highly expressed in the  plasma membrane as indicated 
by the yellow colour around the cells produced from the combination of green 
mAE2 protein and red WGA (Figure 5.1C).  
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Figure 5. 1: Expression and localisation of mAE2 in transiently transfected HEK- 
293T cells. HEK293T cells were transfected with HA-tagged mAE2 cDNA and 
studied two days post-transfection. (A) and (B) show confocal images where mAE2 
was labelled with FITC-conjugated fluorophore (green). Significant intracellular as well 
as plasma membrane staining was observed. (C) Confocal localization of mAE2 in 
transfected HEK-293T cells, stained with the red plasma membrane marker, WGA. 
Plasma membrane localisation of mAE2 was confirmed by yellow staining, (D) control 
non-transfected cells stained with HA primary antibody and FITC-conjugated 
fluorophore. Images are representative of 3 independent experiments for mAE2 
transfected cells, 2 for control, non-transfected cells. DAPI (4',6-diamidino-2-
phenylindole) was used for staining nucleus (blue color).   
 
 
I then investigated the DIDS-sensitivity of the endogenous AE activity and 
compared this to mAE2 transfected cells. In order to test the effect of DIDS on 
the endogenous Cl-/HCO3- exchange activity in non-transfected HEK-293T 
cells, I measured the pHi response of the HEK293T cells to a Cl- free solution, 
in the presence of 25μM DIDS, and compared this to mAE2 transfected HEK-
293T cells. My results showed that perfusion of a Cl- free solution, containing 
25μM DIDS, produced almost complete inhibition of the endogenous Cl-/HCO3- 
AE activity (Figure 5.2A), with a significant decrease in both the magnitude of 
alkalinisation in response to Cl- free solution, and the rate of reacidification after 
Cl- readdition (Figure 5.2C and D). However, 25μM DIDS did not affect the 
magnitude of alkalinisation following Cl- removal in mAE2 transfected HEK 
cells (Figure 5.2B and C), but did significantly reduce the rate of reacidification 
upon Cl readdition (Figure 5.2D).  Therefore, I  measured mAE2 activity in 
transfected HEK-293T cells in the presence of 25μM DIDS in order to remove 
most of the contribution of the endogenous Cl-/HCO3- exchange activity, so that 
the resulting pHi changes were mainly due to the heterologously expressed  
mAE2 activity. 
A 
100µM 
B 
100µM 
C 
100µM 
D 
100µM 
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Figure 5. 2: Effect of 25μM DIDS on the Cl-/HCO3- AE activity in control and 
mAE2 transfected HEK-293T cells. (A) and (B) show representative pHi traces which 
show that 25µM DIDS significantly reduced mAE2 activity in transfected HEK-293T 
cells compared to control, non-transfected, HEK-293T cells, respectively. Summary 
data showing the effect of 25μM DIDS on mean alkalinisation in pHi in response to Cl- 
free solution (C) and the rate of reacidification upon Cl- readdition (D) in control and 
mAE2 transfected HEK-293T cells. Data are shown as Mean±SEM. C: *P<0.01, 
#P<0.001 compared to control. D: *P<0.001 compared to control, n=4 for control, and 
n=3 for +mAE2. Control experiments run in parallel. 
 
 
My previous results showed that 100µM DIDS significantly reduced the 
basolateral AE activity in Calu-3 cells (see chapter 4, section 4.02). To further 
investigate the functional properties of mAE2 activity in transfected HEK-293T 
cells, I performed another set of experiments where different concentrations of 
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DIDS (25μM and 200μM DIDS) were present in the standard Cl- free solution 
(Figure 5.3A). Results showed that 25μM did not affect the magnitude of 
alkalinisation produced by mAE2 activity in transfected cells, but did 
significantly reduce the rate of reacidification upon Cl- readdition (Figure 5.3A 
and B). However, the higher concentration of DIDS, 200μM, caused a 
significant decrease in mAE2 activity, both in the mean change in pHi in 
response to Cl- free solution, and the rate of reacidification following Cl- 
readdition, compared to the control responses (Figure 5.3A and B). In another 
set of experiments, 100µM DIDS caused a marked reduction in mAE2 activity, 
both in the magnitude of alkalinisation in response to Cl- free solution, and the 
rate of reacidification upon Cl- readdition, while 50µM DIDs only significantly 
decreased the rate of reacidification in mAE2 transfected HEK cells (Figure 
5.4A and B). Consistent with this, it has been shown that 200µM DIDS 
significantly inhibited mAE2 in transfected HEK-293 cells (Ruetz et al., 1993). 
The effect of different concentrations of DIDS is summarized in figure 5.4A and 
B.  
   A                                                                                  B                               C 
 
 
 
 
              
 
Figure 5. 3: Impact of DIDS on the mAE2 activity in transfected HEK-293T cell.  
(A) Representative pHi trace showing that 25μM DIDS had no effect on the mean 
alkalinisation in pHi in response to Cl- free solution  but did inhibit rate of 
reacidification upon Cl- readdition , while 200μM DIDS significantly reduced both 
parameters in transfected HEK293T cells, compared to the response in the absence of 
DIDS. (B) Summary of the effect 25μM and 200 μM DIDS on mean alkalinisation in 
pHi in response to Cl- free solution and (C), the rate of reacidification upon Cl- 
readdition. Data are shown as Mean±SEM. B: *P<0.001 compared to DIDS 25μM and 
0Cl-. C: *P<0.001 compared to DIDS 25μM and P<0.001 compared 0Cl-, #P<0.01 
compared to 0Cl-, n=3 for each condition, paired observations. 
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Figure 5. 4: Effect of different concentrations of DIDS on mAE2 activity in 
transfected HEK-293T cells. Summary of mean change in pHi (alkalinisation) caused 
by Cl- removal (A) and rate of reacidification after Cl- readdition (B), produced by 
transfected mAE2 activity in HEK-293T cells in response to different concentration of 
DIDS, when normalized to the control response in the absence of DIDS. Data are 
shown as Mean±SEM.*P<0.001 compared to control, #P<0.05 compared to 50µM, and 
#P<0.001 compared to 100µM and 200µM DIDS, n=6 for 0Cl and 25μM DIDS; n=3 for 
50μM, 100μM, and 200μM DIDS.  
 
 
 
5.3  Effect of cAMP agonist, Fsk, on mAE2 activity in transfected HEK-293T cells 
My previous experiments in Calu-3 cells showed that the basolateral Cl-/HCO3- 
AE activity was almost completely inhibited following an intracellular increase 
of cAMP. In contrast to Calu-3 cells, the cAMP agonist, Fsk, did not affect 
mAE2 activity (Figure 5.5D-F). Interestingly, elevation of intracellular cAMP 
also did not affect the endogenous Cl-/HCO3- activity in control cells, both in the 
magnitude of alkalinisation, and the rate of reacidification (Figure 5.5A-C).  
 
 
 
 
 
 
180 
 
6.8
7.0
7.2
7.4
7.6
7.8
8.0
8.2
8.4
8.6
240s
0Cl- 0Cl-
KREBS/HCO3-+FskKREBS/HCO3-
pH
i
-
0C
l
+Fs
k
0.0
0.1
0.2
0.3
0.4
0.5
M
ea
n 
ch
an
ge
 in
 p
H
i
-
0C
l
+Fs
k
0.0
0.1
0.2
0.3
R
at
e 
of
 r
ea
ci
di
fic
at
io
n 
(p
H
i m
in
-1
)
-
0C
l
+Fs
k
0.0
0.2
0.4
0.6
0.8
M
ea
n 
ch
an
ge
 in
 p
H
i
6.8
7.0
7.2
7.4
7.6
7.8
8.0
8.2
8.4
8.6
KREBS/HCO3- KREBS/HCO3-+Fsk
 0Cl- 0Cl-
240s
pH
i
-
0C
l
+Fs
k
0.0
0.1
0.2
0.3
0.4
0.5
0.6
R
at
e 
of
 r
ea
ci
di
fic
at
io
n 
(p
H
i m
in
-1
)
 A                                                                             B                                C 
 
 
 
    
    
 
 
 D                                                                           E                                  F 
 
 
 
 
 
 
Figure 5. 5: Impact of cAMP on endogenous Cl-/HCO3- anion exchange activity in 
non-transfected HEK-293T cell and mAE2 activity in transfected cells. 
Representative pHi  traces showing that an increase in intracellular cAMP, using 5µM 
Fsk, did not affect the endogenous Cl-/HCO3- AE activity in non-transfected cells (A), 
or mAE2 activity in transfected HEK-293T cells (D). Summary of the effect of Fsk 
(5μM) on mean alkalinisation in response to Cl- free solutions (B), and the rate of 
reacidification following Cl- readdition (C) in non-transfected HEK-293T cells. No 
significant difference (P>0.05), n=7 for each condition, paired observations. Effect 
ofFsk (5μM) on mean alkalinisation in response to Cl- free solution (E), and the rate of 
reacidification following Cl- readdition (F) in mAE2 transfected HEK-293T cells. Data 
are shown as Mean±SEM. No significant difference (P>0.05), n=6 for each condition, 
paired observations.  
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In another set of experiments, the effect of Fsk on mAE2 activity was assessed 
in the presence of 25µM DIDS in the Cl- free solution in order to remove the 
contribution of the endogenous Cl-/HCO3- AE activity to the pHi responses in 
transfected HEK-293T cells (Figure 5.6A). Results also showed that Fsk 
stimulation did not affect mAE2 activity, as both the mean alkalinisation in 
response to a Cl- free solution, and the rate of reacidification upon Cl- readdition, 
were not different to the control response (Figure 5.6B and C), even where the 
endogenous Cl-/HCO3- AE activity had been removed by DIDS. One possible 
explanation for the apparent lack of effect of cAMP on AE2 activity could be 
the absence of CFTR in these cells and/or difference between mAE2 and human 
AE2 sensitivity to cAMP/Fsk. I therefore next investigated the effect of co-
expressing CFTR and mAE2 on the response of mAE2 to cAMP stimulation. 
 
  A                                                                        B                                  C 
 
 
 
        
 
 
Figure 5. 6: Forskolin did not affect mAE2 activity in transfected HEK-293T cells.  
(A) Representative pHi trace showing that increasing [cAMP]i did not affect mAE2 
activity in the presence 25μM DIDS, compared to the control response. Summary data 
showing the effect of increasing intracellular cAMP, using 5μM Fsk, on mAE2 activity 
in transfected HEK-293T cells on mean alkalinisation in response to Cl- free solution 
(B), and the rate of reacidification upon Cl- readdition (C). Data are shown as 
Mean±SEM. P>0.05 no significant difference compared to control, n=3 for 0Cl-+DIDS, 
and n=4 for +DIDS+Fsk. 
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5.4  Role of CFTR in the regulation of mAE2 activity in transfected HEK-293T cells 
  
My results in Chapter 4 showed that a rise in cAMP led to a marked inhibition in 
the activity of the basolateral anion exchanger. Previous results from our lab 
found that the inhibition of the basolateral exchanger appeared to be dependent 
on the expression of CFTR, since the degree of inhibition by cAMP was 
significantly reduced in CFTR-KD Calu-3 cells (Garnett et al., 2013). However, 
it should be noted that a recent study by Kim et al., (2014), found no evidence 
that an increase in cAMP led to the inhibition of the basolateral anion exchanger 
in polarised cultures of Calu-3 cells (Kim et al., 2014). Indeed these authors 
found that when CFTR was activated by cAMP, HCO3- transport via apical-
located CFTR obscured the activity of the basolateral anion exchanger, when 
assessed by pHi measurements using the Cl- removal/readdition method. In order 
to further investigate the potential regulatory effect of CFTR on AE2 activity, I 
have measured mAE2 activity in HEK293T cells after co-expression of CFTR. 
However, I first needed to determine whether CFTR itself contributed to Cl--
coupled HCO3- transport in HEK293T cells, when assessed using the standard 
Cl- removal/readdition technique. 
 
Results summarised in Figure 5.7 show that expression of CFTR in HEK-293T 
cells produced a significant increase in the mean pHi alkalinisation in response 
to a Cl- free solution, compared to non-transfected cells. Although the mean rate 
of reacidification also increased following Cl- readdition in CFTR transfected 
cells, it was not significantly different compared to non-transfected cells (Figure 
5.7A and B). This suggests that CFTR may be involved in Cl--coupled HCO3- 
transport in transfected HEK293T cells. However, in order to further investigate 
this possibility, HEK-293T cells transfected with CFTR were studied in the 
presence of 25µM DIDS to remove the contribution from the endogenous Cl-
/HCO3- AE, as well as in the presence of a CFTR blocker (Figure 5.8A). 
Interestingly, results showed that there was an increase in mean intracellular pH 
upon cell perfusion with a Cl- free solution, in the presence of 25µM DIDS, 
which was significantly reduced by the specific CFTR inhibitor, CFTRinh-172 
(Figure 5.8B). The rate of reacidification in CFTR transfected cells was almost 
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completely inhibited by CFTRinh-172, but it was not significantly different 
compared to the rate in the presence of DIDS alone (Figure 5.8C). Nonetheless, 
these results indicate that (i) CFTR is active under basal conditions and (ii) 
contributes to Cl--coupled HCO3- transport in HEK293T cells. The fact that 
CFTR was active in the absence of a cAMP agonist suggests that HEK-293T 
cells have enough intracellular cAMP under resting conditions to activate 
CFTR, although the reason for this is unknown. An alternative explanation is 
that expression of CFTR (rather than activity) led to the activation of another Cl- 
dependent HCO3- transporter in HEK293T cells which was also blocked by the 
CFTR inhibitor.    
 
 
 
               A                                              B                                                            
 
 
 
 
 
 
 
 
 
 
Figure 5. 7: Role of CFTR in HCO3- transport in HEK-293T cells transfected with 
CFTR, compared to control cells. Summary data shows the effect of expression 
CFTR on Cl--coupled HCO3- transport in CFTR transfected HEK-293T cells, compared 
to untransfected cells. (A) Mean change in pHi in response to a Cl- free solution, and 
(B) the rate of reacidification following Cl- readdition (B). *P<0.05 compared to control, 
n=5 for control, and n=8 for +CFTR.   
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Figure 5. 8: Effect of CFTR expression 0Cl--coupled HCO3- transport in HEK-
293T cells transfected with CFTR under resting conditions. (A) Representative pHi 
trace showing CFTR-dependent HCO3- transports in CFTR transfected HEK-293T 
cells, in the presence of 25μM DIDS. Note that CFTR-dependent Cl--coupled HCO3- 
transport was almost completely inhibited by CFTRinh-172. Summary data showing the 
mean alkalinisation in pHi in response to Cl- free solution (B), and the rate of 
reacidification upon Cl- readdition (C) in CFTR transfected HEK293T cells. Data are 
shown as Mean±SEM. #P<0.001, †P<0.05 compared to 0Cl-, *P<0.001 compared to 
DIDS, n=3 for each condition, Paired observations.  
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It has been found that heterologous CFTR expression in HEK-293 cells, 
significantly increased intracellular pH after stimulation with Fsk in Cl- free 
solutions (Ko et al., 2002). To investigate if cAMP stimulation also affected Cl--
coupled HCO3- transport by CFTR in HEK293T cells, I studied the response of 
the CFTR-transfected cells before and after stimulation with Fsk, in the presence 
of 25µM DIDS (Figure 5.9).  Overall, a comparison of the data in Figures 5.08 
and 5.09 showed that there was no significant difference in mean pHi change in 
CFTR transfected HEK-293T cells under Fsk stimulation compared to 
unstimulated cells, both in the magnitude of alkalinisation (0.25±0.01, n=5, 
compared to the unstimulated response of 0.25±0.00, n=3, P>0.05), nor in the 
rate of reacidification (0.10±0.01, n=5, compared to the unstimulated response 
of 0.12±0.02, n=3, P>0.05). The most likely explanation for the lack of effect of 
cAMP stimulation would be that the transfected HEK-293T cells have enough 
endogenous cAMP to fully activate CFTR, which is in contrast to the results 
obtained by Ko et al., (2002).   
 
       
 
 
           A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
186 
 
-
0C
l
+D
IDS
+Fs
k
DID
S+
Fsk
+G
lyH
-10
1
0.0
0.1
0.2
0.3
0.4
0.5
#
R
at
e 
of
 r
ea
ci
di
fic
at
io
n 
(p
H
i m
in
-1
)
-
0C
l
+D
IDS
+Fs
k
DID
S+
Fsk
+G
lyH
-10
1
0.0
0.1
0.2
0.3
0.4
0.5
0.6
*
#
M
ea
n 
ch
an
ge
 in
 p
H
i
                   B                                                   C                                     
 
 
 
 
 
 
 
 
 
 
Figure 5. 9: Effect of CFTR expression on Cl--coupled HCO3- transport in HEK-
293T cells transfected with CFTR under Fsk stimulated conditions. (A) 
Representative pHi trace showing the effect of   Fsk (5µM) stimulation on HCO3- 
transport in CFTR transfected HEK-293T cells in the presence of 25μM DIDS. CFTR 
activity was nearly completely inhibited by the CFTR inhibitor, GlyH-101. Summary 
data showing the mean alkalinisation in pHi in response to Cl- free solution (B), and the 
rate of reacidification following Cl- readdition (C). GlyH-101 significantly reduced 
HCO3- transport, under Fsk stimulated condition. Data are shown as 
Mean±SEM.*P<0.05 compared to control, n=5 for each condition, Paired observations. 
 
 
 
5.5  Role of CFTR in the regulation of mAE2 activity 
 
5.5.1 Under cAMP stimulated conditions 
Although mAE2 activity in transfected HEK-293T cells was not inhibited by 
Fsk in the presence of 25μM DIDS (Figure 5.6), it was unknown whether the 
presence of CFTR would alter the response of mAE2 to cAMP stimulation. 
Therefore, HEK-293T cells were co-transfected with CFTR and mAE2, and then 
perfused with a Cl- free solution in the presence of 25µM DIDS and 5µM Fsk 
(Figure 5.10A). Results showed that exposure to Fsk significantly reduced the 
mean change in pHi in response to a 0Cl- solution, in the presence of 25µM 
DIDS, although the rate of reacidification was not changed, compared to the 
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control response (Figure 5.10B and C), suggesting that cAMP induced inhibition 
of mAE2 requires the presence of CFTR. This result is consistent with the recent 
finding in our laboratory which showed that intracellular elevation of cAMP, 
using Fsk, did not abolish the basolateral AE activity in CFTR KD Calu-3 cells, 
compared to WT Calu-3 cells (Garnett et al., 2013). Results also showed that the 
mean alkalinisation under Fsk stimulated conditions was significantly reduced 
by the CFTR inhibitor GlyH-101, which indicates that CFTR and mAE2 
contribute equally to HCO3- transport in co-transfected HEK-293T cells (Figure 
5.10B and C). 
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Figure 5. 10: Role of CFTR in the regulation of mAE2 activity in HEK-293T cells 
co-transfected with CFTR and mAE2. (A) Representative pHi trace showing the 
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effect of Fsk in HEK-293T cells co-transfected with CFTR and mAE2, in the presence 
of 25μM DIDS. Summary data shows although Fsk significantly reduced mAE2 
activity, as measured by the mean pHi change induced by zero Cl- (B), it did not affect 
rate of reacidification (C). The CFTR inhibitor GlyH-101, significantly reduced the 
mean alkalinisation in pHi under cAMP stimulated conditions in co-transfected cells 
(B), although the rate of reacidification did not change (C). Data are shown as 
Mean±SEM. B: *P<0.05 compared to DIDS and #P<0.001 compared to +DIDS +FSK. 
C: no significant difference (P>0.05), n=3 for mAE2 0Cl- and +DIDS, and n=6 for other 
conditions.  
 
 
In addition, HEK-293T cells co-transfected with CFTR and mAE2 showed a 
significant increase in the magnitude of the alkalisation in response to a Cl- free 
solution, and the rate of reacidification upon Cl- readdition, compared to  HEK-
293T cells transfected with CFTR only (Figure 5.11A and B), but less activity 
compared to mAE2 only transfected cells. This further supports the idea that 
CFTR expression/activity down regulates mAE2 activity in HEK293T, and 
possibly Calu-3 cells. 
 
  
          A                                                              B 
 
 
 
 
 
 
Figure 5. 11: Role of CFTR in HCO3- transport in transfected HEK-293T cells. 
HEK293T cells co-transfected with CFTR and mAE2 caused a significant increase in 
the mean pHi change in response to Cl- free solution (A), and the rate of reacidification 
upon Cl readdition (B), compared to CFTR-only transfected cells, under Fsk 
stimulation. Data are shown as Mean±SEM. A: *P<0.01 compared to (AE2), #P<0.001 
compared to (AE2+CFTR), †P<0.01compared to (CFTR). B: #P<0.01 compared to 
(AE2+CFTR), n=4 for (AE2), n=6 for (CFTR) and (CFTR+AE2), and n=5 for (CFTR) 
+GlyH-101. 
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In order to investigate whether the CFTR inhibitors, GlyH-101 and CFTRinh-
172, could potentially affect mAE2 in the absence of CFTR, mAE2 activity was 
measured in response to a Cl- free solution, in the presence of 25µM DIDS, 
under cAMP stimulated conditions (Figure 5.12A). Results showed that both 
CFTR inhibitors had no effect on mAE2 activity, (Figure 5.12B and C). This is 
consistent with my previous results in Calu-3 cells where I showed that GlyH-
101 did not affect the basolateral AE activity.  
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Figure 5. 12: CFTR inhibitors, GlyH-101 and CFTRinh-172, did not affect mAE2 
activity in transfected HEK-293T cells. (A) Representative pHi trace showing that the 
CFTR had no effect on mAE2 activity when expressed in in transfected HEK-293T 
cells, in the presence of 25μM DIDS. Summary of the effect of both CFTR inhibitors, 
GlyH-101 and CFTRinh-172, on mean alkalinisation in pHi in response to Cl- free 
solution (B) and the rate of reacidification upon Cl- readdition (C), compared to control 
response. Data are shown as Mean±SEM. No significant difference (P>0.05) compared 
to control, n=3 for 0Cl-, n=5 for +DIDS+Fsk (control), and n=5 for CFTR inhibitor 
treated cells. 
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5.6  Role of Exchange protein directly activated by cAMP (Epac) in the regulation of 
mAE2 activity 
 
I have shown in Chapter 4 (section 4.5.2) that Epac inhibition caused a 
significant decrease in basolateral AE activity in Calu-3 cells. To further clarify 
the role of Epac in the regulation of mouse anion exchange activity, mAE2 
transfected cells were preincubated with the specific Epac inhibitor, ESI-09, 
(Almahariq et al., 2013) for 60 mins.  mAE2 activity was then measured under 
resting conditions in the presence of 25µM DIDS, (Figure 5.13B) and compared 
to untreated mAE2 transfected cells (Figure 5.13A). Results showed that Epac 
inhibition caused a marked reduction in the rate of reacidification, compared to 
untreated cells (Figure 5.13D). Although the mean alkalinisation was decreased, 
it was not significantly different to control cells (Figure 5.13C). The percent 
inhibition of AE2 activity by Epac inhibition in HEK-293T cells was 
significantly lower than the percent inhibition of AE2 in Calu-3 cells (Table 
5.01). This suggests that Epac plays an important role in the regulation of AE2 
activity under resting conditions similar to results obtained in Calu-3 cells.   
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Figure 5. 13: Epac inhibitor, ESI-09, reduced mAE2 activity in transfected HEK-
293T cells. Representative pHi traces showing the effect of ESI-09 (10µM, 
preincubated for 60 min) on mAE2 activity in transfected HEK-293T cells (B) 
compared to untreated mAE2 transfected cells (A), in the presence of 25μM DIDS. 
Summary of the effect of preincubation of cells with 10µM ESI-09 for 60 min, on mean 
alkalinisation in pHi (C) and the rate of reacidification upon Cl- readdition (D). Data are 
shown as Mean±SEM.*P<0.05 compared to +DIDS, n=5 for each condition. 
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 It has been shown that Epac plays an important role in the regulation of CFTR  
(Kazi Mirajul Hoque, 2009), and I demonstrated that Epac was required for 
maintaining the resting  activity of mAE2 in Calu-3 cells (Chapter 4).  I 
therefore investigated if CFTR expression could modulate the regulation of 
mAE2 by Epac. Here, HEK-293T cells were co-transfected with CFTR and 
mAE2, and preincubated with  ESI-09 for 60 min. Cells were then perfused with 
a Cl- free solution in the presence of 25µM DIDS (Figure 5.14B), and results 
compared to control cells co-transfected with mAE2 and CFTR (Figure 5.14A). 
Surprisingly, my results showed that in co-transfected cells the Epac inhibitor 
did not affect either the mean pHi change in response to 0Cl- or the rate of 
reacidification upon Cl- readdition (Figure 5.14C & D). The results in Figures 
5.13 and 5.14 therefore suggest that the presence of CFTR appears to prevent the 
Epac inhibitor from reducing mAE2 activity or alternatively that the Epac might 
not be involved in the regulation of CFTR under basal conditions.  
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Figure 5. 14: Epac inhibitor, ESI-09, did not affect mAE2 activity in HEK-293T 
cells co-transfected with mAE2 and CFTR. Representative pHi traces in which the 
effect of Epac inhibitor  ESI-09 (10µM, 60min preincubation) was assessed in HEK-
293T cells co-transfected with CFTR and mAE2  (B), compared to control (untreated) 
HEK-293T cells co-transfected with CFTR and mAE2 (B). Summary of the effect of 
preincubation of cells with 10µM ESI-09  on mean alkalinisation in pHi (C), and the 
rate of reacidification upon Cl- readdition (D), in ESI-09 treated and non-treated HEK-
293T cells co-transfected with CFTR and mAE2. Data are shown as 
Mean±SEM.*P<0.05 compared to +DIDS, n=3 for control +DIDS, and n=4 for 
+DIDS+ESI-09 treated cells.  
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5.7  Role of intracellular Ca2+ in the regulation of mAE2 activity 
My previous results in Calu-3 cells showed that a decrease in [Ca2+]i markedly 
reduced the basolateral Cl-/HCO3- AE activity under resting conditions (see 
chapter 4, section 4.6.1.2). To further investigate the role of intracellular Ca2+ in 
the regulation of Cl-/HCO3- AE activity,  mAE2 transfected HEK-293T cells 
were preincubated with 50µM BAPTA-AM for 60 min (Figure 5.15B), and then 
mAE2 activity was measured in the presence of 25μM DIDS, and compared to 
untreated mAE2 transfected cells (Figure 5.15A). BAPTA-AM preincubation 
caused a significant decrease in mAE2 activity, both in the magnitude of 
alkalinisation in response to Cl- free solution, and the rate of reacidification upon 
Cl- readdition, compared to the control (non-BAPTA-AM treated cells) response 
(Figure 5.15C and D). The BAPTA-AM induced inhibition of the magnitude of 
alkalinisation was significantly lower in mAE2 transfected HEK-293T cells, 
compared to the inhibition in Calu-3 cells. However, the BAPTA-AM induced 
inhibition of the rate of reacidification was not significantly different in HEK-
293T compared to Calu-3 cells (Table 5.01). This further supports the results 
from Chapter 4 that intracellular Ca2+ concentration plays a significant role in 
maintaining AE2 active under resting conditions.  
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Figure 5. 15: BAPTA-AM reduced mAE2 activity in transfected HEK-293T cells. 
Representative pHi traces showing the effect of Ca2+ chelator BAPTA-AM, (50µM, 
preincubated for 60 min) on mAE2 activity in transfected HEK-293T cells (B) 
compared to untreated mAE2 transfected cells (A), in the presence of 25μM DIDS. 
Summary of the effect of BAPTA-AM (50µM) preincubation for 60 min, in mAE2 
transfected HEK-293T cells, on both the mean pHi change in response to Cl- removal 
(C), and the rate of reacidification upon Cl- readdition (D). Data are shown as 
Mean±SEM. *P<0.05 compared to control, n=7 for AE2+DID, and n=4 for 
+DIDS+BAPTA-AM. 
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5.8  Role of CaM in the regulation of mAE2 activity 
 
As described in my previous results in chapter 4, CaM inhibition by 50µM J-8 
produced a significant decrease in the basolateral Cl-/HCO3- AE activity in Calu-
3 cells. The mean alkalinisation in response to Cl- removal was reduced by 
50±6.9% and the rate of reacidification by 59.3±16.6% (see table 5.01). To 
further investigate the role of CaM in the regulation of anion exchange  activity, 
mAE2 transfected cells were preincubated with 50µM J-8 for 60 min, and then 
mAE2 activity measured in Cl- free solutions in the presence of 25µM DIDS 
(Figure 5.16A), compared to control untreated mAE2-transfecterd cells (Figure 
5.16B). Results showed that CaM inhibition caused a significant decrease in 
mAE2 activity, both in the mean pHi change (56±7% decrease) in response to a 
Cl- free solution, and the rate of reacidification, which declined by 70.8±8.8%, 
upon Cl- readdition, compared to untreated mAE2 transfected cells (Figure 
5.16C and D). The J-8 induced  inhibition of mAE2 activity was not 
significantly different compared to the J-8 induced inhibition of the basolateral 
AE activity in Calu-3 cells, with respect to the mean alkalinisation in response to 
Cl- free solution and the rate of reacidification upon Cl- readdition (see Table 
5.01). This further supports a role for CaM in the regulation of AE activity under 
resting conditions, potentially through a Ca2+-dependent pathway.  
 
           A                                                                                     B  
 
 
 
 
 
 
197 
 
+D
IDS-
0C
l DID
S+
J-8
0.0
0.2
0.4
0.6
0.8
*
M
ea
n 
ch
an
ge
 in
 p
H
i
+D
IDS-
0C
l DID
S+
J-8
0.0
0.2
0.4
0.6
*
R
at
e 
of
 re
ac
id
ifi
ca
tio
n 
(p
H
i m
in
-1
)
           C                                                D                                                            
 
 
 
 
 
 
Figure 5. 16: CaM inhibitor, J-8, markedly reduced mAE2 activity in transfected 
HEK-293T cells.  Representative pHi traces showing the effect of J8 (50µM J-8 
preincubated for 60 min) on mAE2 activity in transfected HEK-293T cells (B) 
compared to untreated mAE2 transfected cells (A), in the presence of 25μM DIDS. 
Summary of the effect of J-8, on the mean change in pHi in response to Cl- free solution 
(C), and the rate of reacidification upon Cl- readdition (D). Data are shown as 
Mean±SEM.*P<0.05 compared to control, n=5 for control 0Cl-+DIDS, and n=4 for J-8 
treated cells. 
 
 
5.9  Role of protein phosphatase 1 (PP1/2A) in the regulation of mAE2 activity  
 
I have shown that inhibition of PP1/2A in Calu-3 cells with 100nM OA caused a 
significant decrease in basolateral AE activity. To further investigate the role of 
PP1/2A in the regulation of mAE2 activity, HEK-293T cells transfected with 
mAE2 were preincubated with 100nM OA for 60 min, and then perfused with a 
Cl- free solution in the presence of 25µM DIDS to measure mAE2 activity 
(Figure 5.17A), and compared to untreated cells (Figure 5.17B). Results showed 
that PP1/2A inhibition caused a significant decrease in the mean change in 
response to 0Cl-, although the rate of reacidification did not change, compared to 
untreated   cells (Figure 5.17C and D). However, the OA-induced inhibition of 
mAE2 activity in transfected HEK-293T cells was significantly different to the 
OA-induced inhibition of basolateral AE activity in Calu-3 cells, both in the 
magnitude of alkalinisation and the rate of reacidification (Table 5.01).  
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Figure 5. 17: PP1/2A inhibition reduced mAE2 activity in transfected HEK-293T 
cells. pHi traces in which the effect of PP1/2A inhibitor, OA (100nM, preincubation for 
60 min), was assessed in mAE2 transfected HEK-293T cells (B), compared to untreated 
mAE2 transfected HEK-293T cells (A). Summary of the effect of okadaic acid on the 
magnitude of alkalinisation in response to Cl- removal (C), and the rate of 
reacidification upon Cl- readdition (D). Data are shown as Mean±SEM.*P<0.05 
compared to 0Cl-+DIDS, n=5 for 0Cl-+DIDS, and n=4 for +DIDS+OA. 
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5.10  Role of CK2 in the regulation of mouse AE2 activity 
5.10.1  Effect of acute exposure to the CK2 inhibitor TBB on endogenous Cl-/HCO3- AE 
activity and mouse AE2 activity expressed in HEK 293T cells 
Since CK2 showed a novel role in the regulation of the basolateral AE activity 
in Calu-3 cells, the effect of CK2 inhibition was also tested on mAE2 activity in 
transfected HEK-293T cells. First, I investigated if CK2 inhibition had any 
effect on the endogenous Cl-/HCO3- exchanger. For these experiments, non-
transfected cells were acutely exposed to TBB and then endogenous Cl-/HCO3- 
AE activity measured in Cl- free solutions (Figure 5.18A). Results showed that 
CK2 inhibition caused almost complete loss of endogenous Cl-/HCO3- AE 
activity, both in the magnitude of alkalinisation in Cl- free solution, and the rate 
of reacidification upon Cl- readdition, compared to untreated cells (Figure 5.18B 
and C). This indicates that endogenous Cl-/HCO3- exchange activity was clearly 
CK2 dependent. Interestingly, and similar to Calu-3 cells, application of TBB 
caused an intracellular acidification  in non-transfected HEK-293T cells (Figure 
5.18A, red trace), which was not significantly different compared to the TBB-
induced acidification in mAE2 transfected cells, (see Fig. 5.19A) both in the 
magnitude of alkalinisation (control 0.60±0.06, n=3;  mAE2 
transfected,0.44±0.06, n=6, P>0.05), and the rate of reacidification (control, 
0.17±0.02, n=3;  mAE2 transfected, 0.12±0.01, n=6, P>0.05). 
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Figure 5. 18: Impact of the CK2 inhibitor, TBB, on endogenous Cl-/HCO3- anion 
exchange activity in non-transfected HEK-293T cells. (A) Representative pHi trace 
showing that acute TBB exposure (10μM) inhibited the endogenous Cl-/HCO3- AE 
activity in non-transfected HEK-293T cells. Summary of the effect of acute exposure to 
TBB on mean pHi change (alkalinisation) following Cl- removal (B), and the rate of 
reacidification upon Cl- readdition (C) in non-transfected HEK-293T cells. Data are 
shown as Mean±SEM.*P<0.05 compared to control 0Cl-.  n=3 for each condition, 
paired observations. 
 
 
 
To further investigate the role of CK2 in the regulation of AE2 activity, mAE2 
transfected cells were acutely exposed to TBB in the presence of 25µM DIDS 
(Figure 5.19A). Results showed that CK2 inhibition significantly reduced mAE2 
activity, both the mean alkalinisation in response to Cl- free solution (by 
62.5±5.1%), and the rate of reacidification upon Cl- readdition by (53.3±6.9%) 
(Figure 5.19B and C), which were not significantly different compared to TBB-
induced percent inhibition of the basolateral AE activity in Calu-3 cells (Table 
5.01). This is consistent with my previous result in Calu-3 cells which showed 
that acute exposure to TBB significantly reduced the basolateral AE activity. 
This implies that CK2 plays an important role in the regulation of mAE2 activity 
under resting conditions in transfected HEK-293T cells. 
 
201 
 
-  0C
l
+D
IDS
+D
IDS
+TB
B
0.0
0.2
0.4
0.6
0.8
*
M
ea
n 
ch
an
ge
 in
 p
H
i
-
  0C
l
+D
IDS
+D
IDS
+TB
B
0.0
0.2
0.4
0.6
0.8
#
†
R
at
e 
of
 r
ea
ci
di
fic
at
io
n 
(p
H
i m
in
-1
)
6.4
6.6
6.8
7.0
7.2
7.4
7.6
7.8
8.0 0Cl-+DIDS0Cl-
HCO3-/KREBS +TBB
0Cl-+DIDS
HCO3-/KREBS HCO3-/KREBS
240s
pH
i
 
        A                                                                                       
  
 
 
 
                
 
         B                                                       C 
   
 
 
 
 
Figure 5. 19: CK2 inhibitor, TBB, significantly reduced mAE2 activity in 
transfected HEK-293T cells.  (A) Representative pHi trace showing that acute 
exposure to TBB (10μM), in the presence of 25μM DIDS, inhibited mAE2 activity in 
transfected HEK-293T cells. Summary data showing that acute exposure of 10μM TBB 
significantly reduced mAE2 activity, both the mean pHi alkalinisation in response to Cl- 
free solution (B), and the rate of reacidification after Cl- readdition (C), in the presence 
25μM DIDS, in transfected HEK-293T cells. Data are shown as Mean±SEM. *P<0.001 
compared to +DIDS, #P<0.001 compared to 0Cl-, †P<0.01 compared to +DIDS, n=7 for 
each condition, Paired observations.  
 
 
In order to further investigate the role of CK2 in the regulation of mAE2 
activity, HEK-293T cells were co-transfected with mAE2 and the alpha catalytic 
(α)-subunit of wild type (WT) CK2 (see Methods), and then cells were acutely 
exposed to 10µM TBB in the presence of 25µM DIDS (Figure 5.20A). TBB 
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significantly decreased mAE2 activity, both the magnitude of alkalinisation in 
Cl- free solution, and the rate of reacidification following Cl- readdition, in 
HEK-293T cells co-transfected with mAE2 and WT-CK2 (Figure 5.20B and C). 
Also, the TBB induced percent inhibition of mAE2 activity in co-transfected 
HEK-293T cells was equivalent to the percent inhibition observed in mAE2 
transfected HEK-293T cells, having only endogenous CK2 (Figure 5.20D and 
E). This suggests that CK2 levels were not limiting in HEK-293T cells, as 
overexpression of the active alpha CK2 subunit did not alter the ability of TBB 
to block AE2 activity. Taken together, these results clearly indicate that keeping 
CK2 in an active state plays an essential role in maintaining both the 
endogenous, as well as mAE2 activity, under resting conditions.  
 
  A 
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Figure 5. 20: CK2 inhibitor, TBB, markedly reduced mAE2 activity in HEK-293T 
cells co-transfected with mAE2 and WT-CK2. (A) Representative pHi trace showing 
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the inhibition of mAE2 activity, by acute exposure to TBB (10μM) in the presence of 
25μM DIDS, in HEK-293T cells co-transfected with mAE2 and WT-CK2. Summary of 
the effect of acute exposure to the CK2 inhibitor, TBB (10μM), on mAE2 activity, both 
the mean alkalinisation in pHi in response to Cl- free solution (B), and the 
reacidification following Cl- readdition in co-transfected HEK-293T cells. Data are 
shown as Mean±SEM. B: *P<0.01 compared to +DIDS, #P<0.01 compared to 0Cl-, 
†P<0.05 compared to +DIDS, n=6 for each condition, except for 0Cl- n=4. Summary of 
the percent inhibition of mAE2 activity by acute exposure to 10μM TBB in HEK-293T 
cells co-transfected with mAE2 and WT-CK2 compared to the effect of TBB on 
endogenous CK2 in mAE2 only transfected cells, both on the mean alkalinisation in pHi 
in response to Cl- free solution (D), and the rate of reacidification upon Cl- readdition 
(E). Data are shown as Mean±SEM, no significant difference (P>0.05) compared to 
control, n=7 for mAE2 (), and n=6 for co-transfected cells (+WT-CK2). 
 
 
 
 
However, in another set of experiments HEK-293Tcells were co-transfected 
with mAE2 and the alpha subunit of CK2 containing a double mutation, V66A 
& I174A, (DM-CK2), which has previously been shown to make CK2 much less 
sensitive than WT-CK2 to TBB inhibition, without altering its catalytic activity 
(Sarno et al., 2005). Expression of the DM-CK2 mutant protein partially 
reduced the effect of TBB on mAE2 activity in co-transfected cells (Figure 
5.21A). In the presence of DM-CK2, TBB had no effect on the rate of 
reacidification following Cl- readdition, compared to the control response, but it 
still caused a significant decrease in the magnitude of alkalinisation (Figure 
5.21B and C). Interestingly, there was a significant decrease in the percent 
inhibition of mAE2 activity by TBB in HEK-293T cells co-transfected with 
AE2 and DM-CK2, both in the mean pHi change and the rate of reacidification, 
compared to HEK-293T transfected with mAE2 only (Figure 5.21D and E). This 
result suggests that having the TBB-insensitive DM-CK2 present was able to 
maintain mAE2 activity even in the presence of the CK2 inhibitor TBB.  
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Figure 5. 21: Impact of the CK2 inhibitor TBB on mAE2 activity in HEK-293T 
cells co-transfected with mAE2 and DM-CK2. (A) Representative pHi trace showing 
the effect of acute exposure to TBB (10μM) on mouse AE2 activity, in the presence of 
25μM DIDS, in HEK-293T cells co-transfected with mAE2 and DM-CK2.  Summary 
of the effect of acute exposure to TBB on mouse AE2 activity in HEK-293T cells co-
transfected with mAE2 and DM-CK2 on mean alkalinisation in pHi in response to Cl- 
removal (B), and the rate of reacidification upon Cl- readdition (C). *P<0.05 compared 
to control (+DIDS), n=9 for each condition, paired observations. TBB-induced percent 
inhibition of mAE2 activity, both the magnitude of alkalinisation in response to  Cl- free 
solution (D), and the rate of reacidification upon Cl- readdition (E) in HEK-293T cells 
co-transfected with mAE2 and DM-CK2, compared to endogenous CK2  in mAE2 only 
transfected cells. Data are shown as Mean±SEM.*P<0.05 compared to control, n=7 for 
endogenous CK2, and n=9 for +DM-CK2.    
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5.10.2  Effect of acute exposure to the CK2 inhibitor, CX4945, on mAE2 activity 
expressed in HEK-293T cells  
 
To provide further support for  CK2 regulation of mAE2  in transfected HEK-
293T cells, CX4945, another potent and selective CK2 inhibitor was tested (Kim 
and Hwan Kim, 2013). Results showed that acute exposure to CX4945 
significantly reduced mAE2 activity, in the presence of 25µM DIDS (Figure 
5.22A), both  the magnitude of alkalinisation in response to Cl- free solution (by 
34.2±7.3%), and the rate of reacidification upon Cl- readdition (by 53.6±7.8%), 
compared to the control response (Figure 5.22B and C). However, the CX-4945 
induced inhibition of mAE2 in HEK-293T cells was significantly lower than the 
CX-4945 induced inhibition of the basolateral AE activity in Calu-3 cells, both 
in the magnitude of alkalinisation and the rate of reacidification (Table 5.01). 
These results support my previous observations in Calu-3 cells, where acute 
exposure to CX4945 caused a significant decrease in the basolateral AE activity, 
but suggest that either mAE2 is less sensitive to the inhibitor. 
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Figure 5. 22: CK2 inhibitor, CX4945, significantly reduced mAE2 activity in 
transfected HEK-293T cells. (A) Representative pHi trace showing the effect of acute 
exposure to CX4945 (10μM) on mAE2 activity, in the presence of 25μM DIDS, in 
mAE2 transfected HEK-293T cells. Summary of the effect of acute exposure to 
CX4945 on mean alkalinisation in pHi in response to Cl- removal (B), and the rate of 
reacidification upon Cl- readdition (C) compared to control response. Data are shown as 
Mean±SEM. (B) *P<0.001 compared to +DIDS, (C) #P<0.001 compared to 0Cl-, 
†P<0.05 compared to +DIDS, n=9 for each condition.  
 
 
 
To investigate the effect of CX4945 further, HEK-293T cells were also co-
transfected with mAE2 and DM-CK2, and then acutely exposed to CX4945, and 
mAE2 activity studied using Cl- free solutions containing 25μM DIDS (Figure 
5.23A). Results showed that the presence of DM-CK2 partially reduced the 
ability of CX4945 to inhibit mAE2 activity as CX4945 failed to affect the mean 
change in pHi in response to Cl- free solution, and the rate of reacidification 
upon Cl- readdition (Figure 5.23B and C). Taken together, the above data 
suggest that CK2 plays an important role in the regulation of mAE2 activity in 
transfected HEK-293T cells under resting conditions, which further supports my 
previous results from Calu-3 cells. 
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Figure 5. 23: Impact of the CK2 inhibitor CX4945 on mAE2 activity in HEK-293T 
cells co-transfected with mAE2 and DM-CK2. (A) Representative pHi trace showing 
the effect of acute exposure of 10μM CX4945 on mAE2 activity in the presence of 
25μM DIDS, from HEK-293T cells co-transfected with mAE2 and DM-CK2. Summary 
of the effect of acute exposure of 10μM CK2 inhibitor CX4945 on mAE2 activity in 
HEK-293T cells co-transfected with mAE2+DM-CK2 on mean alkalinisation in pHi in 
response to Cl- removal (B), and the rate of reacidification after Cl- readdition (D). Data 
are shown as Mean±SEM. (B). No significant difference (P>0.05); n=4 for +DIDS and 
+DIDS +CX4945, and n=3 for AE2 0Cl-. 
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In order to further substantiate a role for CK2 in the regulation of mAE2, I 
performed additional experiments utilising CK2-knockout (KO) HEK-293T 
cells in which either the αCK2 subunit or the α-prime CK2-had been KO (see 
Methods for further details about these cells). For these experiments, mAE2 was 
transfected into both types of CK2-KO HEK-293T cells, and then anion 
exchange activity measured in response to a Cl- free solution in the presence of 
25µM DIDS. Results showed that mAE2 activity was significantly decreased in 
both the αCK2-KO and α-prime CK2-KO HEK-293T transfected cells, as both  
the magnitude of alkalinisation in response to Cl- free solution as well as  the 
rate of reacidification upon Cl- readdition were decreased  compared to the 
control mAE2 transfected cells containing endogenous CK2 (Figure 5.24A and 
B). Since the reduction in mAE2 activity was similar in both types of CK2 KO 
cells, this implies that αCK2 as well as α-prime CK2 subunits play equal roles in 
regulating mAE2 activity, and that maintaining CK2 in active state is essential 
for mAE2 activity. Unfortunately, double α /α -prime KO cells were not 
available for my studies. 
 
             A                                                 B 
 
 
 
 
 
 
Figure 5. 24: mAE2 activity was significantly reduced in CK2-KO HEK-293T 
cells, transfected with mAE2 compared to control mAE2 transfected cells. 
Summary of mAE2 activity in CK2-KO mAE2 transfected HEK-293T cells.  Data 
shows (A) Mean change in pHi in response to Cl- free solution, and (B) the rate of 
reacidification upon Cl- readdition. Data are shown as Mean±SEM, *P<0.05 compared 
to control mA2 transfected cells, n=4 for control,   n=7 for αCK2-KO, n=6 for αprime 
CK2-KO. 
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However, as shown in figure 5.25A and B (black bar graph), acute TBB 
exposure of α-prime CK2-KO HEK cells, transfected with mAE2, produced a 
similar level of inhibition of mAE2 activity, compared to the inhibition  in 
control HEK-293T TBB treated cells (red bar graph), both in the magnitude of 
alkalinisation, and the rate of reacidification. This result may be because TBB 
blocked the other ‘normal’ alpha CK2 subunit that is active in the α-prime cells. 
Interestingly, a very similar reduction in the rate of reacidification was observed 
in CK2-KO cells compared to that seen with TBB exposure (Figure 5.25B, 
green bar graphs vs. black and red bar graphs). However, the percent inhibition 
in the mean pHi change produced by CK2-KO cells was significantly less, 
compared to the percent inhibition caused by TBB in control mA2 transfected 
cells (Figure 5.25A, green bar graph vs. red bar graph). This apparent lack of 
inhibition might be because both CK2 α-subunits need to be KO to produce the 
same effect as TBB on mAE2 activity.  
 
           A                                                         B 
 
 
 
 
 
 
Figure 5. 25: The percent inhibition of mAE2 activity in control and CK2-KO 
HEK-293T cells. Summary of percent inhibition of mAE2 activity in control HEK-
293T cells, compared to CK2-KO HEK-293T cells with and without TBB, both in the 
magnitude of alkalinisation in response to Cl- free solution (A), and the rate of 
reacidification upon Cl- readdition (B). Data are shown as Mean±SEM, *P<0.05 
compared to control responses, n=7 for control,   n=7 for αCK2-KO, n=6 for αprime 
CK2-KO, and n=3 for αprime CK2+TBB. 
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To focus on the role of CK2 subunits in the regulation of the mAE2 activity 
further, αCK2 KO HEK-293T cells were co-transfected with mAE2 and α-CK2 
(WT-CK2), and then mAE2 activity measured in response to Cl- free solutions, 
in the presence of 25µM DIDS. Results showed that transfection of α-CK2 into 
α-CK2-KO HEK-293T cells significantly recovered mAE2 activity, as shown by 
changes in both the mean pHi response to Cl- free solutions, and the rate of 
reacidification following Cl- readdition, compared to mAE2 activity in αCK2-
KO HEK-293T cells co-transfected with empty plasmid (Figure 5.26A and B). 
Taken together, all the above data clearly indicate that CK2 is a protein kinase 
that plays a novel role in the regulation of mAE2 activity.  
 
 
 
 
            A                                                 B 
 
 
 
 
 
Figure 5. 26: mAE2 activity in α-CK2-KO HEK-293T cells cotransfected with 
mAE2 and α-CK2, compared to α-CK2-KO HEK-293T cells co-transfected with 
mAE2 and empty plasmid. Summary of the effect of transfection of mAE2 and α-CK2 
into α-CK2-KO HEK cells on mean pHi change in response to Cl free solution (A), and 
the rate of reacidification upon Cl readdition (B), compared to cells cotransfected with 
mAE2 and empty plasmid. Data are shown as Mean±SEM.*P<0.05 compared to control 
0Cl-+DIDS, n=4 for each condition. 
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5.11 Discussion 
5.11.1 Inhibition of mAE2 activity by DIDS 
 
Although HEK293 cells have a low endogenous Cl-/HCO3- AE activity (Sterling 
et al., 2002), my results showed for the first time that 25µM DIDS almost 
completely abolished this endogenous AE activity in HEK-293T cells. My 
results also showed that the mAE2 activity in transfected HEK-293T cells was 
sensitive to different concentrations of DIDS. Although 25μM and 50μM DIDS 
did not block the magnitude of alkalinisation produced by mAE2 activity in 
response to Cl- free solutions, the two concentrations significantly inhibited the 
rate of reacidification upon Cl- readdition. However, 100μM and 200μM DIDS 
caused a marked reduction in both parameters, with 200μM DIDS significantly 
inhibiting the mean alkalinisation by 57.7±5.8%. Consistent with my results, it 
has been shown that transfected murine AE2 activity was significantly inhibited 
by 68.5% at 300µM DIDS and by 74.2% by 400µM DIDS in HEK-293 cells 
(Ruetz et al., 1993). In contrast to mAE2, my previous results in Calu-3 cells 
showed that 100µM DIDS almost completely inhibited the basolateral AE 
activity (see chapter 4, section 4.2). The different sensitivities to DIDS between 
Calu-3 cells and HEK cells transfected with mAE2  might be due to differences 
in amino acid sequence between mAE2 and the human Calu-3 basolateral AE, 
particularly  with regard to the lysine-residue that DIDS forms  a covalent bond 
with, and which causes inhibition of the AE2 by DIDS (Lee et al., 1991).    
 
 
5.11.2 Role of cAMP in the regulation of mAE2 
 
Although my results clearly showed that intracellular elevation of cAMP caused 
almost complete inhibition of the basolateral AE activity in Calu-3 cells (see 
chapter 4, section 4.4.1.), mAE2 activity was not altered by an increase in 
[cAMP]i, compared to control responses. Consistent with this, it has been 
previously found that AE2 was shown to be active under cAMP-stimulated 
condition in the proximal colon of mouse (Gawenis et al., 2010). However, a 
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recent finding in our laboratory demonstrated that an increase in [cAMP]i, did 
not fully inhibit the basolateral AE activity in CFTR knock down Calu-3 cells, 
compared to WT Calu-3 cells (Garnett et al., 2011; Garnett et al., 2013). 
Therefore, one possible explanation could be the lack of CFTR expression in 
HEK-293T cells (Domingue et al., 2014).  Consistent with this, mAE2 activity 
was found to be significantly reduced (rate of reacidification following Cl- 
readdition) in HEK-293T cells cotransfected with mAE2 and CFTR, compared 
to control responses. This implies that CFTR was required to enable cAMP to 
inhibit mAE2 activity. Exactly how this occurs is not known. Furthermore, Epac 
inhibition did not affect mAE2 activity in HEK-293T cells cotransfected with 
mAE2 and CFTR, which suggests that the presence of CFTR potentially 
abolished the effect of Epac inhibition on the mAE2 activity, because I have 
shown that Epac inhibition caused a marked decrease in the rate of 
reacidification produced by mAE2 activity in transfected HEK-293T cells, 
compared to untreated cells. The underlying mechanism for the effect of CFTR 
expression is not known, but Epac is known to interact with CFTR (Sun et al., 
2000; Hochbaum et al., 2011), and therefore overexpression of CFTR could 
potentially lead to Epac ‘depletion’ inside HEK-293T cells. However, I would 
have predicted that if this was case then this would lead to a reduction in mAE2 
activity, similar to Epac inhibition itself.  
 
 
5.11.3 Role of CFTR in regulating mAE2 activity  
 
It is well known that there is a physical and functional interaction between 
CFTR and several members of the SLC26A family of Cl-/HCO3- AE (Ko et al., 
2004) present in the apical membrane of many epithelial cells. A recent study by 
Garnett et al., (2011) demonstrated  Cl- dependent HCO3- transport across the 
apical membrane of Calu-3 cells via a CFTR-dependent anion exchanger, known 
as Pendrin (SLC26A4) (Garnett et al., 2011). However, most recently, Kim et 
al., (2014) found that CFTR is the predominant pathway for HCO3- secretion in 
Calu-3 cells (Kim et al., 2014). This apparent difference in interpretation is not 
resolved but maybe due to differences in methodologies between our lab and 
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theirs. In addition, it has been shown that heterologous expression of CFTR in 
HEK-293 cells caused a significant increase in Cl- and HCO3- dependent 
transport, as substitution of a Cl- free solution caused an increase in pHi, under 
Fsk stimulated conditions (Ko et al., 2002). However, we have also shown that 
CFTR can also regulate the basolateral AE activity through an unknown 
mechanism. Consistent with this finding, my results showed that CFTR 
transfection caused a significant increase in mean pHi change in response to Cl- 
free solution, and the rate of reacidification following Cl- readdition in HEK-
293T cells, under Fsk stimulated condition, which was almost completely 
inhibited by the CFTR pore blocker GlyH-101. Also, the mean pHi change in 
response to Cl- free solution was significantly larger in CFTR transfected HEK-
293T cells, compared to non-transfected cells. Surprisingly, CFTR transfection 
into HEK-293T cells also produced an increase in HCO3- transport, under 
resting (non-cAMP stimulated) conditions, which was also significantly reduced 
by the specific CFTR inhibitor, CFTRinh-172. This result suggested that CFTR 
was fully active in HEK cells in the absence of exogenous cAMP agonists. One 
possible explanation for this might be that under resting conditions, HEK-293T 
cells have enough intracellular cAMP to activate CFTR which has been 
observed by others (Caci et al., 2003; Moran and Zegarra-Moran, 2005). In 
addition, both CFTR inhibitors, GlyH-101 and CFTRinh-172 did not affect 
mAE2 activity in transfected HEK-293T cells, which is consistent with my 
previous results in Calu-3 cells where GlyH-101 did not affect the basolateral 
AE activity. 
 
 
5.11.4 Role of Ca2+ and CaM in the regulation of mAE2 activity  
 
My work is the first to assess the effect of changes in resting Ca2+ concentration 
in the regulation of mAE2 activity in HEK-293T cells. In BAPTA-AM loaded 
HEK-293T cells, mAE2 activity was significantly decreased, both in the 
magnitude of alkalinisation in response to Cl- free solution, and the rate of 
reacidification upon Cl- readdition, compared to untreated cells. Consistent with 
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this,  Chernova et al., (2010) have also shown that chelation of intracellular Ca2+  
by BAPTA-AM significantly reduced the Cl-  transport by murine AE2, when 
expressed in Xenopus oocytes  (Chernova et al., 2003).This is consistent with 
my previous results in Calu-3 cells (see chapter 4, section 4.6.1.2.), and further 
supports an important role for normal intracellular Ca2+ concentration to 
maintain the resting activity of AE2. In addition, inhibition of CaM caused a 
marked reduction in mAE2 activity in HEK-293T transfected cells, both in the 
magnitude of alkalinisation and the rate of reacidification. A very similar level 
of inhibition was observed in Calu-3 cells. Consistent with this, Stewart et al., 
(2007) and Chernova et al., (2010) demonstrated that mouse AE2 was inhibited 
by the calmodulin inhibitor, calmidazolium, when expressed in Xenopus oocytes 
(Chernova et al., 2003; Stewart et al., 2007). Collectively, these results indicate 
that CaM maintains normal AE2 activity potentially through a Ca2+-dependent 
pathway, under resting conditions. It has been shown that inhibition of CaM-
dependent kinase, CaMKII, did not affect the murine AE2 activity in transfected 
Xenopus oocytes (Stewart et al., 2007), and my previous results in Calu-3 cells 
showed that inhibition of CaMKI, CaMKII, and CaMKIV were not involved in 
the regulation of the basolateral AE activity (see chapter 4, section 4.7.2-3).  
Since there is no stable interaction between CaM and murine AE2 (Chernova et 
al., 2003), it would be of interest to investigate the role of CaM-dependent 
kinases, CaMKI, CaMKII, and CaMKIV, in the regulation of mAE2 activity in 
HEK-293T cells. 
 
 
5.11.5 Role of PP1 in the regulation of mAE2 activity 
 
As described in chapter 4, inhibition of PP1/2A in Calu-3 cells markedly 
reduced basolateral AE activity. Here, I have also shown that treating mAE2 
transfected HEK-293T cells with okadaic acid caused a significant decrease in 
the mean pHi response to a Cl- free solution. This further support the role of 
dephosphorylation in the regulation of mAE2 activity by PP1/2A, potentially as 
a downstream target of CK2, because it has been shown that CK2 plays a critical 
role in the phosphorylation and activation of PP1 (Van Eynde et al., 1994). 
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Further experiments are therefore required to fully deduce the role of PP1 
signaling in regulating mAE2 activity, such as (i) testing mAE2 activity in cells 
treated with TBB and OA (ii), assessing mAE2 activity in PP1 KD cells. 
 
 
5.11.6 Role of CK2 in the regulation of mAE2 activity  
 
This is the first study to demonstrate that CK2 regulates mAE2 anion exchange 
activity in transfected HEK-293T cells. Interestingly, acute TBB exposure 
significantly reduced mAE2 activity, both the mean alkalinisation in response to 
Cl- free solution, by 62.5±5.1%, and the rate of reacidification upon Cl- 
readdition by 53.3±6.9% following Cl readdition. Also, acute exposure by 
another CK2 inhibitor, CX4945, caused a significant decrease in mAE2 activity, 
both the mean change in pHi in response to Cl- free solution by 34.2±7.3%, and 
the rate of reacidification upon Cl- readdition by 53.6±7.8%, compared to 
control, untreated responses. This is consistent with my previous results in Calu-
3 cells, which showed that acute exposure to both TBB and CX4945 
significantly reduced basolateral AE activity. However, CX4945 was 
significantly more effective in inhibiting the basolateral AE activity in Calu-3 
cells than mAE2 activity in HEK-293T cells. The reason for this is unknown but 
may be due to species differences (human vs mouse). Nonetheless, the CK2 
inhibitor data supports a novel role for CK2 in the regulation of mAE2 activity 
under resting conditions. Moreover, co-transfection of HEK-293T cells with 
mAE2 and WT-CK2 did not affect the TBB induced inhibition of mAE2 
activity, compared to mAE2 transfected HEK-293T cells expressing only 
endogenous CK2. However, co-transfection of HEK-293T cells with mAE2 and 
DM-CK2, a mutant that is much less sensitive to TBB inhibition (Sarno et al., 
2005), partially overcame the inhibitory effect of TBB. In addition, the presence 
of DM-CK2 partially prevented the ability of CX4945 to inhibit mAE2 activity, 
particularly in the mean pHi change in response to Cl- free solution. This implies 
that the presence of DM-CK2 in the transfected HEK293T cells potentially 
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blocked the inhibitory effect of CK2 inhibitors on mAE2 activity, which further 
supports a role for CK2 in the regulation of AE2 activity. 
  
Further support for a role of CK2 in regulating anion exchange activity, came 
from results where mAE2 transport was measured in CK2-KO HEK-293T cells 
(αCK2-KO and α-prime CK2-KO), which showed that mAE2 activity was 
significantly decreased, both in the magnitude of alkalinisation in response to Cl- 
free solution, and the rate of reacidification upon Cl- readdition, in both types of 
CK2-KO HEK-293T cells, compared to transfected cells with mAE2 alone. This 
strongly suggests that both catalytic subunits were involved in regulating mAE2 
activity. Interestingly, acute TBB exposure of α-prime CK2-KO HEK cells 
transfected with mAE2 produced a similar level of  inhibition of mAE2 activity 
to the TBB-induced inhibition of mAE2  in wild type HEK-293T transfected 
cells, both in the magnitude of alkalinisation and the rate of reacidification. This 
indicates that TBB potentially blocked the alpha subunit in α-prime CK2-KO 
HEK cells. Moreover, the percent inhibition of mAE2 activity by TBB in normal 
HEK293T transfected cells was significantly greater than the inhibition of 
mAE2 activity in CK2-KO cells, at least with regard to the mean pHi change in 
response to 0Cl-. This result might be due to the fact that both α-CK2 subunits 
need to be KO to produce the same effect as TBB on mAE2 activity.  To further 
support this hypothesis, α-CK2 KO HEK-293T cells were cotransfected with 
mAE2 and α-CK2, and results showed that mAE2 activity was significantly 
recovered, both in the mean pHi change in response to Cl- free solution, and the 
rate of reacidification following Cl- readdition, compared to control co-
transfected cells with mAE2 and empty plasmid. Taken together, all the above 
data clearly indicate that CK2 plays a critical role in the regulation of mAE2 
activity under resting conditions.  
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The key findings of this chapter are summarized below: 
 
• HEK293T cells express an endogenous Cl-/HCO3- AE activity that can be 
effectively inhibited by a low concentration of DIDS, and which is regulated by 
endogenous CK2.  
• Heterologous expression of mouse AE2 confers a robust Cl-/HCO3- AE activity 
which is blocked by DIDS in excess of 25 µM. 
• mAE2 was not inhibited by an increase in [cAMP]i in HEK-293T cells, but 
mAE2 activity was significantly reduced by cAMP in mAE2/CFTR 
cotransfected cells. 
• Epac plays an important role in the regulation of the resting level of mAE2 
activity. 
• A decrease of cytosolic Ca2+ caused a marked reduction in mAE2 activity, as did 
the inhibition of calmodulin. 
• CK2 (both catalytic subunits) plays a novel and essential role in the regulation 
of mAE2 activity in HEK-293T cells. 
 
Table 5.01 shows the summary of percent inhibition in AE2 activity, by 
different pharmacological agents, in HEK-293T cells and Calu-3 cells: 
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Table 5.1: Summary of percent inhibition in AE2 activity, by different 
pharmacological agents, in HEK-293T cells and Calu-3 cells. *P<0.05 significant 
difference compared to results in Calu-3 cells.  
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Chapter 6 Concluding Discussion 
6.1 Summary of main findings 
The aim of the current work was to investigate the signalling mechanisms that 
regulate the CFTR-dependent apical Cl-/HCO3- anion exchanger, as well as the 
basolateral Cl-/HCO3- AE, in  a model human  airway cell line, which secretes a 
HCO3- rich fluid in response to an increase in [cAMP]i. I have utilized a 
dynamic, non-invasive, method to study the activity of the apical and basolateral 
exchangers independently, using polarized cultures of human airway Calu-3 
epithelial cells combined with real-time pHi measurements. This experimental 
set up is representative of the physiological condition, and thus makes the 
findings potentially transferable into an in vivo setting. I have also investigated 
the properties and regulation of mAE2 (SLC4AE2) after being transiently 
transfected into the HEK-293T cells, in order to compare the properties of the 
heterologously expressed transporter with results from the cultured Calu-3 cells. 
 
 
6.1.1 Apical Cl-/HCO3- anion exchanger in Calu-3 cells 
 
The results of this current study have shown that the apical Cl-/HCO3- anion 
exchanger, known as pendrin (SLC26A4), was enhanced in Calu-3 cells by a 
variety of cAMP agonists, such as Fsk, db-cAMP and IBMX, but not by cGMP. 
The mechanism by which increased [cAMP]i mediated this stimulation  was 
assessed using a range of protein kinases inhibitors and other signalling 
molecules. Two different PKA inhibitors, H-89 and RpcAMP, markedly reduced 
the Fsk-stimulated apical Cl-/HCO3- AE activity. This provides further  support 
for an important role of PKA, as well   for a  role of CFTR in the regulation of 
this exchanger, as CFTR activity depends on PKA phosphorylation, and is 
consistent with the most recent finding by Garnett et.al., 2013 (Garnett et al., 
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2013). It also supports previous work that suggested CFTR regulates pendrin 
through a direct interaction between the two proteins via a physical interaction 
between their R and STAS domains, respectively (Dorwart et al., 2008). 
However, PKA inhibition did not fully block the apical AE activity, and I 
suspected that another cAMP-dependent pathway might be involved in the 
regulation of the apical AE activity in Calu-3 cells. My results strongly suggest 
that this was Epac, since Epac inhibition significantly reduced the activity of the 
apical AE under Fsk stimulated conditions. This implies that cAMP-stimulated 
apical AE activity is through a PKA and Epac-dependent mechanism in Calu-3 
cells. Future experiments would need to assess the effect of inhibition of both 
PKA and Epac on AE activity to confirm this.  Paradoxically, inhibition of Epac 
also enhanced the activity of the apical Cl-/HCO3- AE under non cAMP-
stimulated conditions, suggesting that Epac has a dual effect on apical AE 
activity; i.e. inhibitory when cAMP levels are low, but stimulatory when cAMP 
levels rise in response to cAMP agonists.   
Further support for a role of CFTR in regulating the apical AE activity came 
from CFTR inhibitor studies. Here the CFTR inhibitor, GlyH-101 caused a 
reduction in apical AE activity. Since GlyH-101 is a CFTR pore blocker 
(Norimatsu et al., 2012), this suggests that anion transport by CFTR plays an 
important role in the regulation of apical Cl-/HCO3- AE activity in Calu-3 cells. 
This could because Cl- efflux through CFTR provides external Cl- for the anion 
exchanger as has been suggested in pancreatic duct cells (Gray et al., 2001). My 
results are also consistent with the recent finding that the rate of apical AE 
activity was decreased in CFTR knockdown Calu-3 cells (Garnett et al., 2011). 
However, the effect of GlyH-101 on the apical AE activity was nearly abolished 
by application of DIDS to the basolateral perfusate, suggesting that the effect of 
GlyH-101 was indirect and potentially through a change in activity of a DIDS-
sensitive basolateral transporter, which was involved in pHi regulation. The 
identity of this basolateral transporter is uncertain but it could be AE2.   
However, further pharmacological and genetic studies will be necessary to gain 
a complete profile of this basolateral transporter that regulates apical AE activity 
under cAMP stimulated conditions.   
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I also found that intracellular Ca2+ plays an important role in the regulation of 
apical AE activity as BAPTA-AM markedly decreased the activity of the 
transporter. The effect of BAPTA-AM  might be due to a decrease in resting 
[Ca2+]i which could potentially block the synergistic interaction between Ca2+ 
and cAMP, that has been shown to be required for maximal stimulation of 
pancreatic ductal epithelial anion secretion (Lee et al., 2012). Paradoxically, I 
also found that an increase in [Ca2+]i, by thapsigargin, also significantly 
decreased the apical AE activity. This effect could potentially be through a 
PKA-dependent mechanism, because it has been shown that an increase in 
[Ca2+]i can inhibit the PKA- dependent signalling pathway (Santana et al., 2002) 
or even cause direct inhibition of PKA itself (Orie et al., 2009). However, it 
could also be related to a decrease in the plasma membrane levels of CFTR, 
since recent work on the effects of cigarette smoke has shown that a sustained 
increase in cytosolic calcium due to smoke exposure caused internalisation of 
CFTR (Rasmussen et al., 2014). In addition, an increase in [Ca2+]i did not 
abolish the BAPTA-AM induced decrease in the activity of the apical anion 
exchanger, but instead caused a further, and significant, decrease in apical AE 
activity, under Fsk stimulated conditions. This further decrease in AE activity 
might be because thapsigargin caused an increases in [Ca2+]i even in the 
presence of BAPTA-AM, to reduce the PKA-dependent apical Cl-/HCO3- AE 
activity. This effect of thapsigargin is supported by recent results in our 
laboratory, which demonstrated that thapsigargin produced a small increase in 
[Ca2+]i even in the presence of  BAPTA-AM in HEK-293Tcells (W. Patel, 
unpublished observations). The effects of calmodulin, and Ca2+/calmodulin 
dependent kinases on the apical AE activity were also investigated. Here it was 
found that the mechanism by which intracellular Ca2+ regulates the apical AE 
activity was not dependent on either calmodulin or Ca2+/calmodulin dependent 
kinases.    
The role of dynamin in the regulation of apical AE activity was also assessed as 
it has been shown that dynamin is a Ca2+-sensitive protein (Liu et al., 1994). 
Dynamin inhibition caused a significant decrease in the apical AE activity in 
Calu-3 cells, potentially via reducing the expression level of CFTR, and thereby 
reducing the Cl-/HCO3- exchange activity. This effect of dynamin was 
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unexpected as previous studies have shown that dynamin inhibition reduces the 
rate of endocytosis, and generally increases surface levels of transporter such as 
CFTR (Young et al., 2009). It would therefore be of interest to perform cell 
surface biotinylation in dynamin-treated Calu-3 cells to establish whether 
dynamin reduces the surface expression of apical CFTR as well as the Cl-/HCO3- 
AE. 
It should be noted, however, that dynamin inhibition blocks  the release of 
newly formed vesicles from the trans face of the Golgi complex to the plasma 
membrane (Nabi and Le, 2003; Abazeed et al., 2005; Cao et al., 2005), and it 
can also affect the kinetics of released protein into the plasma membrane 
(Anantharam et al., 2011). This therefore could provide an explanation for the 
decrease in apical AE activity. The exact mechanism how this would occur is 
unclear, but one possible explanation could be via the actin cytoskeleton, as 
there is a direct interaction between dynamin and the actin cytoskeleton (Gu et 
al., 2010). However, cytoskeleton disruption did not affect the apical AE 
activity, suggesting that dynamin regulates AE activity through a cytoskeleton-
independent mechanism.  
I also provided new evidence that CK2 also regulates apical AE activity, which 
supports previous work that showed CK2 plays an important role in HCO3- 
secretion in pancreatic duct epithelial cells, under cAMP stimulated condition 
(Treharne et al., 2009). According to sequence analysis of SLC26A4, there is a 
wide range of potential CK2 phosphorylation sites. My results showed for the 
first time that CK2 inhibition caused a marked decrease in the apical AE activity 
in Calu-3 cells, suggesting that CK2 play a novel role in the regulation of this 
transporter in Calu-3 cells. However, it will be important to establish whether 
CK2 inhibition directly affects the apical anion transporter, or whether it works 
through another protein, such as CFTR. 
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6.1.2 Basolateral Cl-/HCO3- anion exchanger in Calu-3 cells 
 
My work has been the first to demonstrate that the IC50 for DIDS inhibition of 
the basolateral Cl-/HCO3- AE activity in Calu-3 cells was about 17µM. However, 
500µM DIDS was required to fully inhibit AE activity, suggesting that other 
DIDS-sensitive transporters might be present in the basolateral membrane of 
Calu-3 cells. This could be other SLC4 family members, such as SLC4A9 (AE4) 
which has been recently found as a basolateral Cl-/HCO3- anion  exchanger in 
mouse submandibular gland acinar cells (Pena-Munzenmayer et al., 2015), or 
even other members of the SLC26 family,  such as SLC26A7, which plays an 
important role in HCO3- transport across the basolateral membrane of gastric 
parietal cells (Petrovic et al., 2003) and intercalated cells of the outer medullary 
collecting duct (Petrovic et al., 2004). SLC26A7 is expressed in Calu-3 cells (J 
Garnett PhD thesis, 2010) and is also sensitive to DIDS (Petrovic et al., 2003). 
However, the IC50 for DIDS block of the basolateral AE activity in Calu-3 cells 
was much lower than the reported IC50 for DIDS inhibition of the SLC26A7, 
which was 126µM (Petrovic et al., 2003). Also, my results showed that 
basolateral AE had a strict dependency on Cl- and HCO3-  but it has been shown 
that SLC26A7 is impermeable to HCO3- (Kim et al., 2005). Thus, my results are 
consistent with the expression of functional AE2 on the basolateral membrane of 
Calu-3 cells under resting conditions. 
In contrast to previous studies which showed that an increase in [cAMP]i had no 
effect on the basolateral Cl-/HCO3- AE activity in Calu-3 cells (Huang et al., 
2012; Shan et al., 2012; Kim et al., 2014), I have demonstrated that the addition 
of cAMP agonists Fsk, ADO, dbcAMP or IBMX almost completely inhibited 
the basolateral Cl-/HCO3- AE activity, which is consistent with the recent study 
by Garnett et al., (2013). In addition, inhibition of the cAMP efflux transporter, 
most likely MRP4, mimicked the effect of cAMP agonists on basolateral Cl-
/HCO3- AE activity in Calu-3 cells. The reasons for the different results are not 
clear but it could be due to differences in cell culture conditions or different 
batches of Calu-3 cells.  
224 
 
My work has also been the first to investigate the mechanism by which 
increased cAMP levels inhibit the basolateral AE activity, and I have shown that 
the downstream targets of cAMP, including PKA, Epac, CNG channel, and 
mTOR, are not involved in the cAMP-induced inhibition of the basolateral Cl-
/HCO3- AE activity. Interestingly, Epac inhibition caused a marked reduction in 
the basolateral AE activity under resting conditions, suggesting, for the first 
time, that Epac helps keep the basolateral anion exchanger active under resting 
conditions. Interestingly, Epac had the opposite effect on the apical anion 
exchanger where it appeared to inhibit pendrin activity under resting conditions. 
The net effect of this regulation by Epac would be to reduce the rate of HCO3- 
secretion under non-cAMP stimulated conditions. This is consistent with 
previous results from our group (Garnett et al., 2011), which showed that under 
resting conditions Calu-3 cells secrete little HCO3- into the luminal 
compartment. It is also consistent with previous results from pancreatic duct 
cells which suggested that basolateral AE2 activity is reduced after cAMP 
stimulation (Ishiguro et al., 2002). Note that I also showed that cGMP was not 
involved in the regulating basolateral Cl-/HCO3- AE activity under either resting, 
or cAMP stimulated conditions, similar to the apical anion exchangers. 
Intracellular elevation of Ca2+ did not affect the activity of the basolateral AE; 
however, intracellular depletion of Ca2+, by BAPTA-AM, caused a significant 
decrease in basolateral AE activity under resting conditions. Interestingly, I have 
shown that intracellular Ca2+ regulates the basolateral Cl-/HCO3- AE activity 
independently of cAMP. On the other hand, the absence of extracellular Ca2+ did 
not affect basolateral AE activity under resting conditions, but it did partially 
remove the cAMP-induced inhibition of this transporter. This latter effect could 
be linked to the CaSR and a change in [cAMP]i production, since cAMP 
production is decreased in the absence of extracellular Ca2+ concentration 
(Ferreira et al., 1998). A drop in cAMP would thus partially overcome the 
cAMP-induced inhibition of the basolateral AE activity. I also found that  
basolateral AE activity was significantly reduced in the absence of extracellular 
Ca2+ in ER Ca2+-store depleted Calu-3 cells, possibly through an increase in 
[cAMP]i, via store-operated cAMP production (Lefkimmiatis et al., 2009). I 
demonstrated that Ca2+/CaM dependent kinases were not involved in the 
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regulation of the basolateral AE activity under cAMP-stimulated conditions, but   
CaM inhibition itself did significantly reduce the activity of the basolateral AE, 
suggesting that decreasing [Ca2+]i potentially inhibits the activity of the 
basolateral Cl-/HCO3- AE via a CaM-dependent mechanism in Calu-3 cells. 
However, it was also shown that CaM and cAMP induce their effects on the 
basolateral AE through a separate regulatory mechanism. 
My studies also found that dynamin inhibition markedly reduced basolateral AE 
activity under resting condition, similar to the effects observed for the apical 
anion exchanger. However, unlike the effect on pendrin activity, actin 
cytoskeleton disruption significantly reduced the basolateral Cl-/HCO3- AE 
activity under resting conditions. However, neither dynamin inhibition nor 
cytoskeleton disruption had any effect on the ability of cAMP to further reduce 
the basolateral AE activity in Calu-3 cells, suggesting that cAMP works via a 
non-dynamin/cytoskeleton mechanism. 
I also demonstrated that CK2 plays an important role in the regulation of the 
basolateral AE activity in Calu-3 cells, possibly through a CaM-dependent 
mechanism since simultaneous inhibition of CaM and CK2 did not produce a 
further decrease in basolateral Cl-/HCO3- AE activity, compared to CaM 
inhibition or CK2 inhibition alone. Furthermore, my work also showed that 
PP1/2A was important in regulating basolateral AE activity, suggesting that 
CK2 may signal through a CaM and PP1-dependent mechanism, as CK2 can 
phosphorylate CaM (Arrigoni et al., 2004) and PP1 (Van Eynde et al., 1994). 
This is consistent with a recent study that  demonstrated CK2 regulates K+-
channel activity through a CaM and PP1-dependent mechanism (Kang et al., 
2014).  
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6.1.3 Regulation of mAE2 in transfected HEK-293T cells  
 
In order to provide further insights into the identity and regulation of the 
basolateral anion exchanger in Calu-3 cells, I studied the properties and 
regulation of mAE2 after transient transfection into HEK-293T cells. My work 
has further investigated the effect of different concentration of DIDS on mAE2 
in transfected HEK-293T cells. It was found that only concentrations in excess 
of 100μM and 200μM DIDS significantly reduced the activity of mAE2 in 
HEK-293T cells. Consistent with this, it has been shown that high concentration 
of DIDS significantly inhibited murine AE2 activity in transfected  HEK-293 
cells, by 68.5% at 300µM DIDS and by 74.2% at 400µM DIDS (Ruetz et al., 
1993). However, in contrast to results obtained in Calu-3 cells, elevation of 
intracellular cAMP did not inhibit mAE2 activity; the most likely explanation 
would be lack of CFTR expression in these cells (Domingue et al., 2014). 
Consistent with this, an increase in [cAMP]i caused a marked decrease in the 
rate of reacidification produced by transfected mAE2 activity in response to Cl- 
free solution in HEK-293T cells cotransfected with mAE2 and CFTR, 
suggesting that CFTR is involved in the cAMP induced inhibition of the mAE2 
activity. 
In a similar fashion to Calu-3 cells, mAE2 activity was significantly reduced by 
a decrease in [Ca2+]i and CaM inhibition, which further reinforces the finding 
that intracellular Ca2+ plays an important role in the regulation of AE2 activity, 
potentially through a CaM dependent mechanism. It was also found that Epac 
inhibition reduced mAE2 activity, and this effect could potentially be through a 
Ca2+-dependent mechanism, since it has been shown that Epac enhances Ca2+ 
release in cardiac myocytes (Oestreich et al., 2009). However, it would be of 
interest to measure [Ca2+]i in ESI-09 treated HEK-293T cells in order to 
investigate whether Epac inhibition affects intracellular Ca2+ concentration. 
Interestingly, the presence of CFTR abolished the effect of Epac inhibition on 
the mAE2 activity in HEK-293T cells cotransfected with mAE2 and CFTR, 
which might be due to the involvement of CFTR in HCO3- transport.  
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My studies have also demonstrated for the first time that CK2 play a crucial role 
in the regulation of mAE2 activity in HEK-293T cells, in a similar fashion to 
Calu-3 cells, as both CK2 inhibitors, TBB and CX4945, caused a significant 
decrease in the mAE2 activity. Interestingly, the TBB-induced inhibition of 
mAE2 activity was significantly reduced by cotransfection of mAE2 with a 
TBB-resistant CK2 mutant (DM-CK2), compared to control cells transfected 
with mAE2 alone. Most interestingly, mAE2 activity was markedly decreased in 
CK2-knockout HEK-293T cells, both in the magnitude of alkalinisation in 
response to Cl- free solution, and the rate of reacidification upon Cl- readdition, 
compared to control cells with mAE2. This effect was significantly recovered by 
cotransfection of CK2-knock out HEK-293T cells with WT-CK2 and mAE2, 
compared to control co-transfected cells with mAE2 and empty plasmid. This 
suggests that CK2 plays a novel role in the regulation of the AE2 activity both in 
the transfected HEK-293T cells and Calu-3 cells. Since inhibition of CaM and 
PP1/2A significantly reduced the activity of the transfected mAE2, CK2 
potentially control mAE2 activity via CaM and PP1 in transfected HEK-293T 
cells.  
 
6.2 Final conclusion 
The present work provides further evidence and insights into how signalling 
molecules control the CFTR-dependent apical Cl-/HCO3- AE, as well as the 
basolateral Cl-/HCO3- AE activity, under resting and cAMP-stimulated 
conditions in Calu-3 cells, and to some extent how the activity of the two anion 
exchangers are coordinated by the cell. 
In the apical membrane of Calu-3 cells, there was no apical AE activity under 
resting condition. However, elevation of [cAMP]i markedly increased apical Cl-
/HCO3-  AE activity in synergism with a normal resting concentration of 
intracellular Ca2+. The cAMP-induced activation of the apical AE activity was 
through a PKA/Epac-dependent mechanism, but did not involve Ca2+/CaM-
dependent protein kinases. CK2 inhibition did not alter the resting activity of the 
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apical AE, but markedly reduced the cAMP-stimulated apical AE (Figure 6.1, 
apical side). 
In the basolateral membrane, there was a DIDS-sensitive, Cl- and HCO3--
dependent Cl-/HCO3- AE activity under resting condition, which was almost 
completely inhibited by elevation of [cAMP]i, This cAMP-dependent inhibition 
was, however, independent of direct downstream targets of cAMP, including 
PKA, Epac, CNG channels and mTOR kinase. Under resting conditions, Epac 
was found to be required to maintain the basolateral AE activity. The resting 
activity of the basolateral AE was Ca2+ and CaM-dependent, but did not involve 
Ca2+/CaM-dependent protein kinases. My work has also suggested for the first 
time that CK2 play a novel role in regulating the resting activity of the 
basolateral AE, potentially through a CaM and PP1-dependent mechanism 
(Figure 6.1, basolateral side).  
Overall, based on the fact that basolateral DIDS significantly increased the pH, 
but not the amount of secreted fluid from Calu-3 cells under resting conditions, 
and that cAMP agonists inhibited basolateral AE activity, I conclude that the 
basolateral anion exchanger is not required for cAMP-stimulated HCO3- 
secretion. Indeed inhibiting the exchanger would be predicted to enhance HCO3- 
secretion, potentially by providing more HCO3- inside the cells and thereby 
increasing the driven force for HCO3- and fluid secretion across the apical 
membrane, where stimulation of Calu-3 cells by cAMP agonist caused a marked 
increase in both the pH and amount of secreted fluid.  
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Figure 6. 1: Current model of the regulatory pathways identified in this study 
which impact on anion secretion in Calu-3 cells. Summary of the potential 
mechanisms regulating HCO3- transport by CFTR-dependent apical Cl-/HCO3- AE, as 
well as the basolateral AE activity in Calu-3 cells. (+) Indicates stimulatory regulation, 
(-) Indicates inhibitory regulation, and (X) indicates not involved. 
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6.3 Future experiments 
In addition to the future experiments I have already described previously in 
chapters 3, 4 and 5, there are also a range of other experiments that could be 
performed in order to reinforce the conclusions from the current study, and to 
provide further information into regulation of the apical and basolateral Cl-
/HCO3- anion exchangers in airway epithelial cells. Human cell lines are only 
models of native cells, thus findings from experiments, and interpreting data 
from an immortalised cell lines, might not reveal what happens physiologically 
in vivo. It has been shown that primary serous and mucous cell cultures derived 
from  human airway glands can be produced, which resemble native serous or 
mucous cells (Finkbeiner et al., 2010). The study by Finkbeiner et al., (2010), 
showed that both cell cultures produced tight junctions become polarized, and 
generated a transepithelial electrical resistance (Finkbeiner et al., 2010). They 
also found that  in both cell types, cAMP stimulation increased short-circuit 
current, via an increase in CFTR-mediated Cl- secretion , which was inhibited by 
the CFTR inhibitor, CFTRinh-172 (Finkbeiner et al., 2010). Furthermore, the 
study by Lee and Foskett, (2010), showed that primary serous acinar cells from 
human and porcine airway submucosal glands play an important role in Cl- 
secretion, via CFTR, in response to vasoactive intestinal peptide and other 
cAMP agonists (Lee and Foskett, 2010), but HCO3- transport was not studied in 
detail. Therefore, it would be beneficial to repeat experiments on primary airway 
epithelia in order to establish whether native serous cells also express apical or 
basolateral anion exchangers, using a similar methodology outlined in this 
thesis. For instance, measurement of intracellular pH in cAMP stimulated native 
serous cells, in the presence of a CFTR inhibitor, with and without basolateral 
DIDS, in order to identify the potential role of apical and basolateral Cl-/HCO3- 
AE in the regulation of pHi and HCO3- secretion. 
Since the apical Cl-/HCO3- AE provides a CFTR-independent source of secreted 
HCO3- in airway epithelial cells, and inhibition of the basolateral AE might 
enable more HCO3- to be accumulated inside the cells via the action of the 
basolateral NBC, my results could have implications for CF, because HCO3- 
secretion is known to be defective in CF airways (Smith and Welsh, 1992). 
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Thus, it would be important to study if  apical and basolateral Cl-/HCO3- anion 
exchangers are present in native serous cells of submucosal glands from CF 
tissues or in cultured CF cell lines. In addition, cell lines such as CFSMEo- and 
6CFSMEo-, which are deltaF508 CF cell lines that do not express detectable 
CFTR protein could also be studied (da Paula et al., 2005).  
My data also suggests that bilateral Ca2+ removal partially removed the cAMP-
induced inhibition of the basolateral AE activity in Calu-3 cells, possibly 
through a CaSR-dependent mechanism. With this in mind, it would be of 
interest to investigate the expression of the CaSR in Calu-3 cells, as well as to 
determine the effect of CaSR agonists or antagonists on the basolateral Cl-
/HCO3- AE activity to gain further insights into the role of CaSR in the 
regulation of the basolateral Cl-/HCO3- AE activity in Calu-3 cells. 
The results obtained in the present study mostly involved the use of 
pharmacological agents. Therefore, it would be important to repeat some 
experiments in genetically modified Calu-3 cells in which the target protein of 
interest had been knocked down or knocked out. Specifically, CK2 knockout in 
Calu-3 cells would provide further insights into the role of CK2 in the regulation 
of apical and basolateral Cl-/HCO3- AE activity in Calu-3 cells. This could 
involve approaches to silence CK2-gene expression in Calu-3 cells, which could 
be performed by recently described technology, such as TALEN and CRISPR-
Cas9. In CRISPR-Cas9 technology, clustered regulatory interspaced short 
palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas proteins), 
endogenous to prokaryotes, are transfected into eukaryotic cells, and then Cas 
proteins unwind and split the targeted specific DNA sequences, and thereby 
inhibit gene expression (Mali et al., 2013; Qi et al., 2013). Alternatively, 
methods that targeted mRNA could also be employed to knock down protein 
expression, as we have previously described for CFTR and pendrin (Garnett et 
al., 2011; Garnett et al., 2013). 
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Appendix 
Mouse AE2 protein contains 51 CK2 phosphorylation motifs described in the 
literature, compared to 42 CK2 phosphorylation motifs in human AE2, and are 
highlighted in below diagram: 
 
 
 Mouse AE2 
MSSAPRRPASGADSLHTPEPESLSPGTPGFPEQEEDELRTLGVERFEEILQEAGSRGGEEPGRS
YGEEDFEYHRQSSHHIHHPLSTHLPPDARRRKTPQGPGRKPRRRPGASPTGETPTIEEGEEDE
EEASEAEGFRAPPQQPSPATTPSAVQFFLQEDEGAERKPERTSPSPPTQTPHQEAAPRASKGA
QTGTLVEEMVAVASATAGGDDGGAAGRPLTKAQPGHRSYNLQERRRIGSMTGVEQALLPR
VPTDESEAQTLATADLDLMKSHRFEDVPGVRRHLVRKNAKGSTQAAREGREPGPTPRARPR
APHKPHEVFVELNELLLDKNQEPQWRETARWIKFEEDVEEETERWGKPHVASLSFRSLLEL
RRTLAHGAVLLDLDQQTLPGVAHQVVEQMVISDQIKAEDRANVLRALLLKHSHPSDEKEFSF
PRNISAGSLGSLLGHHHAQGTESDPHVTEPLIGGVPETRLEVDRERELPPPAPPAGITRSKSKH
ELKLLEKIPENAEATVVLVGCVEFLSRPTMAFVRLREAVELDAVLEVPVPVRFLFLLLGPSSA
NMDYHEIGRSISTLMSDKQFHEAAYLADERDDLLTAINAFLDCSVVLPPSEVQGEELLRSVAH
FQRQMLKKREEQGRLLPPGAGLEPKSAQDKALLQMVEVAGAAEDDPLRRTGRPFGGLIRD
VRRRYPHYLSDFRDALDPQCLAAVIFIYFAALSPAITFGGLLGEKTKDLIGVSELIMSTALQGV
VFCLLGAQPLLVIGFSGPLLVFEEAFFSFCSSNELEYLVGRVWIGFWLVFLALLMVALEGSFL
VRFVSRFTQEIFAFLISLIFIYETFYKLIKIFQEHPLHGCSGSNDSEAGSSSSSNMTWATTILVPD
NSSASGQSGQEKPRGQPNTALLSLVLMAGTFFIAFFLRKFKNSRFFPGRIRRVIGDFGVPIAILI
MVLVDYSIEDTYTQKLSVPSGFSVTAPDKRGWVINPLGEKTPFPVWMMVASLLPAVLVFILIF
METQITTLIISKKERMLQKGSGFHLDLLLIVAMGGICALFGLPWLAAATVRSVTHANALTVM
SKAVAPGDKPKIQEVKEQRVTGLLVALLVGLSMVIGDLLRQIPLAVLFGIFLYMGVTSLNGI
QFYERLHLLLMPPKHHPDVTYVKKVRTMRMHLFTALQLLCLALLWAVMSTAASLAFPFILI
LTVPLRMVVLTRIFTEREMKCLDANEAEPVFDECEGVDEYNEMPMPV 
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 Human AE2 
MSSAPRRPAKGADSFCTPEPESLGPGTPGFPEQEEDELHRTLGVERFEEILQEAGSRGGEEPG
RSYGEEDFEYHRQSSHHIHHPLSTHLPPDARRRKTPQGPGRKPRRRPGASPTGETPTIEEGEE
DEDEASEAEGARALTQPSPVSTPSSVQFFLREDDSADRKAERTSPSSPAPLPHQEATPRASKGA
QAGTQVEEAEAEAVAVASGTAGGDDGGASGRPLPKAQPGHRSYNLQERRRIGSMTGAEQA
LLPRVPTDEIEAQTLATADLDLMKSHRFEDVPGVRRHLVRKNAKGSTQSGREGREPGPTPRA
RPRAPHKPHEVFVELNELLLDKNQEPQWRETARWIKFEEDVEEETERWGKPHVASLSFRSL
LELRRTLAHGAVLLDLDQQTLPGVAHQVVEQMVISDQIKAEDRANVLRALLLKHSHPSDEK
DFSFPRNISAGSLGSLLGHHHGQGAESDPHVTEPLMGGVPETRLEVERERDVPPPAPPAGITR
SKSKHELKLLEKIPENAEATVVLVGCVEFLSRPTMAFVRLREAVELDAVLEVPVPVRFLFLLL
GPSSANMDYHEIGRSISTLMSDKQFHEAAYLADEREDLLTAINAFLDCSVVLPPSEVQGEELL
RSVAHFQRQMLKKREEQGRLLPTGAGLEPKSAQDKALLQMVEAAGAAEDDPLRRTGRPFG
GLIRDVRRRYPHYLSDFRDALDPQCLAAVIFIYFAALSPAITFGGLLGEKTQDLIGVSELIMST
ALQGVVFCLLGAQPLLVIGFSGPLLVFEEAFFSFCSSNHLEYLVGRVWIGFWLVFLALLMVA
LEGSFLVRFVSRFTQEIFAFLISLIFIYETFYKLVKIFQEHPLHGCSASNSSEVDGGENMTWAG
ARPTLGPGNRSLAGQSGQGKPRGQPNTALLSLVLMAGTFFIAFFLRKFKNSRFFPGRIRRVIG
DFGVPIAILIMVLVDYSIEDTYTQKLSVPSGFSVTAPEKRGWVINPLGEKSPFPVWMMVASLL
PAILVFILIFMETQITTLIISKKERMLQKGSGFHLDLLLIVAMGGICALFGLPWLAAATVRSVT
HANALTVMSKAVAPGDKPKIQEVKEQRVTGLLVALLVGLSIVIGDLLRQIPLAVLFGIFLYM
GVTSLNGIQFYERLHLLLMPPKHHPDVTYVKKVRTLRMHLFTALQLLCLALLWAVMSTAAS
LAFPFILILTVPLRMVVLTRIFTDREMKCLDANEAEPVFDEREGVDEYNEMPMPV 
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